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Lay Summary 
A drug or treatment which perfectly cures our neighbour is not necessarily as effective for us. 
This is because each person is a combination of their genetic inheritance, lifestyle, 
microbiome, the presence or impact of other conditions and environmental influence. 
Personalised therapy could potentially offer the most efficient treatment option for each 
individual patient and can help to enhance the treatment efficacy for major diseases. To 
achieve this, clinical and diagnostic data need to be taken from specified locations in the body, 
to provide significant and specific information about the disease and the patient. For cancer, 
one important location is the microenvironment of a tumour, which includes many types of 
biochemical systems: proteins, enzymes and cells, some of which are found in varying 
amounts and with established roles as cancer signallers and thus can be used to classify 
patients. Specifically, an enzyme family, the proteolytic enzymes (called proteases), are linked 
to all steps of cancer development, spread and even suppression. Therefore, selective and 
sensitive detection of proteases inside tumours would enable increased understanding of each 
individual cancer case and inform corresponding treatment development such as radiotherapy.     
It is not however so simple to place a sensing device into the body and take continuous and 
long term measurements. First of all, the sensor should be tiny enough to avoid any damage to 
the body (implant site) or itself during surgical implantation and over the course of 
measurements. Secondly, it should be biocompatible and it is thus less affected by biofouling, 
which is the passivation of the active sensing area by fibrous capsules and proteins due to the 
immune response against foreign substances. For a biocompatible device or material, this 
immune response can be minimised and tolerated for short durations, i.e. to allow the required 
analyses to be completed.  
Accordingly, this research has investigated key developments to enable this approach; the  
effects of miniaturisation and of protection of a specific peptide-based electrochemical 
biosensor which has been developed for protease detection. Results have revealed for the first 
time that this sensing system is able to be miniaturised either using commercial 
microelectrodes or on in-house developed microelectrode and nanoelectrode arrays. Also, anti-
biofouling properties were seen to be improved by incorporating a pH-triggered dissolving 
polymeric coating which also offered controllable delayed activation. This work, in summary, 
has contributed to the development of this peptide-based electrochemical biosensor system 
and enhanced its potential for application as an implanted biosensor.  
iv 
Abstract 
There is real interest in developing selective and sensitive tools to detect protease activity; 
these play pivotal roles in cancer progression with changes in their amounts and types linked 
to several pathological processes such as tumour formation, evolution and even suppression. 
Peptide-based electrochemical assays have been shown to offer several potential advantages 
over other tools and techniques for development into sensing systems. However, their 
implantation and use in vivo is complex as they face serious limitations when considering two 
vital requirements for implantation: sensor miniaturisation for ready implantation and 
localised measurement and controlled anti-biofouling protection. This study presents the 
investigation and analysis of these miniaturisation- and protection-related issues and the 
development of solutions as key steps towards the localised in vivo application and 
measurements.   
 
The first part of the presented work focuses on the potential for assay miniaturisation. This 
used commercial platinum microelectrodes which were modified with self-assembled 
monolayer (SAM)-based protease sensing probes. Building on previous macroelectrode 
studies, which have explored and optimised the use of different SAM structures, redox 
labelling, anchor type and various spacers of different lengths, further optimisation was carried 
out with the aim of developing and defining an optimum microelectrode protocol. Comparison 
of the quantitative analytical performance of macro- and microelectrode systems established 
the feasibility of developing miniaturised platforms for efficient and clinically-relevant 
protease detection. Interestingly, significant differences were observed such as an enhanced 
reproducibility and decreased cleavage rate for the microelectrodes, which were thought to be 
indicative of variation in the SAM probe film structure on these electrode surfaces caused by 
differences in film deposition kinetics. This decreased cleavage (response) rate was mitigated 
by measurement at normal body temperature which was shown to increase kinetics and 
suggested the possibility of more rapid in vivo sensing. 
 
These miniaturisation findings on commercial microelectrodes were translated to in-house 
microelectrodes fabricated as platinum thin film-on-silicon chips. Initial results showed 
reduced SAM probe stability. As the use of stronger SAM probe anchoring (through tripod-
anchored probes) did not solve this problem, the underlying reason was attributed to structural 
differences between  the surfaces of commercial and in-house electrodes, resulting in enhanced 
Pt detachment in the latter. Increasing metal film thickness and post-fabrication annealing did 
v 
not completely overcome this problem, and the remaining decrease in stability was attributed 
to increased Pt surface roughness and destabilisation through successive electrochemical 
oxidation and reduction during acidic cleaning. An alternative electrochemical reductive 
cleaning method was thus developed and tested on enhanced electrode sensing  systems; arrays 
of microelectrodes (MEA) and microcavity nanoband edge electrodes (MNEE) were 
fabricated, cleaned using this reductive method, characterised using typical redox couples and 
then tested for protease sensing. Gratifyingly, these systems were found to be sufficiently 
reproducible and stable for sensing. Although functionalised MNEEs achieved significantly 
higher current densities, there was no great enhancement of response rate from decreasing 
electrode size from micro to nano, consistent with the fact that diffusional  transport is not the 
rate determining step in this cleavage reaction. Given the variability of probe film deposition 
characteristics and the resulting cleavage rates, the applicability of potential-controlled SAM 
probe deposition for controlling probe film formation was investigated as a proof-of-concept 
study.  
 
The second part of this work concentrated on the development of a sensor protection and 
activation strategy against biofouling. A pH-triggered dissolvable polymeric coating was drop-
cast onto clean and probe-modified electrodes and then characterised in terms of the delayed 
activation time, enhancement in anti-biofouling properties and retention of sensing 
characteristics. These results demonstrated that reproducible delayed sensor activation was 
achieved and controlled by optimising parameters such as coating thickness, homogeneity and 
density through the coating method and temperature. Comparative evaluation of polymer-
coated and uncoated probe-modified electrodes in a biologically relevant medium also 
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1.1 Motivation   
All humans are different. Each person is specified by a combination of genetic inheritance, 
lifestyle and environment. It is also the main reason why people exhibit dissimilar health 
conditions during their life such as having particular diseases, different responses to the same 
therapy and varying recovery rates. Personalised therapy (also called as personalised 
medicine) aims to deliver the optimum and the most efficient treatment to each patient, 
identified by extensive analysis of clinical and diagnostic data sets in combination with 
genomic information [1]. Although it is only a few decades old, it has been already established 
that personalised therapy improves the chances of a cure in major diseases such as cancer, 
where early diagnosis and informed treatment have the most significant effect on survival [2]. 
A personalised therapy plan for preventing, monitoring and treating cancer usually consists of  
(i) estimating the potential of developing cancer 
(ii) finding the most appropriate techniques/strategies to minimise additional 
risks  
(iii) comparative analysis of the group of people showing similar 
monitoring/screening to select the most effective treatment with the lowest 
side effects  
(iv) determination of recurrence possibilities to inform longer term monitoring [3].  
However, the rapidly changing and heterogeneous nature of the cancerous tumour 
microenvironment is a challenge for the determination of an optimal therapy procedure. This 
characteristic feature of tumours requires monitoring their real time status in terms of localised 
and transitory changes in such factors as hypoxia, pH and key biomarkers which are expected 
to show whether and how tumours will respond/have responded to courses of radiotherapy 
and/or chemotherapy [4]. In the light of the knowledge that proteolytic enzymes, also called 
proteases, are one of the key biomarkers found in tumour microenvironment and are related to 
all stages of cancer formation and progression [5], development of selective and sensitive 
detection tools are needed to investigate and understand protease activities and how these 
relate to cancer progression and diagnosis.  
The latest developments in protease assays, employing peptide-based electrochemical 
biosensors prepared using self-assembled monolayers (SAMs) on electrode surfaces, have 
attracted widespread attention [6]. Despite peptide-based electrochemical protease assays have 
been shown to offer sensitive and rapid responses, it was emphasised that there is still an unmet 
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need of the biosensor development for disease-related proteases, in addition to commonly used 
models, and the characterisation of their feasibility/performance as well as corresponding 
interference-related challenges in a complex biological environment [6]. Previous background 
works showed the sensitive detection of trypsin in a buffer including some protein-based and 
ionic interferents [7], and the activity of polymorphonuclear neutrophil directly from blood 
samples [8]. This demonstrates their great potential in personalising the therapy by 
undertaking a pivotal role in unravelling the complicated protease-tumour connections. This 
study thus concentrates on the production of useful miniaturisation and protection strategies 
to enhance the development of peptide-based electrochemical biosensor systems further, bring 
them closer to implantation and in vivo biosensing. Beyond this, it is believed that the validity 
and relevance of this study’s findings with prospective electrochemical biosensor research 




Figure 1-1: Schematic illustration of using implantable biosensors for personalised therapy. 
Implantable biosensing devices enhanced with effective miniaturisation and protection strategies can 
enable in vivo measurements, deliver these valuable clinical and diagnostic data to the clinicians and 
the most efficient treatment can then be applied to each specified patient.    
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1.2 Problem Statement   
Developing an electrochemical peptide-based protease sensor system which can be implanted 
into a solid tumour and successfully measures time-dependent changes in protease quantity 
and activity would promote the personalisation of cancer therapy markedly. However, two 
main concerns for an implantable sensor project need to be addressed:  
 
Miniaturisation   
An implantable biosensor should be as small as possible. This is vital in order to ease the pain 
of the implantation process, to minimise the possibility of damage to the targeted tissue or 
sensor platform, to enable local measurement and to reduce the extent of local wound 
healing/foreign body response [9]. Production of electrodes in smaller dimensions (scaling-
down) is a requirement for the miniaturisation of an electrochemical biosensor and it is also 
very effective for the sensor performance [10]. Luckily, state of the art microfabrication 
techniques enable and extend the use of micro- and nanoelectrodes in medical applications. In 
addition, more numbers of electrodes with smaller dimensions can be patterned (in arrays) 
onto a defined substrate area compared to larger electrodes, which will eventually contribute 
to the multiplexed measurement opportunities (of control samples and other target analytes). 
However, it should be noted that arrays have bigger footprints and their use might result in 
increases in the biosensor dimensions. Therefore, the electrode design needs to be optimised 
carefully, considering all these possible impacts. The kinetics, for example, is another variable 
which might be seriously affected due to the changes in mass transport when chemical 
recognition (sensing) elements are immobilised on smaller electrode surfaces. It is also worth 
noting that there are not enough settled models of the formation and re-organisation of SAM-
based recognition probes, although SAMs have been studied for a long time and pretty much 
explored [11]. This might lead to more questions to appear, especially when the recognition 
elements are immobilised onto a minimised electrode region via self-assembly. Furthermore, 
electrode/substrate material used for the fabrication/miniaturisation of biosensors is vital and 
it should be cost-efficient, sensitive, biocompatible and ease of use (and access) [12]. Although 
gold (Au) is known as the most common substrate for SAMs of thiols, platinum (Pt) is 
preferred for long-term implant applications lately due to less corrosion observed compared to 
Au [13]. This requires comparative analysis of Au and Pt electrodes to understand which 
provides more feasibility for SAM-based recognition elements.        
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Biocompatibility  
The second major concern for an implantable biosensor is foreign body response (FBR) which 
may arise in a combination of short term (non-specific protein adsorption, acute inflammation) 
and long term effects (biofouling). Although these have been found to influence any implanted 
material (more or less depending on a biocompatibility characteristics), even short term effects 
will be most likely deteriorating for an (electro)chemical biosensor. Because even if a number 
of electrochemical biosensor systems does not consist of an open and active recognition layer 
directly interacting with environment (but mostly they do), fibrous encapsulation as a long 
term effect of FBR, will be fatal for the detection inhibiting their access to targeted analytes. 
Accordingly, a sensor system employing redox tag-labelled SAM-functionalised peptides 
immobilised onto an electrode surface as the recognition element will specifically need a 
strategy which can maintain in vivo sensing, whilst being less/no affected by biofouling.  
 
1.3 Objectives  
This PhD study has targeted to address the problems stated in the previous section by;  
• Developing a peptide-based electrochemical biosensor for detection of trypsin using 
conventional bulk platinum microelectrodes and investigating the effects of electrode 
miniaturisation on sensor performance in comparison to the gold and platinum 
macroelectrode-based sensing platform  
 
• Translating the optimised sensor to in-house fabricated thin film platinum micro- and 
nanoelectrode architectures on silicon chips 
 
• Evaluating the impact of potential-assisted SAM probe deposition method in terms of 
preparation time and sensor performance  
 
• Analysing the feasibility of pH-responsive dissolvable polymeric coatings for delayed 
activation and biofouling protection of electrochemical protease and pH biosensors  
Accordingly, this study aims to explore the feasibility of an optimised and miniaturised 
electrochemical protease biosensor which is protected and then activated by a pH-dissolvable 
polymeric coating.    
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1.4 Thesis Outline  
This thesis consists of eight chapters in total focusing on background and theory, experimental 
methods for preparation and analysis, optimisation, characterisation and derived conclusions 
with some suggestions of future work.  
Chapter 2 presents background information on cancer, the significance of the tumour 
microenvironment for cancer monitoring and the employment of biosensors for this purpose. 
Also, this is a literature review of the challenges and limitations of in vivo biosensing and a 
number of biosensor protection technologies. The theoretical perspective is also given of 
electrodes, electrochemical techniques and enzyme kinetics.    
Chapter 3 describes the several experimental methods and procedures used for the synthesis 
of sensing probe molecules, electrode fabrication, biosensor preparation and electrochemical 
characterisation.   
Chapter 4 firstly introduces the principle for peptide-based electrochemical protease detection, 
summarising background information on optimisation and characterisation of the proposed 
system developed using conventional gold macroelectrodes. New experimental findings 
obtained using conventional platinum macro- and microelectrodes are then presented to unveil 
the differences in sensor performances between platinum macro- and microelectrode-based 
systems, for the first time. They are investigated in terms of the variations in the probe 
conformation on electrode surface, kinetics and thermodynamics of enzyme-substrate 
cleavage and the effects of non-specific binding. 
Chapter 5 analyses the similarities and dissimilarities in biosensor performance while the 
protease sensing system is further miniaturised by translating from using conventional 
microelectrodes to employing novel platforms: in-house fabricated platinum thin film single 
microelectrodes, microelectrode arrays (MEA) and microcavity nanoband edge electrode 
arrays (MNEE). The efficiencies of some proposed solutions to an experienced stability 
problem of sensing probe molecules on thin film electrode surfaces are also examined.  
Chapter 6 investigates the feasibility of a proof of concept work where self-assembled 
monolayer based sensing probe molecules are immobilised onto electrode surfaces in minutes 
by a potential-assisted technique, in comparison to the overnight incubation which is a 
common procedure performed without any external interference.    
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Chapter 7 explores the applicability of commercial pH-responsive transient polymeric coatings 
to the protease and pH biosensor platforms for delayed activation and protection against 
biofouling. The optimisation and performance of these coatings are investigated using bare 
and probe-functionalised electrodes. 
Chapter 8 gathers the findings and contributions of this work and suggests development work 
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2.1 Cancer and Tumour Microenvironment  
Cancer can be simply defined as uncontrolled growth and reproduction of abnormal cells in 
the body. It is one of the major diseases today, as this growth can spread and be fatal when it 
is not effectively treated. World Cancer Report 2014 which was prepared by the International 
Agency for Research on Cancer (IARC) designated it as a leading cause of deaths worldwide, 
and estimated an increase in the number of annual diagnosed cancer cases from 14 million to 
22 million within the next two decades [14]. It is also predicted that more than half of the 
people born in the United Kingdom after 1960 will be diagnosed with cancer at some point 
during their lifetimes [15]. According to the recent report of American Cancer Society, more 
than 1.7 million diagnosed new cancer cases and 0.6 million deaths caused from the cancer-
related reasons are expected to occur in 2019 in the United States [16]. Figure 2-1 presents the 
list of these estimated numbers of new diagnosed cases and deaths classified according to a 
specific cancer type. This shows that prostate, lung & bronchus and colon & rectum cancers 
are the three leading types of new estimated cases for men, with prostate cancer being replaced 
by breast cancer in women.   
 
The features which lead to cancer formation can be environmental and/or inherited. Despite 
these huge estimated new case numbers and fatality rates, nearly half of the diagnosed cases 
are thought to be avoidable and/or preventable as it is now known that the main reasons are a 
Figure 2-1: Estimates of new cancer cases and deaths expected to occur in the United States in 2019 [16].  
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combination of smoking, obesity, physical inactivity, too much consumption of alcohol and 
unprotected exposure to sunlight UV as well as some viruses and bacteria [16]. This is also 
confirmed by the decreasing rates of new cases and deaths associated with lung, bladder and 
larynx cancers consistent with reduced tobacco use, while the rates are increasing for other 
types such as uterus, postmenopausal breast, and colorectal cancers which are related to excess 
weight and physical inactivity in recent decades [17].  
Notwithstanding this, it is unlikely that action to address such issues will be completely 
effective to prevent all cancers. Hanahan and Weinberg have suggested six different 
capabilities which tumours acquire during cancer development and it is thought that these 
capabilities most likely exist in all types of human tumours [18]. These include self-sufficiency 
in growth signals, insensitivity to growth-inhibitory signals, evasion of apoptosis, limitless 
replicative potential, sustained angiogenesis and tissue invasion and metastasis [18]. Self-
sufficiency in growth signal can be described as the independency of growth signals produced 
by tumours themselves, instead of being depended on the signal generation stimulations 
applied for healthy tissue. In addition to the generation of their own growth signals, they need 
to avoid growth-inhibitory signals in order to maintain proliferation. Apoptosis is a controlled 
cell death mechanism, which normally takes place to avoid an uncontrolled growth in cell 
populations and to secure sustainability. This is resisted by tumours e.g. by having a phenotype 
of unlimited replicative potential which can make tumour cells immortal. This resistance can 
be also contributed by angiogenesis (the formation of new blood vessels) which results in the 
supply of vital oxygen and nutrients to maintain cell growth, tissue invasion (direct tumour 
extension into neighbouring tissues) and metastasis (the spread of tumour cells to distant sites 
of the body through the lymphatic and/or circulatory system). After a decade, a follow-up 
study added two more significant further attributes to this list, the reprogramming of energy 
(glucose) metabolism and evading immune destruction [19]. The analysis of these capabilities 
reveals the complexity and significance of the tumour microenvironment. As defined by 
angiogenesis, blood vessels of tumours develop to supply oxygen and nutrition from normal 
neighbouring cells. However, tumour cells proliferate faster than normal cells in the body and 
this still causes the consumption of this supply after some time and in some areas. This 
eventually results in hypoxic (oxygen-deficient) regions within the tumour microenvironment 
and these regions have been shown to be radiotherapy- and chemotherapy-resistant [20]. The 
correlation between this lower oxygenation level and reduced prognosis associated with the 
condition of tumour after radiotherapy, surgery, chemotherapy or radiosensitizer processes 
was studied for patients diagnosed with head and neck cancer [21], [22]. In addition to 
hypoxia, lower extracellular pH and glucose levels in tumours can also offer further local 
 
  11 
variations compared to normal tissue [23], [24]. The complexity of tumour microenvironments 
is not only promoted by these differences, but there are also many cell types, which are 
effective in the processes related to cancer progression, such as cancer cells and cancer stem 
cells, neutrophils, mast cells, endothelial cells, pericytes, fibroblasts, platelets, macrophages 
and lymphocytes (Figure 2-2) [25], [26]. All these cell types found in the tumour 
microenvironment have specific links to many different states of the cancer formation and 
progression. For example, cancer and cancer stems cells have oncogenic mutations to initiate 
tumour formation, neutrophils have been found to be increased in colon, gastric and lung 
cancer as well as being shown to increase metastasis in animal models, endothelial and mast 
cells correlate with poor prognosis, pericytes are vital for sustainability of blood vessels, 
fibroblasts are tumour promoters in later stages, platelets are excessively observed in 
malignant tumours and lymphocytes (T, B and NK cells) have varying effects for the immune 
system – cancer relationship [26].   
 
This tumour microenvironment, as illustrated in Figure 2-2, also includes proteolytic enzymes 
(proteases) which catalyse proteolysis, defined as the cleavage of proteins into smaller peptide 
chains or amino acids. They are grouped into five different main classes: serine, cysteine, 
Figure 2-2: Schematic illustration of the complex tumour microenvironment [25]. 
 
  12 
aspartic, threonine and metalloproteinases. As they play significant roles in the activity and 
interactions of proteins, they are vital elements in many physiological and pathophysiological 
conditions such as DNA replication/transcription, cell proliferation/differentiation, 
angiogenesis, ovulation, fertilization, wound repair, haemostasis, blood coagulation, 
inflammation, autophagy, necrosis, apoptosis and many others [27]. Correspondingly, they are 
also associated with cancer with essential influences in all tumour progression steps, tumour 
formation, growth, metastasis and invasion [28]. The most significant members of the protease 
family which have direct links to cancer have been identified as [28];  
• Caspases, as they are closely related to apoptotic cell death [29]  
• Cathepsins, due to their links to prognosis, malignancy and metastatic potential [30]–
[32] 
• Matrix metalloproteinases (MMPs), being responsible for peritumour tissue 
degradation and metastasis formation [33] 
• Urokinase-type plasminogen activator (uPA), associated with frequent and earlier 
metastatic interactions, especially in prostate cancer [34], [35].  
Furthermore, other proteases, not only the ones detailed above, might have important links to 
cancer, such as trypsin, which is a serine type digestive enzyme, found to be involved in 
colorectal carcinogenesis, promoting proliferation, invasion, metastasis and thus leading to 
poor prognosis and shorter disease-free survival [36].  
Figure 2-3 shows some examples of individual proteases which have interactions with 
different cell types found in tumour environment. On the other hand, recent studies revealed 
that more than 30 proteases which belong to three different main groups have also tumour-
suppressive effects, including induction of apoptosis (by caspase 3, 5, 6, 7, 8, 10), activation 
of autophagy (the controlled mechanism for the removal of useless or dysfunctional 
components in a cell) (by autophagin 3), angiogenesis inhibition (by MMP19, gelatinase B, 
ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs, 1, 8, 9, 15, 18) 
and inhibition of proliferation (by cathepsin L, ras-converting enzyme 1) [37].     
Therefore, considering its unstable and variable characteristics compared to normal tissue, the 
tumour microenvironment (and the above detailed proteases) can be introduced as key players 
in developing personalised treatment of cancer patients [38], [39].   
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2.2 Biosensors 
A chemical sensor can be described as a self-contained device which enables real-time analysis 
of a test sample and provides information (a signal) in terms of the amount (concentration) of 
a targeted chemical substance (termed as the analyte) in the sample [40]. As depicted in Figure 
2.4, a chemical sensor consists of two main elements; (1) a recognition element which interacts 
with the analyte and this interaction results in a change in physical and/or chemical properties 
depending on the concentration of the analyte and this change is translated by (2) a 
transduction element that converts the resulted change to another detectible/measurable 
quantity (the signal).   
Figure 2-3: Major cell types and contributing proteases found in the tumour microenvironment [28].  
Figure 2-4: Schematic illustration of a chemical sensor, an assembled device consisting of two main 
components, a recognition and a transduction element in order to interact with a target analyte.  
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When the recognition system of the sensing device is based on a biochemical or biological 
analyte, the term biosensor is often used instead of the term chemical sensor and the 
recognition element is a biorecognition element (or bioreceptor) [40]. The range of 
applications for biosensors is extremely broad [41] and it can include disease diagnosis and 
monitoring [42], environmental monitoring [43], drug discovery [44], food quality [45] and 
toxicology analysis [46]. The most appropriate recognition and transduction methods can be 
determined from the many possibilities and then optimised for the desired application. 
Biological systems such as enzymes, peptides, cells, aptamers and DNAs have been used as 
biorecognition elements in many studies. This builds on natural selection which results in 
specific and sensitive biorecognition elements for a biological analyte. The biorecognition and 
selectivity can be based on a combination of different types of chemical/biochemical 
interactions including affinity interactions, nucleic acid hybridisations, substrate-enzyme 
catalysis reactions or gas and vapor sorption [40]. In order to ease the detection of biological 
analytes, biosensors often employs labels (e.g. enzymes, fluorescent dyes, isotopes, 
nanoparticles, redox probes) which can be defined as molecules attached to the analytes 
(molecules of interest) to detect their activity or presence [47]. However, labels might change 
intrinsic physical properties of the analytes and they might have some important drawbacks 
such as increased material costs, complex sensor designs and possibility of decreasing affinity 
between the biorecognition element and the analyte [48]. In order to avoid these possible 
effects, label-free biosensing was developed and it has become a trending approach which 
enabled the detection of the analytes based on their physical properties (size, weight, 
impedance, charge, refractive index etc.), without a need of any particular label [48].  
Similar to recognition methods, various transduction techniques are available depending on a 
type of biorecognition element utilised. Most common types of transduction are based on 
thermal changes, mechanical effects (mass-based changes), electrical (resistive and capacitive) 
changes, electrochemical and optical methods [40]. In the biosensors where thermal changes 
are being used as transduction method, the enthalpy of reaction, often as a result of enzyme-
activated catalytic reactions, gives rise to the change in temperature which is converted to a 
resulting signal [40]. These calorimetric assays can be used for sensing the heat produced due 
to the interaction of bacteria or pesticides with particular enzymes. They are really good assays 
but only when ΔT is significantly large, for example in the case of a change in chemical bonds 
such as bond-breaking or bond-formation. Also, it is hard to measure ΔT, especially in vivo 
due to difficult measurement technologies. These assays are also not very target-specific as 
differences in heat could be resulted from any non-specific interaction.  
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In other cases, the interaction with an analyte might be designed to lead to a change in electrical 
properties of recognition elements, such as resistance [49] or capacitance [50] which can be 
obtained as output signal. Although the choice depends on some variables (i.e. analyte type, 
analyte concentration, measurement environment), majority of biosensors employs mass-
based, optical and electrochemical transduction methods, as illustrated in Figure 2-5.  
 
In the biosensors using a mass-based transduction method, there is a piezoelectric quartz 
crystal as a transducer (Figure 2-5a). This quartz crystal oscillates at a (resonance) specific 
frequency under an applied AC voltage. However, when the target analyte interacts/binds to 
the immobilised receptor, the quartz crystal gains mass and its resonant oscillation frequency 
decreases. Owing to a piezoelectric characteristic, this change in the frequency is converted to 
a voltage value and measured by a wave sensor. As being a more sophisticated form of these, 
surface acoustic wave (SAW) sensors [51] are produced by microfabrication and they offer 
stability, rapid responses and most significantly very high sensitivities of around ~10-15 g, to 
detect even single molecules. This enables the detection of very small analytes such as viruses, 
bacteria, nucleic acids and hormones [52]. In addition to all these traditional recognition and 
transduction techniques, the advancements in nanotechnology in the recent years paved the 
way for the development of nanobiosensors, where nanomaterials such as quantum dots, 
carbon nanotubes, graphene etc. are used as labels, carriers or signal amplifiers [53], [54]. 
They are also integrated to paper-based diagnostics providing cheaper, easier, more rapid and 
sensitive measurement possibilities [55].   
Figure 2-5: Schematic representation of a) mass-based, b) optical and c) electrochemical transduction 
systems in biosensors. Adapted from [58]. 
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Optical transduction (Figure 2-5b), on the other hand, benefits from the emergent interactions 
(dispersion, reflection, absorption, scattering, transmission, fluorescence, luminescence, 
surface plasmon resonance) occurring between light and matter [56]. Developments in the 
optical biosensor area also improved significantly by the application range of label-free 
detection methods, where the analyte and recognition element can directly interact without any 
requirement for immobilisation of another sensitive probe attached with a signal generating 
label [57]. In this way, these biosensors are able to detect and/or monitor a high number of 
samples in real time. However, they require a detector (spectrophotometer) to convert and 
measure the resulting signals and this usually causes their miniaturisation to be more 
challenging than other types of biosensors. This limits their resolution/sensitivity and 
applicability for in vivo measurements [42].  
Electrodes are used as transducers in electrochemical transduction and they are responsible for 
converting and reporting the interaction between analyte and recognition element as a change 
in different electrochemical outputs such as current, potential, conductance or impedance [58]. 
Electrochemical biosensors (Figure 2-5c) are widely used in biosensing for many years and 
offer vital advantages including enhanced sensitivities and low detection limits as well as the 
capability of electrodes to be readily modified with varying biorecognition moieties [59]. 
Thanks to these virtues, for example, electrochemical-based glucose sensors have been 
successfully commercialised and considerably used now by many diabetes patients to self-
monitor their glucose levels in blood with rapid response times without the need for going to 
a hospital to take a blood test [41], [60]. This has been a significant achievement in terms of 
the historical perspective of biosensing, because glucose sensors dominate the biosensor 
market with an approximately 70% share (of $31.5 billion, the market value estimated to be 
reached by 2024), also considering the increase in the rates of diagnosis with diabetes (having 
a prevalence of 8.5%, among the adult population, in 2014, while it was estimated as 4.7% in 
1980), as well as the requirement for diabetics to keep their blood sugar levels under 
observation at specific intervals [41], [61], [62]. Moreover, there is a growing interest in the 
electrochemical detection of the blood concentration of lactate, leading to the development of  
commercial lactate monitoring devices for clinical and sports medicine purposes, because the 
level of this fermentation product was found to be increasing after intensive exercises and it 
has been also linked to ischemia, trauma and haemorrhage as a relation to oxygen depletion 
[59], [63]. In addition, there are many other electrochemical-based biosensor applications 
which have been commercialised by different companies located all over the world and being 
used for clinical, food & environmental analysis and biowarfare identification purposes [64].  
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Although the above-given progress and achievements of biosensors,  there are, of course, some 
requirements as well, which should be fulfilled in route to commercialisation. These can be 
summarised as followed [65];  
• Doing a market analysis for a biosensor which to be developed for detection of a 
particular target analyte  
• Investigation of contribution to existing knowledge and determination of know-how 
points to be (or already) obtained for recently developed biosensor technology   
• Characterisation and assessment of the biosensor performance while in use and 
following the storage time (of minimum 6 months after which a biosensor should be 
still responsive)   
• Making stability/durability, cost and ease of production analyses for each component 
found in the biosensing device   
• Specification of hazards and ethical concerns which might be arisen due to the use of 
the produced biosensor.  
 
2.2.1 Biosensors for the Detection of Cancer Biomarkers and Proteases  
In many cancer cases, tumour growth proceeds rapidly and/or the metastasis occurs into other 
parts in the body until the patient is diagnosed and assigned to the most appropriate treatment 
programme. This situation leads to an inoperable tumour placement in tissue or incurable (even 
with an intense radio- or chemotherapy) cancer development in vital organs such as the brain, 
lung, pancreas etc. Moreover, the conventional methods used for cancer diagnosis including 
biopsies as well as ultrasound and magnetic resonance imaging focus on the phenotypic 
properties of tumours, and they are thus thought not to be efficient enough to provide its 
detection at an early stage [58]. Furthermore, when it is considered that a particular type of 
cancer consists of very complex disorders with various genetic or epigenetic-induced reasons, 
instead of being a simple disease, one can understand that there is an urgent need for the 
development of alternative detection technologies based on individual patient circumstances 
[66]. Concisely, cancer therapy can be personalised depending on the condition of cancer, the 
habits of the patient and the responses during treatment.  
The detection and monitoring of biomarkers, which can be described as molecules (proteins, 
hormones, enzymes, nucleic acids) that undergo significant changes in amount, can be used as 
the basis of these advancements. They are classified into three subgroups, (i) diagnostic 
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biomarkers which are related to the detection of the disease, (ii) prognostic biomarkers which 
are related to the possibilities of the recurrence and (iii) predictive biomarkers which are 
related to the responses of the cancer against the treatment [58]. In recent years, much effort 
has been spent on the investigation and identification of cancer-specific biomarkers and Table-
1 lists below some examples, which are typically detected in body fluids (blood, saliva, urine, 
cerebrospinal and amniotic fluid) and tumour tissue/cell, and found to be activated in a 
particular cancer type [67].  
 
These given biomarkers can be used for various clinical applications as they are related to 
different phases of the cancer progression. For example, carbohydrate antigen 125 (cancer 
antigen 125) is used for monitoring therapy and detecting the recurrence of ovarian cancer, 
human epidermal growth factor receptor 2 (HER2) helps to choose a suitable therapy for breast 
cancer, α-Fetoprotein is used for diagnosis and staging in liver cancer cases and prostate-
specific antigen (PSA) is utilised for cancer discrimination and screening [68]. Although each 
marker should be expected to correspond to a distinct change in terms of tumour formation or 
progression, detection of multiple biomarkers at the same time is required in some cases for 
specific cancer diagnosis. For example, PSA levels also increase in men with benign prostate 
disease if a prostatectomy operation is not performed and only doing a PSA-monitoring might 
thus be misleading for prostate cancer diagnosis [69]. This lower cancer specificity of some 
biomarkers requires multiple biomarker detection and analysis by utilising integrated 
multiplexed measurement options.  
The literature includes a considerable number of works where many biomarker types have 
been shown to be detected using different approaches. For example, multi-walled carbon 
Table 2-1: Common biomarkers used for cancer detection and monitoring [67].   
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nanotubes (CNT) were fabricated and used in an immunosensor developed on screen printed 
carbon electrode array and achieved the detection of prostate cancer-related PSA (with a limit 
of detection, LoD: 5 pg/mL) and bladder cancer-related IL-8 (LoD: 8 pg/mL) in this way [70]. 
Another immunosensor approach was used by Zhao et al. for the detection of liver cancer-
related α‐fetoprotein with a LoD of 0.07 pg/mL. This was based on the conjugation of capture 
antibody attached chitosan-modified screen printed electrodes and signal antibody-labelled 
single wall carbon nano horn structures with in-situ grown nanogold, which is exposed to 
oxidation at +1.3 V for 30s, followed by a cathodic differential pulse voltammetry (DPV) scan 
in 0.1 M HCl [71]. Furthermore, immunosensor-based detection of α‐fetoprotein is also 
available using mass-based techniques. This was shown by a sensor system based on hybrid 
nanomaterial (gold nanoparticles and nano hydroxyapatite) coated piezoelectric crystals which 
were labelled with anti-α‐fetoprotein antibodies [72]. In a similar system, ferritin which is a 
significant prognostic marker for malignant lymphoma, cervical and breast cancer, was 
captured by anti-ferritin antibodies that were immobilised onto quartz crystal microbalance 
(QCM) [73].  
In another study, electrochemical hybridisation-based genosensor was developed by firstly 
modifying gold electrodes with peptide nucleic acid (PNA) as a SAM layer and then 
accumulating with indigo carmine, which showed a decrease in its DPV current upon 
hybridisation with the target DNA (15‐mer sequence unique to p53 tumour suppressor gene), 
giving a LoD of 4.31 pM within a linear range of 0.01 – 10 nM [74].  
Carcinoembryonic antigen (CEA), an important biomarker of lung, breast, gastrointestinal and 
ovarian cancer was detected using optical techniques such as fluorescence resonance energy 
transfer (FRET) which based on the fluorescence quenching ability of palladium nanoparticles 
towards upconverting nanoparticles [75], and chemiluminescence (CL) assays which based on 
the signal amplifier gold nanoparticles [76] or immunomagnetic beads formed by 
superparamagnetic iron oxide nanoparticles [77]. The lowest LoD estimated among these CL 
assays was 0.8 pg/mL obtained by FRET method.  
Human epididymis protein 4 (HE4) was detected by Yuan et al. in blood samples from patients 
with ovarian cancer, with a LoD of 4 pM [78]. The sensor system was based on localised 
surface plasmon resonance (LSPR) technique where silver nanoparticles were used as a 
nanochip substrate for capture antibody.  
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A significant breast cancer biomarker, carbohydrate antigen 15-3 was shown to be detectable 
label-free [79]. This was achieved developing an electrochemical immunosensor based on the 
incorporation of N-doped graphene sheets which significantly enhanced the electron transfer 
and gave a LoD: 0.012 U/mL.  
The capture and detection of miRNA let-7b was achieved from human breast, cervical and 
lung adenocarcinoma cell lines with a 0.3 fM LoD, where the sensing platform was based on 
Fe3O4@Ag magnetic nanoparticles and surface-enhanced Raman scattering (SERS) technique 
[80].  
In a different work reported by Gruhl and Länge, SAW-based biosensor enabled the detection 
of the breast cancer markers HER-2 and a tissue inhibitor of metalloproteinases (TIMP-1) with 
LoDs of 2 ng/mL and 10 ng/mL, respectively [81]. Besides, it was shown that two different 
methods can be integrated to make a biosensor platform more sensitive against target analytes, 
and advantages of both can be benefitted in this way. In a very recent work by Wang et al., 
acoustics and microfluidics were combined to create an acoustofluidic biosensor and utilised 
to provide size-based isolation of salivary exosomes, which thought to be improving diagnosis 
and prognostic screening of human papillomavirus (HPV)-associated mouth and throat 
(oropharyngeal) cancer [82].    
In addition to the serious functions of these given biomarkers, the significance and individual 
distinctness of protease activity in almost all stages of cancer has been previously detailed. 
Consequently, they also should be considered as vital biomarkers which need to be detected 
and monitored in order to help determination of the most convenient, efficient and personalised 
treatment. Typically, they are known to be responsible for protein regulation in the body, 
hydrolysing peptides by cleaving them between two amino acids and breaking down into two 
shorter peptide chains. As depicted in Figure 2-6, a protease can cleave a peptide chain at a 
specific hydrolytic site, which to be recognised by the protease. For example, when amino acid 
AA-4 corresponds to a positively-charged lysine or arginine in this case, it is enough for 
trypsin to cleave the peptide, whereas the sequence typically should be LVPRGS (See 
Glossary for amino acid abbreviations) for thrombin [6]. There are also examples in literature 
using different peptide sequences for the detection of other proteases such as MMP-9 (peptide: 
GPLGMWSRC) [83], cathepsin B (peptide: LRFG) [84] and caspase-3 (peptide: 
DGADAGGC) [85]. Therefore, the composition of a comprehensive databank of peptide 
sequences is really important in terms of achieving the perfect selectivity (where signal change 
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is obtained against only target, not for any other non-specific substances), because a 
considerable part of protease sensing research employs peptides as recognition elements.   
 
Protease biosensors can be classified as affinity and activity assays. In affinity-based protease 
sensing, their detection and quantification are practiced with respect to their binding to a 
substrate, instead of their activities; whereas in activity assays, their catalytic functions are 
targeted because a cleavage is measured [6]. This eventually provides more analytical, 
sensitive and disease-related information [6]. Several techniques were previously benefitted 
to develop protease assays and they can be briefly exemplified including the detection of HIV-
1 by FRET [86], thrombin by bioluminescence resonance energy transfer (BRET) [87], MMPs 
by nanoparticle-integrated colorimetric assay [88] and magnetic nanoparticles [89], caspase-3 
by SPR [90] and trypsin by fluorescence [91], SERS [92], enzyme-linked [93] and liquid 
crystal-based assays [94].  
Despite all these accomplishments where different approaches have been employed, it is worth 
noting that established biomarker detection methods have drawbacks e.g. enzyme-linked 
immunosorbent assay (ELISA) or polymerase chain reaction (PCR) have slow response times, 
expensive material costs and inability of continuous real time monitoring [58]. In addition, the 
inability of optical techniques for multiplexed measurements and incompatibility of mass-
based techniques for miniaturisation are serious limitations for in vivo biosensing. This drives 
a growing interest in developing electrochemical-based new generation sensing platforms to 
achieve individual specific biomarker detection. Specifically, electrochemical peptide-based 
protease assays are thus of greater significance in this respect, offering an huge promise for 
monitoring/screening the real-time status of a tumour and personalising cancer treatment, if 
they can be developed on microdevices and placed into a solid tumour [95]. This would be an 
inevitable challenge -if not impossible- for majority of the aforesaid techniques. The detailed 
Figure 2-6: Schematic representation of a peptide chain cleaved by a substrate-specific protease at a 
particular hydrolytic site. Adapted from [6].  
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discussion (with some critical background) of electrochemical peptide-based protease sensors 
can be found in Section 4.1.   
In addition to all these, an EPSRC-funded research project, Implantable Microsystems for 
Personalised Anti-Cancer Therapy (IMPACT) [4], [95] has aimed to develop new strategies 
to personalised cancer treatment using fabricated, miniaturised and implanted smart sensor 
chips. This is expected to allow chemo- and/or radiotherapy to be more sensitively targeted 
against cancer cells, by measuring time-dependent status of an individual tumour. 
 
2.2.2 Miniaturisation  
Miniaturisation is one of the emerging trends in analytical sciences in recent years, since 
scaling down the systems/materials reduces preparation times, production costs, sample 
volumes, human-induced errors, amounts of chemical waste significantly as well as enhanced 
device performance and eases implantation [96]. Miniaturisation is far more than simple 
downscaling. It allows greater portability, ease of operation and analysis.  
The origin of miniaturisation of analytical devices and their components actually was in the 
fabrication of miniature gas chromatographic analysers, micropumps and microvalves in the 
1980s, and has now evolved to micro- (µm) and nanoscale (nm) devices [97]. The development 
of micro total analysis systems (µTAS), so-called “lab-on-a-chip technologies” has also 
promoted the interest in miniaturisation with the aim of integrating all steps such as sample 
preparation (even including chemical synthesis), analyte separation and detection together on 
a microchip [96], [98]. Also, there has been always a great interest in miniaturising biosensors. 
Analytical sensing devices applicable to biosensing were first manufactured on the macroscale 
nearly seven decades ago (Clark’s oxygen sensor [99]), whereas today’s biosensor elements 
proceed into the fabrication in nanoscales [100], consisting of materials like nanowires, 
nanoparticles, carbon nanotubes, nanorods and graphene. The main reason of this is to increase 
sensing capabilities and enable in vivo measurements. In addition, the successful integration 
of biology and electronics fields (leading to the field of bioelectronics) combining biological 
substances and silicon chips was an important milestone in biosensor miniaturisation [101]. 
These are mostly attributed to the development of microtechnology and advanced fabrication 
techniques starting from 80’s which then facilitated micro and nano patterning technologies 
for recognition components, microfluidic biosensors (lab-on-a-chip) and 
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microelectromechanical system (MEMS)-based biosensors. All of these are widely benefitted 
in biomedical and many other applications [102].  
Miniaturised systems propose significant advantages such as [102]; 
• decreasing the need for expensive materials thus lowering the production costs 
• the ability to manipulate measurement environment  
• multiplexed detection 
• integration of separate elements 
• they are less affected by non-uniform sample distributions.  
Although miniaturised biosensors typically exhibits above-mentioned advantages, decreasing 
sensor dimensions is a potential of new drawbacks in some cases which might include 
increased response times, reduced sensitivity, loss of linearity and drifts. These would be a 
noteworthy limitation particularly for dynamic environments. Therefore, a miniaturised device 
should be either optimised and/or re-designed according to the consideration of application-
specific balance between these variables. It is also possible to utilise other strategies  based on 
fluid flow, thermal gradient, electric field, internal motors to minimise the response times 
[103]. Further information can be found in Section 5.1.  
 
2.3 The Development of Implantable Devices and Biofouling  
2.3.1 The Significance of Implantable Technologies  
The advancements achieved in the area of biosensing so far paved the way for diagnosis and 
monitoring of several diseases. However, the majority are based on lab bench analysis of the 
samples taken from patients using methods (e.g. bloodletting, needle biopsy, colonoscopy) 
which might be uncomfortable and even destructive or harmful sometimes e.g. by promoting 
infection or affecting disease rate. These circumstances can cause patients to feel more 
reluctant to engage with examination and therapy. More importantly, bench-based analysis is 
not able to give rapid and continuous information that can be vital for diagnosis and treatment 
of rapidly changing diseases such as cancer. However, this challenge raised for bioanalytical 
devices/biosensors could be dealt if they can be converted into implantable devices which can 
be placed into the body to monitor the real-time events through in vivo measurements. Critical 
changes related to the disease can then be way to an electronic receiver outside which will be 
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interpreted by clinicians afterwards. Of course, implant technology can be used also to inform 
drug delivery devices, in addition to bioanalytical platforms. This methodology is thought to 
become central in enabling the personalised therapy in coming years [104].  
The development of devices for continuous glucose monitoring can be considered as the first 
achievement of implantable biosensing. As clinic-based measurement techniques using 
extracted blood samples from diabetic patients have been time consuming and stressful, huge  
glucose sensor market progressed fast, leading to production of firstly the devices designed 
for home use by patients themselves on extracted blood samples [105] and more recently 
implantable versions, which can offer long term measurements for up to 180 days [106]. 
Another type of implantable biosensor, an intravascular blood gas sensor, was also developed 
by Paratrend (Diametrics Medical Inc.) combining electrochemical and fibre optic-based 
techniques for the detection of pH, PCO2 and PO2  [107]. Another study focused on the detection 
of glucose, lactate and pyruvate found in brain, where an enzyme-based biosensor was 
developed and implanted to the medial prefrontal cortex of anaesthetised rats, because that the 
levels of these substances have been thought being related to changes in brain energy 
metabolism and thus corresponding neurological disorders [21], [108]. The sensor was found 
to be sensitive to basal levels of all three substances and some externally-induced (glucose and 
insulin administration) changes. Moreover, using a miniaturised Clark-type electrochemical 
oxygen sensor, real-time oxygen tension was measured in an anesthetized rat intestine, during 
ischaemia and hypoxia conditions [109]. Furthermore, a silicon-based bioresorbable sensor 
was fabricated by Rogers and his colleagues, combining the materials which are already 
known to be resorbable due to hydrolysis and/or metabolic action, then implanted to rat models 
to demonstrate its applicability for monitoring pressure and temperature [110]. Additionally, 
this work showed the platform can be integrated with a data-communication system and can 
also be modified to detect fluid flow, motion and pH changes. As a first attempt to use an 
implantable biosensor for a cancer case, an implantable device with a semi-permeable 
membrane was fabricated and included with nanoparticles of magnetic relaxation switches 
[111]. Although this MRI-assisted device was performed for only short term applications such 
as in vivo determination of soluble cancer biomarkers, it is thought that it can be possible to 
adapt it to sense chemotherapy drugs/biomarkers and metabolites as well. Of course, 
implantable technologies are not only limited to biosensors, but also offer opportunities for 
drug delivery applications. For example, fabrication of microelectromechanical systems 
(MEMS)-based silicon chips have been suggested for this purpose, to include a set of 
reservoirs which can be filled with a particular drug and then the chip can be implanted to a 
target location of the body. The idea has been based on the external stimulus-induced 
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activation and opening of a thin layer material (seal) which protects the reservoir until the time 
of planned delivery. This method was first suggested by Robert Langer and colleagues in 1999 
[112], and then adapted and used in different works including magnetically controlled 
docetaxel delivery for the treatment of diabetic retinopathy disease [113], batteryless insulin 
pump [114], human parathyroid hormone fragment delivery for osteoporosis treatment as first-
in-human testing [115] and many others [116]. In addition to MEMS-based devices, drugs can 
be loaded into various polymers and hydrogels which do release the loaded drugs when they 
are exposed to external stimuli like temperature, magnetic field or pH following the 
implantation [117]. Despite the performances not yet tested in vivo, there are also other 
interesting examples in literature, where a smart design has been fabricated to improve the 
operability of the device to perform as a biosensor and a drug delivery system in combination. 
In the first one, pH sensitive hydrogel, poly(HEMA-co-DMAEMA), which was loaded with 
glucose oxidase, catalase and insulin, was diffused by glucose when exposed to body fluid and 
swollen by gluconic acid which is an enzymatic conversion product of glucose, leading to the 
release of insulin, where the amount and rate of the release based on glucose concentration 
[118]. The later one used polypyrrole–gold bilayer as an electroactuated flapping seal for a 
drug loaded well [119]. In this work, the biosensing was achieved by polymerised hydrogel 
glucose biosensor which was immobilised on the backside of a gold cap.  
It should be emphasised that most of the proposed materials and devices in this area might 
have been stated as ready to implantation, but not actually subjected to human clinical trials 
yet. Because, the approval of a device developed for a medical purpose takes considerable 
time as it requires to be found as successful in all stages of bench analysis and animal trials. 
As a significant criterion, they should be characterised and confirmed in terms of the sensor 
performance, durability, robustness and passiveness against host immune responses to be 
induced in the case of an implantation.  
 
2.3.2 Host Immune Responses and Biofouling   
All materials/devices enhance host immune responses when implanted, as a result of the self-
protection mechanism of the body [120]. This interaction occurring between the material and 
tissue is one of the major problems challenging implantable biosensor and drug delivery 
platforms, and thus is a serious limitation for an efficient and long-term utilisation. Biofouling 
can be described as non-specific cell and/or protein adsorption and causes most of the 
implanted devices to lose their functionality by surrounding their active sensing area and in 
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long-term provoking a tissue reaction, called as foreign body response (FBR) [21]. Therefore, 
it can be seen as the most destructive stage of the host immune responses. Because material-
tissue interaction-induced adverse effects might be bidirectional, the possibility arises of local 
tissue damage formation in addition to local disruption in the device. All implantable elements 
should therefore be characterised in terms of their biocompatibility prior to any clinical testing 
[121]. Likewise, if a device is to be clinically approved following these characterisations, it 
should be fabricated at the beginning according to the regulations of an established 
organisation such as International Organisation for Standardisation (ISO), which published the 
relevant standards document ISO 10993: Biological Evaluation of Medical Devices [21], 
[122]. This emphasises, at this juncture, the significance of understanding the stages of the 
inflammation in order to be able to evaluate biocompatibility and ensure biocompatible device 
production.   
As illustrated in Figure 2-7, the main stages of inflammation [21] exhibited by the host against 
an implanted device can be mainly classified to  
• tissue injury 
• blood-material interactions 
• provisional matrix formation 
• acute and chronic inflammation 
• granulation tissue formation 
• fibrosis/fibrous encapsulation.  
Figure 2-7: Schematic diagram of the inflammation stages caused by an implanted device/material [21].  
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Blood-material interactions and provisional matrix formation are first and early (within 
minutes to a few hours) inflammatory responses activated due to an injury to vascularised 
tissue and usually include protein absorption, thrombosis and blood clot formation [123]. The 
provisional matrix might include and release fibrin, platelets, inflammatory and endothelial 
cells to help to healing of the injured tissue. This early response is followed by sequential acute 
and chronic inflammation. Acute inflammation also continues for a short duration (minutes to 
a few days, usually less than a week) similar to blood-material interactions. Neutrophils 
consisting of polymorphonuclear leukocytes and PMNs are transferred from blood vessels into 
the implanted area and nearby tissue, where the localisation of leukocytes leads to the release 
of proteolytic enzymes (proteases) and they all together try to phagocytose the foreign 
materials [124]. In addition to neutrophils, mast cells, interleukin-4 and interleukin-13 proteins 
have also significant roles in the determination and governance of the host response [124]. 
Chronic inflammation, taking place following the acute inflammation, proceeds for a 
significantly longer period (weeks to years) and it is characterised by the presence of 
macrophages, monocytes and lymphocytes, where toxicity or infection are also commonly 
seen problems [123]. Foreign-body reaction can be considered as a succeeding phase after the 
chronic phase and is characterised by the formation of foreign body giant cells (FBGC) and 
also the presence of degradative enzymes and inflammatory mediators [21]. Furthermore, the 
size and geometry might be also effective in the biocompatibility characteristics of implanted 
materials and devices. Veiseh et al. placed various materials (plastics, metal, ceramic and 
hydrogel-based) in different dimensions into rodent and non-human primate animal models to 
check any correlation between the material size/shape and biocompatibility [125]. They 
observed that all materials which are spherical and of 1.5 mm, or in greater dimensions, 
resulted in more biocompatibility compared to smaller dimensions and other geometries. It 
was also stated that this correlation was independent of surface area and it was valid for all 
tested material types. On the other side, Bhushan and his colleagues have been recently 
inspired from mosquitoes and fabricated a microneedle of significantly reduced dimensions 
and a different shape than commercially available options, in order to ease the drug delivery 
and blood drawing [126]. These microneedles were designed to include two small needles, 
one of which releases a numbing agent when inserted, whereas the other one (which was 
suggested to be more flexible and able to vibrate) draws the blood or releases the drug. 
Although the later work has not been tested in vivo for biocompatibility yet, both together 
demonstrate the importance and extent of the miniaturisation as well as the design of implanted 
material and devices.  
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Although it is possible to control the FBR in some cases by alterations in the surface properties 
of an implanted material if it is biocompatible, it is very difficult to completely avoid from the 
fibrosis/fibrous encapsulation which initiated by macrophages. This capsule simply surrounds 
the implant and isolates it from the relationship with the tissue environment, being a serious 
hindrance against the functionality of a biosensor [127].  
It is also worth noting that these inflammation stages have been characterised mostly in normal 
tissues so far, not in a tumour tissue, except only a few works. The first one is an early study 
of Mahoney and Leighton, where only minimal extent of FBR was observed against a cotton 
thread implanted into rodent tumours, in comparison to the one placed into normal tissue [128]. 
Other one is a more recent work by Gray et al. where a tumour xenograft model was developed 
and used to investigate the performances of six different materials (silicon dioxide, silicon 
nitride, Parylene‐C, Nafion, biocompatible epoxy resin and platinum, all of which are planned 
to be included in tumour pH and O2 sensors of the same project) in terms of FBR activation in 
a solid tumour [109], [129]. The study concluded that no biofouling and variations were 
observed in other events including tumour necrosis, proliferation, apoptosis, immune cell 
infiltration or collagen deposition.  
 
2.3.3 Different Approaches to Enhance and Protect Implantable 
Materials and Devices against Host Responses   
The advancements in bioelectronics and the increasing number of implantable sensor/material-
based applications day by day necessitate the development of different strategies for their 
protection against biofouling as well as smart activation within the body. Figure 2-8 shows 
some of these strategies that referred to different techniques such as surface functionalisation, 
microfabrication, polymer chemistry and biosynthesis. Each of these examples will be briefly 
summarised below as a reference to a reader regarding which methods have been practicable 
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Figure 2-8: Various biofouling protection techniques for implantable devices based on A) surface 
modification [130], B) conjugated polymer actuation [131], C) microneedle reservoirs [132], D) NO-
releasing coatings [134], E) biocompatible hydrogel coating [136] and F) biosynthesised membrane 
[137].  
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In the first work, micropatterned superhydrophilic and superhydrophobic surfaces were 
created by plasma vapor deposition of n-octadecyltrimethoxysilane self-assembled monolayer 
and vacuum ultraviolet (VUV) irradiation onto Si wafers, before they were used as substrates 
for mouse 3T3 fibroblast cells or protein adsorption using 10% fetal bovine serum in 
phosphate-buffered saline, PBS (Figure 2-8A) [130]. It was found that the superhydrophilic 
areas of micropatterned surfaces were more favorable for attachment of the cells after the 
evaluation of cultured cells for both 1 h and 24 h. Although the proliferation of cells adhered 
on the superhydrophilic areas occurred immediately, constant contact was observed to be 
necessary for proliferation for the cells on the superhydrophobic regions. For protein 
adsorption, a similar preference was observed where the extent of proteins on flat hydrophilic 
surfaces found to be higher than flat hydrophobic surfaces.  
Another study showed the potential of a polymer, polypyrrole (PPy) doped with 
dodecylbenzenesulfonate (DBS) to work as a smart actuator in implantable neural interface 
devices (Figure 2-8B) [131]. For this purpose, the microfabricated bilayer design was 
electrochemically cycled at 22 oC or 37 oC, in aqueous NaDBS or artificial cerebrospinal fluid; 
where it was found that the performance of deflection (bending) was similar in both 
environments, although the increase in the temperature consumed 70% more charge, effecting 
the bending amount negligible. These polymer actuators can be used as caps to protect 
electrodes or drug-loaded cavities during implantation and partly inflammation, and they can 
be activated on-demand.  
As depicted in Figure 2-8C, a flexible eye patch which can host drug-loaded micro reservoirs 
was fabricated as a self-implantable device which is activated upon the gentle thumb pressing 
on the ocular surface in order to release the load either with biphasic kinetics or sequentially 
for different drugs [132]. It was shown that the sustained release can be controlled and 
prolonged up to two weeks using different matrices to load the drug molecules.  
Another type of biofouling protection can be performed using nitric oxide-releasing elements, 
as it is known for a while as a successful inhibitor of platelet and bacterial adhesion [133]. 
Soto et al. showed that NO-releasing silica nanoparticles can be included into polyurethane 
coatings and integrated with the needle-type glucose biosensor which was then implanted into 
a swine model and evaluated for 10 days (Figure 2-8D) [134]. It was emphasised that NO 
release improved the analytical performance of the in vivo glucose sensor and it was thought 
that coating are capable of releasing even higher NO extent for longer durations up to several 
weeks which would be very significant for long term glucose screening in diabetic patients.  
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Biocompatible hydrogels are also drawing attention in recent times, as they could possess a 
significant potential as a component of implantable biosensor and/or a drug delivery matrix 
[135]. Yu and his colleagues developed a novel hydrogel which based on a copolymer of 
hydroxyethyl methacrylate and 2,3-dihydroxypropyl methacrylate, where its porosity and 
mechanical properties were then optimised with the addition of N-vinyl-2-pyrrolidinone [136]. 
Eight sensors consisting of platinum / glucose oxidase / epoxy-polyurethane / N-vinyl-2-
pyrrolidinone hydrogel were implanted in rats subcutaneously and evaluated for 4 weeks. It 
was observed that all sensors remained functionable until 21 days, while only 3 of them 
survived at the end of 4 weeks period when also biological evaluation was carried out and it 
was showed that the thicknesses of the fibrous capsules encapsulating the hydrogel-coated 
sensors were less than the ones without the hydrogel (Figure 2-8E).  
In a very recent work by Robotti et al., the performance of microengineered non-resorbable 
biosynthesized cellulose membranes (micropatterned with designed geometries) was 
evaluated in terms of anti-fibrotic protection of a pacemaker which was implanted into a 
chronic minipig animal model [137]. Biological assessments were done after 3 and 12 month-
periods following the implantation. It was reported as a conclusion that the biosynthesised 
cellulose membranes reduced the average thickness of the fibrotic tissue by 66%, in 
comparison to the control pacemakers which were not wrapped with a membrane (Figure 2-
F). This might offer a potential for easier cardiac surgery conditions and less risky 
circumstances for patients.  
Despite the detailed achievements of the summarised examples which can offer good 
opportunities for drug delivery or label-free biosensing, most of the electrochemical biosensor 
platforms typically require labels (redox tags etc.) as their sensing (recognition) elements 
which either need to be in a direct contact with the target analyte or integrated with a membrane 
layer. In both cases, non-specific binding of proteins and cells, or biofouling will be induced 
and affect the sensor performance when they are implanted into any location of the body. This 
therefore presents a highly challenging problem with respect to implantation and 
biocompatibility of probe-based electrochemical biosensors. Luckily, many biocompatible 
materials based on polymers, hydrogels, SAMs and peptides are available to produce anti-
fouling interfaces [138]. However, their feasibility and compatibility is not fully explored 
when in combined/integrated with SAM-based electrochemical systems. This underlies the 
significance of their potential and thus research interest in order to develop SAM-based 
electrochemical platforms with enhanced biocompatibility.   
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2.4 Self-Assembled Monolayers  
Self-assembled monolayers (SAMs) are formed by the spontaneous formation of molecules as 
a monolayer on a substrate surface by adsorption. Following successful initial adsorption, they 
usually reorganise to form ordered monolayer structures. Because of their significant potential 
as a cheap, simple and well-controlled surface coating method, their fundamentals have been 
widely studied and they have been employed in plenty of applications. Although a monolayer 
film was first observed by Langmuir in 1917 where he observed the formation of one-
molecule-thick amphiphile film, the SAM concept was initially suggested by Zisman and his 
colleagues in 1946 where they studied the spontaneous formation of alkylamine monolayers 
on a platinum substrate [139]–[141]. SAMs can be considered as enhancement of Langmuir-
Blodgett films where a monolayer or multilayers of molecules can be transferred from a 
liquid/gas interface onto a solid substrate [142], because SAMs offer ease of fabrication owing 
to their self-organisation characteristics.  
There is usually a stronger interaction in SAMs between head groups and substrate atoms 
(Figure 2-9). Particular groups (tails) within SAM molecules can be also functionalised on-
demand depending on an application. Since the time when first suggested, SAMs with 
different head groups and their interactions between varying substrates were reported in a 
number of studies including thiols on metals (gold, silver, copper, palladium, platinum and 




Figure 2-9: Schematic illustration of a typical self-assembled monolayer (SAM). 
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SAM formation (growth) is produced by two main processes [147]:  
(i) the solution-phase transport of molecules to solid-liquid interface and their 
adsorption 
(ii) self-organisation on the surface.  
Both of these processes are based on both thermodynamics and kinetics, resulting in the 
growth that is determined or controlled by changes in variables such as temperature, 
concentration, surface structure and interactions. For example, the adsorption rate of SAMs 
can be diffusion-controlled, adsorption-controlled or both in a mixed regime [147]. Figure 2-
10 established SAM formation mechanisms which correspond to two hypothetical isothermal 
paths observed at T1 (a temperature below the triple point, Ttriple which can be defined as the 
temperature value at which the solid, liquid and vapor phases of SAMs coexist in equilibrium) 
and T2 (a temperature above Ttriple) in the quasi-equilibrium phase diagram which was 
produced based on the experimental evidences [147].  
Instead of a continuous path, a common SAM formation is thought to follow the phases 
included in the diagram:  
(i) low density 2-D vapor phase where SAM molecules are randomly dispersed on 
the surface  
(ii) intermediate 2-D liquid phase where some of SAMs are not conformationally 
well-ordered 
(iii) high density 2-D solid phase where close packed and well-ordered molecules are 
present.  
At lower temperature case, T1, SAM molecules are firstly adsorbed and create a dilute vapor 
phase. Afterwards, a solid-vapor mixed state appears at a low surface concentration where the 
nucleation and growth of solid phase islands are observed and isolated vapour phase molecules 
surround them. Then, they together further propagate and spread to create an ordered 
monolayer on the surface. It is slightly different and more complicated at higher temperature, 
T2. At a certain surface concentration, an intermediate low density phase appears, where 
molecules then nucleate and grow. However, as also illustrated in the same figure, this phase 
might be a disordered 2-D liquid phase or an ordered 2-D solid-like but lower density phase 
where lying molecules can be observed.  
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Figure 2-10: Schematic illustration of the differences in growth of a generic SAM system with respect 
to two hypothetical isothermal paths (at a temperature T1 or T2) indicated in the quasi-equilibrium 
phase diagram. Adapted from [147].  
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In both conditions, ongoing adsorption creates a conversion from the low density phase to the 
high density phase where solid phase islands again surrounded by liquid or vapour phase 
molecules, which eventually grow and cover the substrate surface in an ordered orientation. 
However, it has been noted that this summary is the simplest form of the SAM formation 
mechanisms and more complex dynamics are very likely to be seen especially at non-
equilibrium conditions [147]. Although the given isothermal paths in Figure 2-10 are 
hypothetical, it was previously shown by experimental studies that there are distinct growth 
mechanisms taking place at varying temperatures. For instance, Carraro et al. showed that 
island growth was seen at temperatures below 16 °C, homogeneous growth dominated at 
temperatures above 40 °C and a mixed regime was observed at intermediate temperatures 
during the self-assembly of octadecyltrichlorosilane-based monolayers on silicon oxide 
surfaces [148]. In another work, Messerschmidt and Schwartz presented that the monolayer 
growth mechanism of octadecylphosphonic acid on sapphire surfaces was also dependent on 
the temperature [149]. In this work, the nucleation of close-packed and vertical islands and 2-
D vapor-solid phase transition was observed at lower temperatures (2 °C), while a continuous 
2-D liquid-solid phase transition was seen instead at higher temperatures (22 °C). There was 
again a mixed regime at an intermediate temperature (15 °C) where both formation 
mechanisms were seen to be dominating simultaneously at different locations of the surface. 
It is also known that the SAM growth process may be affected by a number of other variables. 
For example, Bain et al. observed that the formation of alkyl thiols including longer chain tails 
(with a number greater than 8) on gold substrates was more controlled compared to SAM 
molecules with shorter chains [150]. Furthermore, it was found that there was an inverse 
proportion between the resulting film quality and the solubility of thiol in the solvent used 
[151]. The presence of SAM defects (pinholes) on surfaces is another common issue related 
to a complex mechanisms and the lack of a controlled deposition technique [152]. Although 
the kinetics (rate) of SAM surface coverage was found to be affected from several variables 
including the nature and concentration of the SAM molecule, solvent type, chain length and 
adsorption energies [147], the fastest step was attributed to initial chemisorption (typically 
occurs in seconds/minutes), which was followed by a little slower (3-4 times) chain 
straightening step, and its re-organisation which takes place 35-70 times slower [153].  
In order to precisely understand the characteristics of SAM layers and investigate the presence 
of any defects, different analytical techniques can be utilised including a) electrochemical 
methods, b) mass-based techniques, c) optical spectroscopy, d) contact angle measurements, 
e) scanning probe microscopy and f) surface-sensitive electron spectroscopy (Figure 2-11) 
[141]. Electrochemical methods such as cyclic voltammetry (CV) and electrochemical 
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impedance spectroscopy (EIS) have been used to provide significant information related to 
SAM layer thickness, film quality and possible defects [154]. Mass-based (piezoelectric) 
techniques such as quartz crystal microbalance (QCM) or surface acoustic wave (SAW) 
equipments have been utilised to monitor the relative changes in mass on a substrate, which 
occur due to the SAM adsorption or the selective binding of analytes to already immobilised 
receptor SAMs, thus the quantity of adsorbate molecules and the corresponding kinetics have 
been analysed [155]. Optical spectroscopy have been employed to explore a variety of SAM 
properties such as identification of the functional parts by IR spectroscopy [156], surface 
monolayer coverage by UV-vis [157] and fluorescence spectroscopy [158] as well as SAM 
layer thickness by ellipsometry [159] and SPR [160]. In order to understand the wettability 
characteristics of SAM-adsorbed surfaces, contact angle measurements can be carried out as 
a simple method. In this way, composition and structure of the adsorbed layers have been 
initially and easily assessed prior to the utilisation of any complex technique [161]. 
Furthermore, surface wettability (hydrophilic/hydrophobic) is really a determinant variable in 
terms of the biocompatibility of materials, thus the wettability characterisation for SAMs has 
been stated as being fundamental [162]. Of course, the structure of the substrate to be covered 
by SAM molecules should be also considered as another parameter in addition to the SAM 
chemistry, because both are known to be important in determining the wettability. Another 
useful method which gives insight related to SAM orientation, packing and surface potential 
is scanning probe microscopy, which includes atomic force microscopy (AFM) [163], kelvin 
probe force microscopy (KPFM) [164], scanning tunnelling microscopy (STM) [165] and 
scanning electrochemical microscopy (SECM) [166]. Although they are grouped under the 
same category, each has fundamental differences in terms of the types and functions of the 
scanning probes [167]. Surface-sensitive electron spectroscopy techniques (e.g. X-ray 
photoelectron spectroscopy, XPS or Auger electron spectroscopy, AES) have been also used 
to make an elemental analysis, providing deeper chemical information about the adsorbates 
[168]. Because of that controlled and reproducible SAM formation is not typically simple due 
to occurring in multiple stages, it might be required to have comprehensive characterisation 
that can only be achieved by combining some or all of these analytical techniques, instead of 
utilising a single one.  
 
  37 
 
SAMs have been employed in a variety of applications including wettability alterations, pH 
and ion sensing, biocompatible functionalisation, lubricant and corrosion-protective coatings 
as well as biosensing. For example, Wang et al. achieved superhydrophobic (with a contact 
angle of ~153o) and superhydrophilic (with a contact angle of 0o) surfaces by adsorption of n-
octanoic acid and n-propanoic acid, respectively, onto initially-modified (by electrochemical 
deposition to result in micro- and nano hierarchical structures) copper films by immersing in 
ethanolic solutions for 12 h [169]. This alteration was attributed to the chain length of acids, 
where short chain ones were found to be disordered and methyl groups were exposed, whereas 
longer chain acids were more well-packed and ordered which enhanced the proportion of 
hydrophobic methyl groups [169]. This structural distinction between shorter and longer 
chains was also consistent with the previously mentioned observation of Bain et al. regarding 
alkyl thiols on gold [150]. They have been also used for pH sensing e.g. Hickman et al. 
deposited ferrocenyl thiol (ferrocene as pH-insensitive reference) and quinone thiol (quinone 
as pH-sensitive indicator) onto gold microelectrodes and measured the voltammetric changes 
between the oxidation and reduction peaks of quinone to detect pHs between 1 and 11 [170]. 
In addition to pH sensing and wettability alterations, there are examples where SAM molecules 
were employed to control and design cell (or protein)-surface interactions. For example, Chang 
et al. showed that the ratios of two SAMs with functional groups -NH2 and -COOH (becoming 
Figure 2-11: Common analytical techniques used for SAM characterisation can be given as a) 
electrochemical methods, b) mass-based techniques, c) optical spectroscopy, d) contact angle 
measurements, e) scanning probe microscopy and f) electron spectroscopy.  
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NH3+ and COO
_
 based on pH) on substrate surfaces can be accordingly changed to modify the 
surface charge density which lead to the alterations in the cell adhesion [171]. The increase in 
the surface potential was found to promote the adhesion density of laminin-dominant epithelial 
cells without any significant change in their morphologies which were attributed to the 
stronger adsorption of positively charged laminin. Contrastingly, morphology changes were 
observed in fibroblasts with greater adhesion to NH3+, attributed to the presence of negatively 
charged fibronectin which exhibited stronger interaction to the positively charged surfaces. 
Other work by Widge et al. showed that combined SAM systems containing mixtures of 
thiolated poly(alkylthiophene) and alkanethiols functionalised with a neural cell adhesion 
molecule (binding antibody, NCAM), improved the biocompatibility of neural electrodes 
(with ongoing neurite outgrowth up to 7 days) [172]. Coatings of self-assembled monolayers 
have not only been applied to enhance the biocompatibility of biomaterials, but also for 
tribological purposes such as creating more lubricious [173] and corrosion-resistant materials 
[174]. In addition to these useful applications, they are commonly employed as recognition 
moieties to build biosensing platforms, owing to these advantages: (i) easy, stable and well-
ordered formation, (ii) a cellular compatible structure for biomolecule adhesion, (iii) easy 
modification of the head and functional group depending on the application, (iv) minimised 
amount required for surface coverage, (v) practical shelf life (stability/durability) and (vi) 
applicability of varying techniques for their detailed characterisation [175]. Although there are 
some accompanying limitations; (i) high sensitivity of immobilised biological substances 
towards changes in external variables (pH, temperature, ionic conductivity) and corresponding 
fluctuations in their activity, (ii) lack of chemical inertness, (iii) instability against thermal and 
electric field changes, (iv) contamination and impurity problems which might hinder the 
sensing [175], biological recognition and host-guest interactions by SAMs have been 
successfully investigated using the techniques given in Figure 2-11 and utilised for the 
detection of DNA, antibody-antigen interactions, enzymes, vitamins and many others so far, 
as previously reviewed in detail [141].  
Of the various approaches to SAM design, redox-active SAM molecules which are 
immobilised onto electrode surfaces have drawn significant recent attention. As shown in 
Figure 2-12, these consist of a mixed monolayer; a redox centre, a bridge and a diluent [176]. 
They can be easily prepared and then the electron transfer which occurs between redox centre 
and underlying substrate (electrode) is monitored by various electrochemical techniques, some 
of which have been detailed in Section 2.6. The role of the flexible or conjugated bridge is to 
enable electron transfer, by connecting the electrode surface and the redox moiety, while the 
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diluent molecules are used to create an enough space between two individual SAMs in order 
to ease the electron transfer for flexible, bending bridges, to increase accessibility of analytes 
and to hinder any possible interaction between analogous redox centres [176]. The structure 
of the bridge element is especially significant for redox-active SAMs in terms of electron 
transfer kinetics and binding of the target analyte and this is why it is generally selected based 
on a specific application. The literature includes studies on alkane bridges, functional groups, 
conjugated bridges and peptide bridges [176]. It should be also noted here that redox-labelled 
peptide-based SAM molecules distinctly vary from others, offering densely packed stable 
surface films and further recognisability e.g. to enzymes, in addition to their investigations 
which made quite understandable the relationship between the electron transfer mechanisms 
and peptide/SAM surface conformation [177].   
 
2.5 Electrochemistry 
2.5.1 Reduction-Oxidation (Redox) Reactions   
Electrochemistry is the study of interrelationship between electrical changes (current and 
voltage) and chemical reactions. For example, an induced change in the potential might be 
seen as a result of a chemical reaction, or an applied potential can lead to a difference in the 
mechanism of a chemical reaction. Electrochemical reduction-oxidation reaction, where the 
transfer of electron(s) between chemical species creates an oxidised and corresponding 
reduced form, is one of the main types of chemical reactions studied under the title of 
electrochemistry. The following reaction (Figure 2-13) where 2e- and nH+ is transferred 
between leuco-methylene blue (LMB, reduced form) and methylene blue (MB, oxidised form) 
is a common redox system used throughout this work. Of course, it should be noted that the 
number (n) of H+ transferred depends on the pH and pKa of MB and LMB.  
Figure 2-12: The structure of redox-active SAM molecules. Adapted from [176]. 
 




The redox reactions generally occur at the interface of a bulk solution and a metal electrode 
surface. In this case, the leuco-methylene blue (reduced form of methylene blue) which is in a 
close proximity or bound to the electrode surface is oxidised reversibly when a specific 
potential, E > E ′ is applied and converted to methylene blue. This results in the transfer of two 
electrons into the electrode surface and the formation of a current which is then measured by 
an electrochemical technique in the external circuit. Conversely, when E < E ′, MB turns to 
LMB and 2e- per MB are donated from the electrode.  
 
The relationship between the electrode potential and the concentration of reacting chemical 
species in an electrochemically reversible electron transfer can be defined by the Nernst 
equation below [178];  






)                                                   (2.1) 
where E is the applied potential, 𝐸′ is the formal potential (the potential when Cox = Cred) of 
the reaction, n is the number of electrons transferred per mole of reagent/product, R is the 
universal gas constant, T is the temperature in Kelvin, F is the Faraday constant and Cox and 
Cred are the concentrations of oxidised and reduced forms of the chemical species. At the 
electrode surface, 𝐸′ is replaced by the standard electrode potential Eθ, when Cox and Cred are 
replaced by the activities aox and ared, instead of the concentrations. Activity can be defined as 
a measure of the effective concentration of substances in non-ideal (real) solutions and thus 
can be affected from some variables such as solution composition, pressure and temperature. 
Activity and concentration can be converted into each other using the relation, a = γ ⋅ C where 
γ is the activity coefficient.  
Figure 2-13: Typical reduction-oxidation reaction between leuco-methylene blue (LMB) and 
methylene blue (MB).  
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In non-equilibrium conditions, however, the Nernst equation would not able to define the 
relationships between the electrode potential and other variables. Because the electrode 
potential will be different from the equilibrium potential, when there is a current passing 
through the electrochemical cell. In this case, Butler-Volmer equation (equation 2.2) [179] can 
define the current density at the electrode in terms of the overpotential (η = E* - E) which is 
the difference between the electrode potential (E) at equilibrium and the electrode potential 
(E*) when there is an external current passing through the cell;  
                                                     𝑗 = 𝑗0 { 𝑒
(1−𝛼)𝜂𝐹/𝑅𝑇  −  𝑒−𝛼𝜂𝐹/𝑅𝑇 }                                        (2.2) 
where 𝑗 is the current density, 𝑗0 is the exchange-current density (equal opposite current 
density at equilibrium), α is the transfer coefficient, η is the overpotential, F is the Faraday 
constant, R is the universal gas constant and T is the temperature.  
 
2.5.2 Three-Electrode Cell  
In order to measure the changes in these electrical parameters during the redox reaction, a 
standard three-electrode cell was used in this work (Figure 2-14). This setup consists of 
working, counter and reference electrodes. The working electrode (WE) is the main location 
where the redox reaction takes place. The reference electrode (RE), having a fixed potential, 
holds/controls the potential at the working electrode in defined values, by applying a potential 
difference between them. In this way, the controlled potential of the working electrode by the 
reference electrode can lead the chemical reaction occurring and its rate can be measured from 
the current passing between the working electrode and the counter (auxiliary) electrode (CE) 
which completes the electrical circuit and provides the required current for the working 
electrode. They are usually used in larger dimensions compared to the size of working 
electrode to avoid any limitation in its current. Macro-, micro- and nanoelectrodes were used 
as the working electrodes, silver/silver chloride (Ag| AgCl| KCl (3 M)) as the reference 
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2.5.3 Characteristics of Macro-, Micro- and Nanoelectrodes  
Size (or dimensions) is highly significant and effective parameter determining electrode 
response. Specifically, microelectrodes and nanoelectrodes (typically between 1 nm and sub-
micron) exhibit several differences over macroelectrodes which are larger than 100 µm and 
usually on the millimetre scale or above. These include lower currents, lower capacitances, 
higher signal-to-noise ratios, reduced footprint and enhanced mass transport. Although they 
present lower currents compared to macroelectrodes, they have higher current densities and 
signal to noise ratio, because current density is defined as the current passing per a unit area, 
which is proportional to the square of the electrode radius, r2 for a disc-shaped electrode, 
whereas the current is proportional to the radius of the disc, r [180]. Therefore, it is established 
that current densities increase in order from macroelectrodes to microelectrodes to 
nanoelectrodes.  
The rate of an electrochemical reaction can be affected by two factors; rate of electron transfer 
and mass transport. Mass transport is the movement of chemical species, which are able to 
undergo redox reactions, from the bulk solution to the electrode surface. There are three modes 
of mass transport, which are diffusion, migration and convection [178]. Diffusion occurs 
during a chemical reaction due to a concentration gradient which forms between reduced and 
oxidised species at the solution-electrode interface. If the reduction takes place at the electrode 
Figure 2-14: Schematic of the three-electrode measurement system. 
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surface, for example, the concentration of oxidised species will be less at the electrode than in 
bulk solution, which results in the movement of oxidised species in the bulk solution towards 
electrode, whereas reduced species move to the bulk solution. Migration is the motion of 
charged species based on electrostatic forces often induced by potential gradient. Convection 
is the transport mode based on mechanical forces such as stirring and vibration. Although 
natural convection always exists and influences current densities of the electrodes, this effect 
is minimised for microelectrodes and nanoelectrodes where diffusion is significantly higher 
which makes natural convection comparatively negligible [181], [182].  
A diffusion field (layer) develops when reactant species are depleted at the electrode surface 
and this field provides more substances to be moved towards the electrode to contribute to 
continuity of reaction (Figure 2-15). The thickness of the diffusion field formed on a 
macroelectrode is larger than electrode and this promotes linear (planar) diffusion [182]. On 
an electrode with smaller dimensions, e.g. microelectrodes or nanoelectrodes, the thickness of 
diffusion field is similar to electrode and this results in hemispherical (radial) diffusion to 
dominate [182].  
 
It is established that hemispherical diffusion is much more efficient than linear diffusion and 
thus leads to several advantages for microelectrodes and nanoelectrodes over macroelectrodes 
such as steady state currents which are independent of time, reduced convection, higher current 
densities and lower noise-related issues [183], [184]. Especially for sizes reduced to the 
nanoscale, reduced iR drop also adds to these advantages. This can be defined as the potential 
difference between the extent applied by the potentiostat and the actual potential at the working 
electrode, induced by the electrolyte resistivity [185]. Reduced iR drops can thus open 
additional possibilities for measurement in more resistive environments [185].  
Figure 2-15: Diffusion field (layer) profiles at the interface of the electrode-bulk solution. This results 
in  species to move towards the electrode surface. It can occur either as linear (planar) diffusion which 
is commonly valid for macroelectrodes or hemispherical (radial) diffusion which dominates when 
electrode size is reduced.  
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Because microelectrodes and nanoelectrodes present lower amplitudes of currents due to their 
reduced electrode area, they are often fabricated in arrays in order to maximise the measured 
signal [186]. It should be noted that hemispherical diffusion and its advantages can be still 
secured for electrode arrays as well as enabling currents of similar amplitudes to 
macroelectrodes as long as the electrodes act independently [154], [187]. To achieve this, the 
interelectrode spacing should be optimised to avoid any overlap/interaction between the 
diffusion fields. If neighbouring electrodes are located too close in a proximity, the 
overlapping of diffusion fields can cause hemispherical diffusion to become linear, leading to 
the macroelectrode behaviour which would not be desired for many applications where 
miniaturised electrodes are employed (Figure 2-16). Optimal spacing depends on the timescale 
of an experiment [188] (See Section 5.3).  
 
 
2.6 Electrochemical Techniques  
There are many electrochemical techniques which can be used for the analysis of 
electrochemical reactions. The three types of electroanalytical methods [189] are (i) 
conductimetric (impedimetric) where the response is analysed with respect to the conductance 
of the solution, (ii) potentiometric where the potential difference between two electrodes 
(working and reference) is measured when a current is applied, and (iii) amperometric 
(voltammetric) where the current is measured at a fixed applied potential between working and 
reference electrodes. The most appropriate technique should be chosen carefully because each 
technique offers advantages for particular purposes and range of applications [189]. Based on 
our need which requires the sensitivity due to monolayer detection, the amperometric 
techniques including cyclic voltammetry, square wave voltammetry and chronoamperometry 
were used in this work. In the following sections, the principles of these techniques and the 
resulting response and its analysis are outlined.  
Figure 2-16: Diffusion fields might overlap at the surfaces of electrode arrays due to smaller 
interelectrode spacings.  
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2.6.1 Cyclic Voltammetry (CV) 
Cyclic voltammetry (CV) is the most commonly employed technique in electroanalysis 
because it can provide both qualitative and quantitative information about redox reactions, 
electron transfer kinetics and adsorption processes [184]. In this technique, the potential 
applied at the working electrode is swept linearly from a starting potential, E1 to a final 
potential, E2 and then back again at a constant sweep (scan) rate, v. This gives a triangular 
potential waveform. The currents obtained as a result of these applied potentials are measured 
by the potentiostat and a current vs potential plot is generated, which is called a cyclic 
voltammogram. A particular range of potentials applied to the working electrode is always 
chosen in order to promote the redox reactions of the electroactive species under 
electrochemical investigation [182]. A typical cyclic voltammogram and a triangular potential 
waveform is shown in Figure 2-17. The arrows in the figure show the potential sweep 
direction. According to this, when a higher potential is linearly swept at the working electrode 
from E1 to E2, a neutral chemical species M is oxidised and becomes M+, which is then reduced 
and turns back to initial form when the potential is swept backwards. The slope of the applied 
potential waveform can give the scan rate in voltage (measured against a reference electrode) 
per second.  
 
Figure 2-17: Triangular potential waveform applied to the working electrode and a resulting typical 
cyclic voltammogram for the reversible redox reaction of M+ + e- ⇌ M in a solution containing both M 
and M+. Adapted from [184]. 
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                           (2.3) 
where n is the number of electrons, A is the electrode area in cm2, C is the bulk concentration 
in mol/cm3, D is the diffusion coefficient in cm2/s, v is the potential scan rate in V/s, T is the 
temperature in Kelvin, F is the Faraday constant in C/mol and R is the universal gas constant 
in J/mol·K. This establishes that the peak current is directly proportional to the bulk 
concentration and electrode area at fixed scan rate, and it increases with the square root of the 
scan rate. This dependence on the scan rate is actually indicative of a mass transport-controlled 
reaction when linear diffusion e.g. to a macroelectrode is occurring [184]. An increase in the 
scan rates results in less time for diffusion and a corresponding decrease in the diffusion layer 
thickness at the electrode, leading to higher currents [190]. However, this equation, and the 
linear relationship between ip and v1/2  is only valid for freely diffusing redox species in bulk 
solution. If the redox species were adsorbed onto the electrode surface and rapid 
(electrochemically reversible) electron transfer occurs, the rapid reaction of this fixed amount 
of species results in the peak current becoming directly proportional to the scan rate, instead 
of its square root (See equation 4.5).  
As well as the peak current, the position of these peaks in the voltammogram is also 
characteristic of the processes occurring at the working electrode. It has been established for 
an electrochemically reversible reaction that the difference between the anodic (Ep,a) and 
cathodic (Ep,c) peak potentials (called the peak separation, ΔEp) is 59/n mV at 298 K [190]. 
For such a reversible (Nernstian) response, this can then be used to determine the number of 
transferred electrons. It should be emphasised that electrochemical and chemical reversibility 
are not the same. While chemical reversibility refers to the stability of the analyte against 
chemical side reactions when carrying out multiple oxidation and reduction cycles, 
electrochemical reversibility describes rapid electron transfer kinetics between the electrode 
and electroactive species. In the case of electrochemical reversibility, electron transfer is often 
easy due to a low transition state barrier compared to the thermal energy and Nernstian 
equilibrium and a balance between appreciable reduction/oxidation rates is observed. If a 
reaction is electrochemically irreversible, electron transfer becomes slower and more difficult 
due to a high transition state barrier; net oxidation or reduction reactions thus require much 
larger changes in reduction/oxidation overpotentials (potentials to be made much more 
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negative/positive of the formal potential) for a reaction to occur, leading to a wider peak 
separation and domination of either oxidation of reduction. 
Cyclic voltammetry has been employed for the characterisation of macroelectrodes and 
microelectrodes for many years, and their characteristic responses are well-established. 
Although they typically result in peak currents for macroelectrodes due to linear diffusion, a 
sigmoidal shape for micro- and nanoband edge electrodes is observed due to hemispherical 
diffusion (Figure 2-18) [191]. Unlike macroelectrodes, these microelectrodes and 
nanoelectrodes show diffusion-controlled, steady-state mass transport behaviour indicative of 
these diffusion limited currents being stable and independent of time. Therefore, 
macroelectrode currents are expected to change with varying scan rates, unless scan rates are 
so high that the diffusion layer thickness is much smaller than the electrode dimension and 
hemispherical diffusion has not been established, whereas scan rate should not affect the 
currents registered for such micro- or nanoelectrodes [183], [185], [192]. However, even in 
this case, the diffusion layer thickness still grows with time, and if micro- or nanoelectrodes 
are fabricated in arrays instead of individual electrodes and they are located sufficiently close 
as explained in Section 2.5.3, at slow scan rates neighbouring diffusion fields may overlap and 
this may eventually lead to linear diffusion again occurring, and the reestablishment of peak 
currents in voltammograms.  
 
 
Figure 2-18: Characteristic CV responses of macro- and microelectrodes as a result of linear or 
hemispherical diffusion.  
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The equations for the diffusion limited current, iL, registered at large overpotentials when the 
current has become independent of potential, for different types of electrodes previously 
reported [182], [192] are found below:   
 
Single microdisc:  𝑖𝐿 = 4𝑛𝐹𝐷𝐶𝑟                                         (2.4) 
Single hemispherical microelectrode:  𝑖𝐿 = 2𝜋𝑛𝐹𝐷𝐶𝑟                                 (2.5)        
Microelectrode (disc) array (with no overlap):  𝑖𝐿 = 4𝑛𝑁𝐹𝐷𝐶𝑟                    (2.6) 
Nanoband edge electrode (disc) array (with no overlap):  𝑖𝐿 = 0.956𝑛𝑁𝐹𝐷𝐶𝑟           (2.7) 
Nanoband edge electrode (square) array (with no overlap):  𝑖𝐿 = 0.956𝑛𝑁𝐹𝐷𝐶𝐿           (2.8) 
 
where n is the number of electrons, N is the number of electrodes in the array, F is the Faraday 
constant, D is the diffusion coefficient (cm2/s), C is the bulk concentration (mol/cm3) of the 
redox species in the solution, L is the edge length (cm) and r is the radius (cm) of an individual 
electrode in the array. 
 
2.6.2 Square Wave Voltammetry (SWV)  
Square wave voltammetry (SWV) is a type of linear sweep method related to CV, which 
combines a superimposed square wave potential waveform on the staircase potential applied 
to a working electrode, when using a PC-controlled potentiostat [189] (Figure 2-19). In this 
way, the current at the working electrode is measured while the potential of the working 
electrode (with respect to the potential of reference electrode) is linearly swept in time. The 
square wave is typically characterised by a pulse height (square wave amplitude, ΔEp), the 
staircase height (ΔEs), the pulse time (width of the pulse, tp) and the period of cycle (ts) [184]. 
The square wave frequency, f is related to the pulse time, f = 1/2tp. Typically, the staircase 
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As also illustrated in the figure with red lines, the current is collected at two times, typically 
at the end of the forward and backward potential pulses. This current sampling technique 
minimises the effect of non-Faradaic capacitive (charging e.g. double-layer) current on the 
final signal. When the sum of the forward and backward current for each square wave is 
calculated and plotted against the potential applied, any peaks in the resulting curve correspond 
to redox reactions, and the peak height and area can give information about the concentration 
of reactant and products. The relationship between the magnitude of the peak and the 
concentrations is given by a modification of Cottrell equation [191] (See Section 2.6.3); 
                𝑖𝑝 =  
𝑛 𝐹 𝐴 𝐶√𝐷
√п𝑡𝑝
 𝛥𝛹𝑝                                               (2.9) 
where ip is the SWV peak current, n is the number of electrons, F is Faraday constant, A is the 
electrode area in cm2, C is the concentration in mol/cm3, D is the diffusion coefficient in cm2/s, 
tp is the width of the potential pulse and ΔΨp is a dimensionless parameter fixing the SWV 
peak height, relative to the limiting response in normal pulse voltammetry. It was previously 
suggested that ΔΨp can be only estimated by mathematical modelling and simulations, and it 
is independent of the frequency and concentration for a reversible electrochemical reaction 
[193]. This means that ip is proportional to the concentration. Also, a linear relationship 
Figure 2-19: Schematic waveform for SWV technique which consists a staircase potential (with a 
staircase height of ΔEs and a cycle period of ts) and a superimposed square wave (with an amplitude of 
ΔEp and a pulse width of tp). Red lines show the time points for the collection of the currents which take 
place two times per each scan at the end of the forward and backward potential pulses. Adapted from 
[184].  
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between ip and the square-root of the frequency is a criterion of a reversible electrochemical 
reaction of a dissolved redox couple [193].  
Because square wave voltammetry technique offers many advantages such as reduced analysis 
duration, short potential pulses and higher detection limits (higher sensitivity), this is one of 
mostly used techniques in electroanalysis and therefore can be found available in most of the 
conventional potentiostats [184].  
 
2.6.3 Chronoamperometry (CA)  
Chronoamperometry (CA) is the measurement of the changes in the current of an electrode 
over time while the potential at the electrode is jumped from a rest potential to a fixed reaction 
potential. It can be also called potential step voltammetry. The starting potential value is 
typically the point where species are electrochemically inactive [182], whereas the second 
applied potential corresponds to a value which promotes the species to undergo redox reactions 
typically under mass transport-limited control. The relationship between the current and time 
is described by the Cottrell equation [178] for the linear diffusion on an electrode and mass 
transport controlled reaction of the oxidation of e.g. M to M+;  
         |𝑖| =  
𝑛 𝐹 𝐴 (𝐶∞ − 𝐶0)√𝐷
√п𝑡
                                            (2.10) 
where i is the current, n is the number of electrons, F is Faraday constant, A is the electrode 
area in cm2, C∞ is the bulk solution concentration of the M in mol/cm3, C0 is the concentration 
of M at the electrode surface in mol/cm3, D is the diffusion coefficient in cm2/s and t is the 
time in s. According to this relationship, |i| gets closer to zero with time because of the 
progressive depletion of M at the electrode surface. This oxidation of M to M+ also results in 
a drop (or even disappearing) in a large peak typically found in the current-time plot, due to 
the high concentration gradient of M at the electrode surface. Chronoamperometry has been 
used in this study to apply varying oxidative and reductive potentials at the electrode surface 
in order to test whether the potential-assistance makes any difference in the deposition rate of 
SAM-functionalised probe molecules.  
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2.7 Enzyme Kinetics  
Enzymes are biocatalytic substances most of which are proteins but there are some which are  
nucleic acid-based. They have an active site where the substrate specific catalytic activity 
occurs; typically through binding followed by reaction. Experimental evidence shows that the 
specific binding between the substrate and enzyme can be explained by either one of two 
model approaches [194]:  
(i) a “lock-and-key” model where the three-dimensional structure, conformation and 
multiple interactions (bonding) between the substrate and enzyme compounds are 
totally complementary 
(ii) an “induced fit” model where active site needs some major conformational 
rearrangements induced by the substrate for successful binding.  
The substantial binding energy can be provided by the combination of a variety of bonds such 
as hydrogen bonding, van der Waals (vdW) bonding or electrostatic (ionic) bonding. The types 
of the binding interaction may vary across different types of enzymes (nucleases, kinases, 
proteases, isomerases, polymerases) or even within the same enzyme family. Although each 
enzyme has a specific substrate preference, enzymes may be grouped according to similarities 
in their structures and catalysis mechanisms. For example, a protease group called serine 
proteases have commonly three amino acids (serine, histidine and aspartate) which are 
responsible for hydrolysing the peptide bond in the substrate [195]. There exists a pocket at 
the active site of the serine proteases, where the substrate specificity is driven by the chemical 
nature of this pocket [195]. This is because an amino acid next to the cleavage site in the 
substrate inserts into this pocket during catalysis and interacts there with a specific amino acid 
of the protease [195]. Figure 2-20 shows an example of this, where the pocket at the active site 
of trypsin contains aspartate, a negatively charged amino acid, which can build an ionic 
interaction with positively charged arginine or lysine moieties found in the specific substrates 
[195].  
Correspondingly it is possible to summarise that the specificity of enzyme-substrate binding 
might be various for different enzyme families and groups, and they can be altered by the 
conformation of substrate compounds as well as the contributions of the molecules at the 
enzyme active site. Still, the features of enzyme structures have been well-defined by long 
standing research efforts and fortunately increased the understanding of the basis for catalysis 
mechanisms. 
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The Michaelis-Menten mechanism proposes two steps for the kinetics of reactions catalysed 
by enzymes. In the first step, an enzyme-substrate complex is formed, followed by either the 
formation of products in the second step or the release of the unaltered substrate [179]. This 
can be also expressed using the rate constants, 
       k1         kcat 
                                                        E + S  ⇄  ES  →  P + E                                                   (2.11) 
       k-1 
The mechanism suggests three fundamental features for the enzyme-catalysed reactions [179]: 
 
(i) Initial rate of product formation is proportional to the total amount of enzyme 
concentration, [E]0 for a given initial concentration of substrate, [S]0.   
(ii) The rate of product formation is proportional to [S]0 if [S]0 is in low concentrations 
for a given [E]0.  
(iii) For a given amount of [E]0 and a high concentration of [S]0, the formation rate of 
product [P] is independent of [S]0 amount. In this case, it reaches the maximum 
rate (velocity) value, υmax.  
 
According to these, the product formation rate can be stated as,  
 
Figure 2-20: Schematic illustration of trypsin binding to the substrate via ionic interaction. Adapted 
from [195].  
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v = kcat [ES]              (2.12) 
 
where kcat, also called turnover number, is the rate constant which equals the number of 
substrate molecules reacting to form product per enzyme molecule in a second and [ES] is the 
concentration of the enzyme–substrate complex. When the system is in steady-state 
conditions, there will be no change in [ES] which means [179], 
 
                d[ES]/dt = 0 = k1 [E][S] – k-1 [ES] – kcat [ES]                             (2.13) 
 
 [ES] = (k1 / (k-1 + kcat)) [E][S]            (2.14) 
 
And this then turns to the Michaelis-Menten equation, when an enzyme-substrate interaction 
specific Michaelis constant, KM is defined as ((k-1 + kcat) / k1),  
 





                                                            (2.15)  
 
When KM >> [S]0, the rate will be proportional to proportional to [S]0 and the equation will 
change to υ = (kcat / KM) [S]0 [E]0.  
 
However, when [S]0 >> KM, it will be independent of [S]0 and reach the maximum velocity, υ 
= Vmax = kcat [E]0, as this can also be seen in the Figure 2-21 below. 
 
Figure 2-21: Relationship between the reaction rate and substrate concentration for an enzyme-
catalysed reaction.  
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3.1 Materials and Reagents  
Trypsin (MW 23.4 kDa), bovine serum albumin (BSA) (MW 66.5 kDa), calcium chloride, 
casein (MW 24 kDa), dopamine hydrochloride, ethanol, isopropyl alcohol, sodium dodecyl 
sulfate (SDS), trypsin inhibitor (Glycine wax, soybean), 6-mercaptohexanol (MCH), 2,2′-
(ethylenedioxy)diethanethiol (DT) and 10x phosphate-buffered saline (PBS) were purchased 
from Sigma Aldrich (UK) and used as received without any further purification. Amino acids 
were purchased from GL Biochem Ltd. (Shanghai). Eudragit® L 100-55, L 100 and S 100 
polymeric powders were supplied by Evonik Nutrition & Care GmbH. All reagents were of 
analytical grade. Protease-free deionised water (Millipore Milli Q, 18.5 MΩ-cm) was used for 
the preparation of all solutions.  
 
3.2 Synthetic Methods  
The chemical probes used throughout this work were synthesised by Dr. Matteo Staderini 
and/or Dr. Nicolaos Avlonitis. Further details of the experimental protocols for the synthesis 
of the redox-labelled peptides (both substrate and control probes) with mono or tri-branched 
(tripod) anchor can be found elsewhere [7], [196], [197]. The following summary focuses on 
the description of the general procedures and the main synthetic steps.   
N-(carboxypropyl)methylene blue (4) was synthesised (Figure 3-1) using the 
previously described procedure [7], [198]. N-Methyl-N-(carboxypropyl)aniline (2) was 
prepared starting from commercially available materials. N-methyl aniline (1 equiv.) and 
ethyl-4-bromobutyrate (1.1 equiv.) were dissolved in acetonitrile. To this solution 2,6-lutidine 
(1.15 equiv.) was added and refluxed overnight. N-Methyl-N-(carboxypropyl)aniline (2) (1 
equiv.) was obtained following base mediated hydrolysis of (1). 2-Amino-5-
(dimethylamino)phenylthiosulfonic acid (3) was prepared in-house by using Wagner`s 
protocol [199] and then (2) and (3) (both 1 equiv.) were mixed and dissolved in a mixture of 
methanol/water (2.5/1 v/v) and heated to below reflux (60 °C). To this reaction mixture silver 
carbonate (50% w/w) was added in portions and refluxed for 2 hours. After 2 hours, the 
reaction mixture was cooled to room temperature, filtered and concentrated under reduced 
pressure. The product, N-(carboxypropyl)methylene blue (4) was isolated by dry column 
chromatography, eluting with a gradient of chloroform/methanol/acetic acid.  
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Figure 3-1: Synthesis of N-(carboxypropyl)methylene blue [7]. 
After synthesis of carboxylic acid derivative of the methylene blue, redox-labelled peptides 
(5) (Figure 3-2) were synthesised via Fmoc solid-phase peptide synthesis (SPPS) chemistry. 
Aminomethyl polystyrene resin was first functionalized with 4-[(2,4-dimethoxyphenyl)-
(Fmoc-amino)methyl]phenoxyacetic acid linker (Fmoc-Rink-amide linker). The resin was 
swollen in dichloromethane (DCM) and the Fmoc group deprotected using piperidine (20% in 
DMF (N,N-dimethylformamide))  to obtain the free amine for the coupling of each amino acid, 
PEG or alkyl spacer. The carboxylic acid group on the amino acids/spacer/redox agent 
(including Fmoc-PEG(2-12)-OH, Fmoc-8-Aoc-OH, Fmoc-Phe-OH, Fmoc-D-Phe-OH, Fmoc-
Arg(Pbf)-OH, Fmoc-D-Arg(Pbf)-OH, Fmoc-Cys(Trt)-OH or N-(carboxypropyl)methylene 
blue) were activated using N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium 
hexafluorophosphate (HBTU) with N,N-Diisopropylethylamine (DIPEA) in DMF. To achieve 
activation, the reaction mixture was stirred for 2 min and then transferred into a SPPS cartridge 
and the reaction shaken for 3 hours. The mixture was washed three times in succession with 
DMF, DCM and methanol. The Kaiser test [200] was performed to check completeness of 
coupling at each step. Afterwards, to enable cleavage from the resin, the TFA-based cleavage 
cocktail (TFA/EDT/water/TIS 94/2.5/2.5/1 v/v) was added to the pre-swollen resin and stirred 
for 3 hours at room temperature. After three hours, the reaction mixture was filtered, and the 
resin was washed again with the cleavage cocktail to ensure the collection of all the peptide. 
The filtrate was added into cold diethyl ether and the solid was collected by centrifugation 
(x3). The resulting solid was dissolved in water/acetonitrile mixture (1/1 v/v) and purified by 
semi-preparative reverse-phase high-performance liquid chromatography (RP-HPLC) system 
(Agilent 1100 equipped with a Zorbax Eclipse XDB-C18 reverse-phase column).  
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Figure 3-2: Chemical structure of the synthesised redox-labelled peptide probe (MB-Phe-Arg-Arg-
PEG-2-COOH) [197].  
 
As shown in Figure 3-3 and 3-4, mono- and tripod-anchor were synthesised by the multistep 
reactions previously described [7], [197]. Both probes (mono or tripod-anchored) were 
synthesized using N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
(EDC.HCl) and hydroxybenzotriazole (HOBt) chemistry. To a solution of compound (5) in 
DMF, EDC.HCl (3 equiv.) and HOBt (3 equiv.) were added and the reaction mixture was 
stirred for 2 hours to ensure complete activation. To this solution, the mono- or tripod-anchor 
was added and stirred for 24 hours at room temperature. The solvent was evaporated under 
reduced pressure and all protecting groups were hydrolysed with the addition of the TFA-
based cleavage cocktail. The mixture was stirred for 30 min and the progress of deprotection 
was monitored by analytical HPLC (Agilent 1100 equipped with a Phenomenex Kinetex® 5 
µm XB-C18 100 Å LC column). After complete conversion, the solvent was evaporated in 
vacuo and the reaction was purified by semi-preparative RP–HPLC. # 
 
Figure 3-3: Synthesis of mono-anchored redox-labelled peptide probe. Reaction conditions: i) DTPM-
NMe2, MeOH, overnight; ii) (3- Bromopropoxy)-tert-butyldimethylsilane, NaH, DMF, 24 h; iii) TBAF, 
THF, overnight; iv) MeSO2Cl, Et3N, DCM, 3 h; v) KSAc, anhydrous THF, overnight; vi) HCl/MeOH 
(1/4), 3 h, reflux; vii) triphenyl methanol, TFA, overnight; viii) hydrazine monohydrate, anhydrous 
THF, 1 h; ix) redox-labelled peptide product (MB-Phe-Arg-Arg-PEG-2-COOH, Figure 3-2), HOBt, 
EDC, DMF, 24 h; x) TFA/EDT/water/TIS, 30 min [197].  
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Figure 3-4: Synthesis of tripod-anchored redox-labelled peptide probe. Reaction conditions: i) DTPM-
NMe2 1, MeOH, overnight; ii) (3-bromopropoxy)-tert-butyldimethylsilane, NaH, DMF, 24 h; iii) 
TBAF, THF, overnight; iv) MeSO2Cl, Et3N, DCM, 3 h; v) KSAc, anhydrous THF, overnight; vi) 
HCl/MeOH (1/4), 5 h, reflux; vii) triphenylmethyl chloride, DCM, 3 h; viii) hydrazine monohydrate, 
1 h; ix) redox-labelled peptide product (MB-Phe-Arg-Arg-PEG-2, Figure 3-2), HOBt, EDC, DMF, 24 h; 
x) TFA/EDT/water/TIS (94/2.5/2.5/1), 30 min [197].  
 
3.3 Electrodes  
The working electrodes used throughout this work were either commercial (conventional) or 
non-commercial (in-house fabricated). Commercial electrodes consisted of macro (2 mm-
diameter) and micro (25 µm-diameter) gold and platinum disc electrodes (Figure 3.5) 
purchased from IJ Cambria, UK. All experiments in Chapter 4 and part of the work in Chapter 
5 were performed using these electrodes. In addition, for the characterisation of potential-
controlled deposited SAM probes in Chapter 6 and polymeric coatings in Chapter 7, 
commercially available (Metrohm Dropsens, UK, Figure 3.6) screen-printed electrodes (SPEs) 
were used: gold 4 mm-diameter (DRP-C220BT). Non-commercial electrodes used in this work 
were fabricated in-house (as thin Pt layer electrodes on Si substrates) at the Scottish 
Microelectronics Centre (SMC) by Dr. Ewen Blair, Dr. Jamie Marland, Dr. Ilka Schmueser 
and/or Dr. Andrew Piper, and used to perform experiments, mainly for Chapter 5. The 
fabrication details for single microelectrodes as well as micro- and nanoelectrode arrays are 
given below. 
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Figure 3-5: A photograph of the bulk gold and platinum macro- and micro disc electrodes. 
 
 
Figure 3-6: A photograph of Dropsens screen-printed gold electrode of 4 mm-diameter. 
 
3.3.1 Fabrication  
Standard photolithography, deposition and etching techniques [182], [183], [185], [201] were 
used for the in-house fabrication of single microelectrodes, microelectrode arrays (MEA) and 
microcavity nanoband edge electrode arrays (MNEE) in this work. Figure 3-7 illustrates the 
schematic process flow of the photolithography, deposition and etching steps. Firstly, positive 
photoresist layer is coated on a material to be patterned and exposed to UV light through a 
photomask, leading to a patterning of exposed and unexposed photoresist areas as well as the 
development and thus removal of the exposed photoresist from the substrate. Then residual 
pattern of the photoresist is used as a protecting layer in the selective etch of the underlying 
material and the patterned material is left when it is removed.  
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Figure 3-7: The photolithography and etching process. A) Positive photoresist layer is coated on a 
material to be patterned and B) exposed to UV light through a photomask, leading to C) a patterning of 
exposed and unexposed photoresist areas and D) the development and thus removal of the exposed 
photoresist from the substrate. E) Residual pattern of photoresist is used as a protecting layer in the 
selective etch of the underlying material and then F) removed, leaving the patterned material. 
 
Using this process flow, architectures of the fabricated single microelectrodes and arrays were 
designed to consist of a patterned platinum electrode layer which was deposited onto a 
thermally-oxidised silicon dioxide insulation and a Ti adhesion layers and a top silicon nitride 
insulation layer patterned to define the sizes of the electrode regions and the contact openings 
(Figure 3-8). As shown, the last etching step (F-2) of both Si3.1N3.9  and Ti/Pt metal layers, 
instead of Si3.1N3.9 only, makes the only difference between MEA and MNEE devices, leaving 
a Pt nanoband at the edges of the defined area of the microcavity. 
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Figure 3-8: Top view and cross-sectional schematic diagrams (not to scale) of the fabrication steps 
involved in the development of single microelectrodes, microelectrode arrays (MEA) and microcavity  
nanoband edge electrode arrays (MNEE). A silicon wafer (A) was insulated with an oxide layer by 
thermal oxidation (B) and a platinum layer was deposited on a titanium adhesion layer (C). The metal 
film was patterned to avoid the possible exposure of metal around the perimeter of the final diced chip 
(D). This was followed by the deposition of low-pressure chemical vapour deposited (LPCVD) silicon-
rich silicon nitride as the top insulator (E). Then the electrodes and contact pads were formed by etching 
holes into the top insulator. This resulted in the single microelectrode or MEA (depending on the mask 
layout and patterning) via only etching the Si3.1N3.9 layer (F-1) or the MNEE via etching of both Si3.1N3.9 
and Ti/Pt metal layers (F-2). The colour code of materials is given below. Adapted from [185] [201].  
 
3.3.2 Single Microelectrodes   
The importance of using miniaturised electrodes of controlled dimensions to determine 
fundamental and reproducible sensor response and their advantages over commercial bulk 
electrodes are extensively discussed in Section 2.5.3. A set of such microelectrodes was 
therefore fabricated in-house and used to characterise SAM-functionalised peptide-based 
biosensor performance for this work. They used the same architectures as the previously 
designed, produced and well-characterised microelectrodes, for different applications within 
the group [182], [183], [202].  
There were two different electrode designs used to fabricate the single microelectrodes 
involved in this work; thin track (TT) and superthin track (STT) devices. Figure 3-9 shows 
both devices with optical microscope images of the electrode and contact track areas as well 
as the photolithography mask layouts used for their fabrication. Although they have identical 
system dimensions (35 mm x 3.75 mm x 0.55 mm), contact pad areas (3 mm x 5.8 mm of that 
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exposed 2.8 mm x 5.6 mm), electrode shapes and dimensional ranges, their contact track areas 
differs from each other which results in a varying area of the top insulator. The reason the 
contact track width was reduced from TT to STT devices was to reduce the area in which a 
failure of the top insulator might occur (critical area reduction). This failure point, such as a 
hole or crack, can expose the contact track metal which would lead to the electrode area 
increasing when dipped into the solution for aqueous measurements. This increase in the 
electrode area results that the microelectrode does not have a well-defined area anymore, 
which lead to a failed device. The critical area reduction also results in different resistances 
between the electrodes and the contact pads, which is observed to be higher for the superthin 
track electrodes than thin track electrodes. 
The detailed fabrication run sheet for the development of single microelectrodes (including 
layer thicknesses) can be found in Appendix-1.  For both device designs fabricated and tested, 
4-inch <100> n-type Si wafers were used to fabricate 40 individual devices including disc-
shaped electrodes, with five different diameters respectively: 10, 20, 30, 50, and 100 μm. The 
reason for using only disc-shaped ones (instead of squares or any other) as in-house built 
electrodes was to make an equitable performance comparison between these in-house 
fabricated electrodes and the commercial bulk disc electrode results which are analysed in 
Chapter-4.  
 
Figure 3-9: Top: mask designs used for photolithography process and photographs of in-house 
fabricated single disc microelectrodes with 20 µm-diameter; A) superthin track and B) thin track 
devices. Lower: optical microscopy images of the electrodes and contact tracks. 
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3.3.3 Microelectrode (MEA) and Nanoelectrode (MNEE) Arrays  
In addition to the single microelectrodes, microelectrode arrays (MEA) and microcavity 
nanoband edge electrode arrays (MNEE) were also fabricated and tested in terms of biosensing 
performance as substrates for SAM-based probes. Again, standard photolithography, 
deposition and etching techniques were used to obtain reproducible and well-defined MEA 
and MNEE devices [185], [201]. This time, a variety of different electrode structures was 
fabricated on each wafer, including arrays of disc-shaped microcavities with a diameter of 10, 
20, 30 μm and separated by 1D, 2D, 3D and 4D, where D is equal to the diameter distance of 
each microcavity. It means that, a MEA described 20µm-4D for example, consists of an array 
of disc microelectrodes with a diameter of 20µm, each separated by 80 µm distance from its 
neighbour electrode. The electrodes in an array are located in the square alignment. The area 
of the occupying array on a device was 5 × 5 mm2. Figure 3-10 shows a photograph of a MEA 
20µm-4D device, with optical microscopy images of that and a MNEE 10µm-2D. As it can be 
clearly seen, the colour difference of the electrodes (light grey for Pt in MEA, dark grey for 
SiO2 in MNEE) in these images indicates the successful etching of the metal layer and the 
formation of the nanoband in the MNEE devices [203]. Again, a detailed fabrication run sheet 
for the development of the MEAs and MNEEs (including layer thicknesses and the number of 
electrodes included per array) can be found in Appendix-2.  
 
Figure 3-10: A) A photograph of a microelectrode array (MEA 20µm-4D) and B) cross-sectional 
schematic diagram (not to scale) for a MEA 20µm-2D device with constituent material layer 
thicknesses. Optical microscope images of C) a microelectrode array (MEA 20µm-4D) and D) a 
microcavity nanoband edge electrode array (MNEE 10µm-2D) are also given. 
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3.4 Sensor Preparation and Characterisation  
3.4.1 Electrode Cleaning 
In order to obtain reliable and reproducible responses from the SAM-functionalised probes 
which were immobilised onto the electrodes, surfaces should be both clean and similar in terms 
of roughness before immobilisation of the probe molecules. Therefore, optimised protocols 
were developed by many experimented observations through this work. As a result of this, one 
can summarise that optimised protocols used for cleaning of electrodes depend on the material 
(platinum or gold) and type (commercial bulk or in-house built thin metal film on silicon chip 
or screen-printed ink). The cleaning of commercial macro and micro gold and platinum bulk 
disc electrodes (Figure 3-5) consists of three steps.  Firstly, gold electrodes were immersed in 
a piranha solution (prepared as 3:1 v/v mixture of sulfuric acid, H2SO4 (95%) and hydrogen 
peroxide, H2O2 (30%), CAUTION! piranha solution is strongly oxidising and should be 
handled with care!) and platinum electrodes were dipped into concentrated H2SO4 (95%) for 
10 min to remove organic residue from their surface. Then, they were successively polished 
to a progressively finer surface finish using a polishing cloth and a sequence of aqueous 
slurries containing first 1 μm, then 0.3 μm and finally 0.05 μm alumina particles (Buehler, 
Germany). This step was applied to achieve consistent surface roughness/smoothness in each 
experiment. Finally, each electrode was subjected to an electrochemical cleaning step by 
carrying out CVs, performing a number of cycles of E (between 0 and +1.6 V for gold, between 
-0.35 and +1.6 V for platinum) vs Ag| AgCl| KCl (3 M) in 0.1 M H2SO4 at a potential scan 
rate of 100 mV·s-1 until having reproducible and similar CVs to the characteristic 
voltammograms reported [201], [204], [205]. Some examples of characteristic CVs for cleaned 
gold and platinum macro- and microelectrodes are given in Figure 3-11. As seen in both Au 
macroelectrode and microelectrode cleaning CVs, a single Au oxide reduction peak (which 
seems sharper for microelectrode) can be observed at 0.8 V. Additionally, multiple oxidation 
peaks overlapped between 1.0 – 1.5 V are characteristic marks for a clean gold surface. For 
both Pt macro- and microelectrodes, there is a similar peak around 1.5 V which shows oxygen 
evolution. For Pt macroelectrode, the peak which is observed around 0.3 V signifies the Pt 
oxide reduction, whereas a sigmoidal response can be seen instead for Pt microelectrode, 
which presents the O2 reduction. Usually, a couple of peaks are also seen between -0.35 – 0 
V, which presents hydrogen evolution, adsorption and desorption. However, the current ranges 
used for the plots are not narrow enough to exhibit all of these characteristic features.  
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Figure 3-11: CVs of commercial i) Au macroelectrode (2 mm-diameter), ii) Au microelectrode (25 µm-
diameter), iii) Pt macroelectrode (2 mm-diameter) and iv) Pt microelectrode (25 µm-diameter) recorded 
in 0.1 M H2SO4 (between 0 and +1.6 V for Au, between -0.35 and +1.6 V for Pt) at a scan rate of 100 
mV.s-1 vs Ag| AgCl| KCl (3 M) reference electrode.  
 
On the contrary to bulk electrodes, only electrochemical cleaning was applied to other 
electrode types (in-house fabricated single microelectrodes, MEAs, MNEEs and commercially 
available SPEs), because concentrated acid cleaning or alumina polishing step would be 
extremely harsh and damaging condition. Their characteristic cleaning CVs and the 
development of an alternative electrochemical (reductive) cleaning technique are discussed in 
Chapter 5.   
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3.4.2 Sensing Layer Preparation 
3.4.2.1 Probe Immobilisation by Incubation (without any applied potential) 
Extending the established macroelectrode protocol [7], the respective probe layer was formed 
as a mixed monolayer SAM (redox-tagged peptide, DT and MCH) on a freshly cleaned 
electrode surface. Two different methods were followed for this purpose; dip coating for 
commercial bulk electrodes and drop-casting for in-house built electrodes and SPEs. For dip 
coating, the electrodes were immersed overnight at 4 °C in a 40 μM solution of the redox-
tagged peptide (either substrate: containing cleavable L-amino acids or a control: containing 
uncleavable D-amino acids) and freshly prepared DT (600 μM for macroelectrodes, 150 μM 
for microelectrodes) in ethanol. After washing with ethanol, the resulting SAM-modified 
electrode was immersed in 1 mM MCH in ethanol (for 1 h for macroelectrodes and 10 min for 
microelectrodes). It should be noted that these differences in the optimised SAM deposition 
protocol are consistent with the expected enhancement in sensitivity and mass transport 
kinetics of reactions at microelectrodes.  Finally, washing was carried out, firstly in ethanol 
and then in 1x PBS. For other type of electrodes, probe molecules were drop-cast on electrode 
surfaces. To do this, 10 μL of probe solution (with or without DT depending on a purpose) in 
1x PBS was pipetted and then slowly released onto the flat electrode surfaces as uniformly as 
possible. 1x PBS was used as solvent for this type of electrodes, instead of ethanol, to avoid 
evaporation before adsorption of SAM-modified molecules. The rest of the steps were 
followed as detailed above, keeping all the concentrations and durations identical. The 
modified electrodes were stored in 1x PBS at 4 °C until use. 
3.4.2.2 Potential-Controlled Probe Immobilisation  
In addition to the probe immobilisation which was processed by incubation without any 
applied potential, SAM-based probes were also immobilised by an electrochemical potential-
controlled technique. To achieve this, freshly cleaned and characterised electrodes were 
immersed in 1x PBS solutions containing SAM-based probes, followed by the immediate 
initiation of the previously programmed NOVA software protocol. The protocol was based on 
the application of the desired potentials for specific time periods by chronoamperometry (CA) 
and then monitoring the surface SAM coverage by rapid CV scans and SWV measurements. 
The solution was changed from PBS to ferri/ferro cyanide (FFC) between CA and CV steps 
for SAM integrity tests as there was a need for external redox agent to monitor the coverage 
through the redox reaction.  
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3.4.3 Electrochemical Measurements  
All electrochemical measurements were carried out using a conventional three-electrode 
electrochemical cell (Figure 2-14) which was driven by a computer-controlled AutoLab 
PGstat-30 Potentiostat running the GPES 4.9/NOVA 1.11/NOVA 2.1 software (Metrohm 
Autolab B.V., The Netherlands). An in-house built platinum-coated silicon dioxide chip was 
used as an auxiliary electrode. Previously described electrodes were used as working 
electrodes depending on the specific type of experiments which are detailed in the following 
chapters. All the working electrode potentials, E, were applied with respect to and are reported 
relative to a Ag| AgCl| KCl (3 M) reference electrode (Bioanalytical Systems, Inc., USA). The 
same reference electrode was used and abbreviated as Ag/AgCl for the rest of the work. A 
Lauda Eco Silver thermostatic bath (VWR International Ltd, UK) with an external pumping 
system and a water-jacketed glass cell (Figure 3-12) was used to control the temperature of all 
the experiments conducted at 25 °C or 37 °C. Origin 2018, MATLAB R2015a and/or MS 
Office Excel 2016 software was used for the analysis of the data. A code (See Appendix-3) 
was created in MATLAB for peak height calculations and enabled faster analysis of the time-
consuming overnight experiment data.       
 
 
Figure 3-12: Photographs of the water-jacketed glass cell integrated with three-electrode system inside 
the Faraday cage and the thermostatic bath (Lauda Eco Silver) used for temperature-controlled 
experiments.    
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The SAM-modified working electrodes from Section 3.4.2 were immersed in buffer solutions 
(usually prepared with 1x PBS, as it has an optimum pH, 7.4 for biological activity) and 
subjected to electrochemical measurements using square wave voltammetry (SWV, applying 
E at a frequency of 60 Hz, with an amplitude of 25 mV and a step potential of 5 mV) until a 
stable background signal was obtained. After addition of the target enzyme (trypsin), or the 
proteins (BSA, casein, FBS) for characterisation of non-specific binding/biofouling, the SWV 
signal was continuously monitored with time. Following the established analysis method for 
gold macroelectrodes[7], [196], the resulting signal is expressed as the relative change in the 
SWV peak current with respect to the initial peak current (henceforth called the % signal 
change).  
 
3.5 Preparation and Characterisation of Polymeric Coatings  
In order to prepare sensors as the substrates for polymer coatings which were tested in terms 
of delayed response (activity) and anti-biofouling characteristics, previously detailed protocols 
(Section 3.4.2.1) were followed. Gold SPE working electrode surfaces (unmodified or probe-
modified) were coated with the pH responsive polymers Eudragit® S100. To achieve this, 
polymeric powder was first dissolved in isopropanol at one of three different concentrations 
(8, 16 or 32% (w/v)). 10 μL of this solution was then drop-cast on a modified or an unmodified 
(bare) electrode surface, either as a single layer or consecutive layers of 10 μL (1-layer, 2-
layers or 3-layers). After drop-casting, the solvent isopropanol was left to evaporate at room 
temperature. Polymer-coated electrodes were then allowed to dry and stabilise for an 
additional couple of hours before use. Figure 3-13 illustrates all steps which were involved in 
the preparation of the polymer-coated electrodes for anti-biofouling and delayed activity 
assessments. They were then incubated in solution of 1x PBS (characterisation-optimisation) 
or 5 mM FFC (for unmodified electrodes as an external redox agent is required to monitor bare 
electrodes) or DMEM-FBS mixture (biofouling characterisation) of which the fixed pH value 
was measured using Fisherbrand Hydrus 400 pH meter (Thermo Fisher Scientific, UK), and 
then electrodes were subjected to electrochemical characterisations with time using CV and 
SWV measurements to monitor the dissolution of the coated polymer layers. For both CV and 
SWV measurements performed, methylene blue potential window (-0.05 to -0.4 V vs 
Ag/AgCl) was selected for probe-modified electrodes and the FFC potential window (0 to 0.5 
V vs Ag/AgCl) was selected for unmodified electrodes, as expected. In all experiments, the 
redox signal (peak current height at a fixed redox potential (E) of either methylene blue or 
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FFC) was monitored until it reached the maximum value and did not change any further with 
time, which corresponded to the complete dissolution of the polymer coating. The resulting 
signal was expressed as 100% (because the initial redox signal was zero for all cases, proving 
barrier polymer layer integrity) and the relative change (% signal change) in the redox signal 
was evaluated with respect to this value and plotted versus time.  
 
Figure 3-13: Representation of the modification and activation of a probe-modified screen-printed 
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4.1 Introduction  
Proteases (also called as peptidases) are enzymes that catalyse the hydrolysis of amide bonds 
in a peptide chain, thus breaking the peptides into smaller chains or single amino acids. Their 
dysregulation is widely recognised as playing a significant role in many physiological 
conditions and various disease states [206]. They are attracting widespread attention as key 
biomarkers of disorders such as Alzheimer’s [207], cancer [5], cardiovascular diseases [208] 
[209], cystic fibrosis [32], diabetes [210] and HIV [211]. The development of both sensitive 
and selective assays and sensors that monitor protease activity has therefore generated 
noticeable interest in recent years. According to Ong et al., it is possible to classify these 
methods into two main groups:  
• homogeneous assays (that include those based on colorimetry, mass spectrometry and 
fluorescence resonance energy transfer) 
• heterogeneous assays (that include those based on electrochemical techniques, 
surface-enhanced Raman scattering and surface plasmon resonance) [6].  
In heterogeneous systems, the recognition elements (sensing probes) are typically immobilised 
onto solid surfaces, which provide a ready interrogation, signal generation and detection 
interface, when the target analyte is present in the neighbouring aqueous medium. In 
homogeneous systems, however, both probe and analyte are present in the same aqueous 
medium, which can result in contamination and detection challenges. The principle of 
detection for both assay systems is based mainly on the recognition and cleavage of a specific 
peptide sequence attached to various signal reporters (e.g. fluorophores, nanoparticles, 
quantum dots or redox tags) by a peptide-specific protease. Then the reporter generates an 
output signal following the interaction between the peptide and protease, providing analyte 
detection [212]–[215].  Amongst the various methods used for protease sensing, there has been 
a remarkable growth in reputation of electrochemical peptide-based biosensors, as they offer 
• high sensitivity 
• rapid response times 
• ready multiplexing 
• the use of cheap instrumentation 
• ease of miniaturisation for point-of-care (PoC) applications [216].  
Such electrochemical peptide-based biosensors typically use a specific substrate peptide 
attached to a redox tag as the selective recognition moiety and the protease as analyte. There 
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is extensive literature on protease detection using this approach [7], [8], [83], [196], [197], 
[217]–[229]. For example, Liu et al. described a method that allowed detection of matrix 
metalloproteinases (MMPs), whose proteolytic activities have close association with cancer 
progression, at very low concentrations with a limit of detection (LoD) of 3.4 pM [225]. An 
alternative approach was developed by Lee et al., who reported on the reference electrode-free 
sensing of MMP-9 using the self-gating effect on a concentric electrode system consisting of 
an island and an enclosing electrode [83]. More recently, Zheng et al. suggested a new strategy 
to amplify the sensor sensitivity resulting from multiple catalytic reactions triggered by 
palladium-polydopamine (Pd-PDA) nanocomposites. In this way they sensed MMP-7 with a 
very low concentration of 3.1 fg mL-1 [230]. In addition to these and other works targeting 
MMP type enzymes [231], there has been increased interest and activity in sensing other 
significant proteases such as β‑Secretase (BACE1) [232], botulinum neurotoxin (BoNT) 
[233], caspase [234], cathepsin [235] and prostate specific antigen (PSA) [236]. Furthermore, 
researchers in the chemistry strand of the IMPACT project (detailed in Section 2.2.1), has 
previously proposed, produced, characterised and optimised a macroelectrode-based sensor 
system for the detection of trypsin activity using a peptide-based self-assembled monolayer 
(SAM) probe on an electrode surface [4], [7], [196], [197]. This sensor was translated 
successfully to the analysis of other proteases, e.g. human neutrophil elastase (HNE), allowing 
clinically relevant measurements of its activity in human blood [8]. Despite all these 
achievements in the area of protease sensing using electrochemical biosensors, most of these 
systems still use relatively large-scale electrodes which leads to limitations with respect to 
sensor performance as well as applicability to implantation. More specifically, as well as being 
smaller, with a less invasive footprint, microelectrodes offer other potential advantages over 
macroelectrodes that include more rapid diffusion (which can lead to shorter and more 
controlled response times through enhanced and more reproducible mass transport) and higher 
signal-to-noise which leads to higher sensitivities [180], [237]. This makes using 
microelectrodes an attractive route for electrochemical biosensors, in addition, miniaturised 
technologies offer advantages for biosensor design such as  
• Integrated high-fidelity manufacturing with lower manufacturing costs per sensor 
• The ability to work with small quantities of materials and samples 
• Ease of multiplexed measurement options [102], [103].  
Therefore, there are strong drivers for the development of miniaturised electrochemical 
systems for biosensors for the detection of proteases.  
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This chapter will describe the principle of detection for peptide-based electrochemical 
biosensors used for protease sensing. It will then cover some work consisting of step-by-step 
optimisation and characterisation of the proposed sensing system developed using gold 
macroelectrodes. This will also provide an understanding of the reason why a particular 
sensing probe was used through the rest of the work for characterisation of platinum macro- 
and microelectrodes.  It will investigate the differences in sensor performance between macro- 
and microelectrode-based systems and how these differences could be explained in terms of 
the dissimilarities in the probe conformation on electrode surface, kinetics and 
thermodynamics of enzyme-substrate cleavage and the effects of non-specific binding. 
 
4.2 Principle of Detection and Sensing Probes 
The proposed electrochemical detection principle was based on the specific proteolytic 
cleavage of the redox-tagged peptide probes anchored onto the electrode surface by the target 
protease, which should lead to the release of the soluble redox-tagged peptide fragment and a 
corresponding decrease in the redox peak as measured by square wave voltammetry (SWV) 
technique (Figure 4.1). As a target enzyme, a serine protease trypsin was selected as a model, 
because it is widely researched and has important links to diseases such as pancreatitis [238] 
and colorectal cancer [239].  
As details given in the synthesis and electrode preparation parts (Section 3.2 and 
Section 3.4), the sensing (recognition) layer consists of a mixed SAM; the probe with the target 
peptide tagged with methylene blue (MB) and attached to a thiol-terminated polyethylene-
glycol (PEG)-6 spacer, backfilling with mercapto hexanol (MCH) to minimise pinholes in the 
SAM layer and co-adsorbent PEG-based dithiol (DT) molecules to support the orientation, 
specificity and accessibility of the probe on the electrode surface. Two different MB-labelled 
peptides were used, the L-amino acid sequence for trypsin-cleavable substrate or the D-amino 
acid sequence analogue as a trypsin-uncleavable control. The general sequence structure is 
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Figure 4-1: Principle of detection of the peptide-based electrochemical platform. The protease (trypsin) 
catalyses the cleavage of the immobilised redox-labelled peptide releasing the redox-containing 
fragment into solution and leading to a decrease of the electrochemical signal which is measured by 
SWV. 
 
Figure 4-2: Chemical structure of the probe, containing methylene blue (blue) as the redox tag, 
Phenylalanine-Arginine-Arginine (orange) as the peptide sequence and PEG-6 (green) as the spacer and 
cysteine (red) as the anchor. 
 
4.3 Optimisation of the Sensing Probes 
The general sensing layer detailed in above section was the one mostly used throughout the 
work and this was the optimal design secured after various modifications [7], [196], [197]. 
This section will present a summary of these modifications developed by Dr. Eva Gonzalez-
Fernandez and Dr. Matteo Staderini, through experiments performed using gold 
macroelectrodes. Different SAM models were designed, synthesised and characterised during 
this optimisation phase. These modifications consisted of spacer type (alkyl or PEG-based 
chain), SAM configuration (binary or ternary), redox tag (ferrocene or methylene blue), spacer 
length (PEG-x) and an anchor (mono or tri-branched).    
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4.3.1 Effect of the Spacer Type  
Four analogous sensing layers were designed and synthesised, each having a spacer type of an 
alkyl (aminohexyl)-based (substrate-modified: L-amino acids or control-modified: D-amino 
acids) or a PEG-based chain (substrate-modified: L-amino acids or control-modified: D-amino 
acids) as the only difference in the probe (Figure 4.3). Each of the probe-modified gold 
macroelectrodes was then characterised in a 1x PBS solution by SWV measurements (Section 
2.6.2) before and after the addition of trypsin. The rate of signal decrease recorded before and 
after enzyme was found to be similar (5-10% due to the change in redox signal with time) 
within experimental error for both substrate- and control-modified surfaces with the probe 
including the alkyl spacer [7]. This suggested that the enzyme was not able to bind the 
recognition site and release the redox-tagged fragment into solution. However, in the case of 
the probe containing the PEG-based spacer, a clear signal loss (25%) was observed for 
substrate-modified electrodes, whereas it was only about 5% for control-modified ones, 
confirming successful protease cleavage [7]. It suggested that a PEG type spacer was far better 
than an alkyl type spacer in terms of enabling effective protease cleavage. This is quite 
reasonable as PEG spacers are already known to increase the hydrophilicity of a surface as 
well as to create a less packed SAM layer, owing to their highly solvated nature, compared to 
the more packed SAMs which can be found in alkyl chain-included probes [240], [241]. This 
less packed SAM formation might have promoted the interchain enzyme accessibility and 
binding, which resulting in the cleavage of the peptide sequence.  
 
 
Figure 4-3: Chemical structures of two spacer types characterised during the optimisation phase, 
polyethylene glycol (PEG)- or alkyl-based. 
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4.3.2 Effect of the SAM Configuration  
Four different SAM configurations were prepared and tested; B-SAM (substrate-modified or 
control-modified) and analogous T-SAM (substrate-modified or control-modified) as depicted 
in Figure 4.4. T-SAM was prepared by the introduction of DT as the third component. All 
electrodes modified with each sensing phases were subjected to SWV measurements in 1x 
PBS.  
 
Figure 4-4: Two different SAM configurations used during the optimisation phase, binary (B-SAM) 
and an analogous ternary (T-SAM) structure which was prepared by the introduction of dithiol (DT) 
molecules as the third component. 
 
As seen in Figure 4.5, both control- and substrate-modified T-SAM configurations did not 
show any signal loss until the enzyme addition which took place at time t = 20 min. On the 
other hand, a signal decrease of around 10% was registered for the substrate-modified B-SAM 
configuration before enzyme addition, which most probably indicates its lower background 
redox signal stability or inhibition of the electron transfer between the redox tag and the 
electrode. This might be due to the interchain interactions occurring between closer probe 
molecules in B-SAM orientation and/or the limited mobility of these molecules. After trypsin 
was added at min 20 and the signal was monitored for a further 70 min, a clear signal decrease 
of ~50% was recorded for substrate-modified T-SAM, while uncleavable control-modified T-
SAM surfaces still did not show any significant signal change. It is worth noting that the signal 
decrease was only around 15% for the B-SAM configuration, even after 70 min incubation 
with the enzyme. The explanation for this enhanced amount of signal decrease observed for 
the T-SAM compared to the B-SAM configuration could be a more diluted SAM surface due 
to introduction of the DT molecules, because DT molecules are expected to increase the 
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spacing between the probes thus increasing enzyme accessibility and the total amount of probe 
cleavage. This can be achieved without a requirement to change the cleavage rate of each 
enzyme but only by increasing the proportion of cleavable probe on the surface [242], [243]. 
Because it was also reported by Buscher et al. that the surface coverage is significantly related 
to the intermolecular interactions and corresponding SAM orientation until a monolayer is 
formed [244]. However, in this case, increasing the DT concentration increased the percentage 
signal loss for concentrations below 150 µM, whereas there was little variation for the 
concentrations between 150 and 900 µM. 600 µM was selected as the optimum DT 
concentration added to the SAM deposition solutions [7]. 
 
Figure 4-5: Percentage signal decrease registered upon trypsin addition (100 nM) for substrate-
modified B-SAM (purple squares), control- (red triangles) and substrate-modified T-SAM (blue circles) 
in 1x PBS. The addition of trypsin (at time t = 20 min) is denoted by the yellow sector symbol. Average 
data and error bars are typically from 3 individual SAM sensing layers. Adapted from [7].  
 
4.3.3 Effect of the Redox Tag 
In order to analyse and optimise the redox tag included in the probe structure, analogous 
peptides were prepared and tagged with either ferrocene (Fc) or methylene blue (MB) 
molecules (Figure 4.6). Both substrate- and control-modified Fc-tagged peptides showed a 
steady decrease of the registered signal of ~10% until the time (t = 20 min) when the enzyme 
was introduced (Figure 4.7). On the other hand, the registered signal from MB-tagged peptides 
was constant within experimental error. Considering the strong Au-thiol bonding reported 
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previously [245] and identical anchors in all peptide types used for this characterisation, 
similar probe anchoring stability on electrode surfaces should be expected thus this difference 
cannot be justified as being due to any probe loss. In this case, any difference should be 
attributed to the stability of the redox tag, as it undergoes repeated electrochemical cycling 
during SWV measurements.  
 
Figure 4-6: Representation of two different probe structures with different redox tags attached, 
ferrocene (Fc) and methylene blue (MB) as well as their chemical structures.   
 
Figure 4-7: Percentage signal decrease registered upon trypsin addition (100 nM) for Fc-tagged and 
MB-tagged peptides in 1x PBS. Responses from control (red triangles) and substrate (blue circles)-
modified SAMs are represented for both cases. Average data and error bars are typically from 3 
individual SAM sensing layers. Adapted from [7]. 
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Comparing the registered signal decreases from both control-modified Fc- and MB-tagged 
peptides, it can be suggested that use of MB significantly decreased the undesired background 
signal decrease which enables a more clear and reliable distinction from the substrate-modified 
probes, generating more robust and readily analysable data and developed detection sensitivity 
and selectivity. This observation was also found to be consistent with the literature where the 
relative lack of stability was attributed to the tendency of the oxidised form of ferrocene, 
ferrocinium (Fc+) to undergo nucleophilic attack, followed by a ligand exchange, leading to 
an irreversible change in the redox activity [246]. 
 
4.3.4 Effect of the Spacer Length 
As seen in the detailed probe structure in previous sections (Section 3.2 and Section 4.2), the 
spacer moiety plays a role as a bridge between the anchoring thiol group and the enzyme-
specific peptide chain in promoting enzyme accessibility and probe flexibility. In order to 
analyse and define the optimum length and nature of the spacer, analogous peptides with 
varying PEG-based spacers (PEG-2, PEG-4, PEG-6, PEG-8 and PEG-12) and an alkyl-based 
spacer were synthesised (Figure 4.8) and interrogated by the addition of both a target enzyme, 
trypsin and non-specific binding protein, bovine serum albumin (BSA). All included MB as 
the redox tag and were prepared with the T-SAM configuration for which the parameters were 
already optimised and defined (Section 4.3.2). Firstly, all probes were evaluated in terms of 
their initial SWV signal in PBS. Initial peak currents of the two longest PEG-spacer lengths 
(PEG-8 and PEG-12) were found to be almost 2-fold lower than the three shorter spacers and 
PEG-2 had the highest peak SWV signal. This is expected considering that the longer spacer 
lengths lead to less efficient redox transfer between the redox tag and the electrode surface 
[247] Because the mechanism for electron transfer can change when the spacer length is 
altered. It was previously reported that electron tunnelling mechanism (where the electron 
tunnels through the large energy barrier between the donor and the acceptor via quantum 
mechanical effect by passing through virtual states of the molecular bridges) dominates for 
shorter chain oligoglycine spacers, whereas for longer chains, the electron transfer occurs via 
hopping mechanism (where the electron is temporarily found on the molecular bridge between 
the donor and acceptor, creates radical species and then transfers from the donor to the acceptor 
in different steps by passing the low energy barrier) [248] [249]. In addition, all peptides were 
also evaluated in terms of the specific (which occurs in the case of trypsin cleavage) as well 
as non-specific (which occurs in the case of any undesired enzyme or protein binding to the 
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probe, followed by restricted probe flexibility and signal loss due to the lack of efficient 
electron transfer) interactions. Their ability to deal with biofouling was assessed through 
comparative analysis by monitoring the electrochemical signal change upon addition of BSA 
and trypsin. 
 
Figure 4-8: Chemical structures of the different PEG spacer lengths with the number of ethylene glycol 
(EG) units, denoted by PEG-x, and an alkyl-based spacer (8-aminooctanoic acid, Aoc). 
 
Figure 4.9 presents the percentage signal change registered for substrate-modified surfaces for 
the specific interaction with 100 nM trypsin (green columns) compared to 100 nM BSA 
(orange columns). For all the different PEG-based and alkyl spacers tested, reassuringly the 
percentage signal change registered for the specific interaction was larger than for the non-
specific interaction. The black line in Figure 4.9 shows the fraction of the specific versus non-
specific registered signal, as a means of evaluating the degree of anti-fouling quantitatively 
for each spacer, PEG-6 was the best spacer length with highest specific versus non-specific 
ratio. This observation was also consistent with the analysis of the kinetics, where effective 
rate constants (keff) for specific and non-specific interactions were compared as illustrated in 
Figure 4.10. It is also worth noting that alkyl-based spacer showed the poorest anti-fouling 
properties, compared to the PEG-based spacers which further supports the argument discussed 
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in Section 4.3.1. This is most likely due to the hydrophilic nature of PEG molecules, as this 
hydrophilic nature has been thought to minimise the intermolecular interactions between the 
probe molecules and non-specific proteins, when they are not modified with any external effort 
[250], [251].  
 
 
Figure 4-9: Percentage signal change for the specific interaction registered upon addition of trypsin 100 
nM (green columns) or for the non-specific interaction with BSA 100 nM (orange columns) after 70 
min incubation in 1x PBS. Black line represents the specific versus non-specific ratio of percentage 
signal change registered for each probe. Average data and error bars are typically from 3 individual 
SAM sensing layers. Adapted from [196]. 
 
 
Figure 4-10: Ratio for the measured effective reaction rate constant, keff , for specific (trypsin 100 nM) 
versus non-specific (BSA 100 nM) binding. Adapted from [196]. 
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4.3.5 Effect of the Anchor  
It was mentioned in the previous sections that there is an interest in developing peptide-based 
electrochemical biosensors for many sensing applications and the immobilisation strategy of 
the recognition probes for these systems is mostly via SAM-based through a thiol group which 
can be strongly bonded to Au or Pt electrode surfaces. Therefore, unproblematic application 
and stability of this anchoring between the probe structure and the electrode is vital for reliable 
sensing, especially in complex biological media. For this reason, as a final optimisation 
parameter for macroelectrodes, the robustness and durability of a peptide probe tagged with a 
single or a tri-branched (tripod) thiol anchor (Figure 4.11) was investigated in terms of the 
performance, thermal and chemical stability. When the initial SWV signal was measured, they 
were found to be 1.9 ± 0.5 μA (n = 19) and 6.0 ± 2.0 μA (n = 14) for the mono-anchored and 
tripod-anchored probes, respectively. This is consistent with a higher amount of tripod-
anchored probe being immobilised on the surface due to its enhanced and thus favoured 
binding energy (owing to the multiple thiol-Au bonding) relative to the backfilling MCH and 
DT molecules.  
 
Figure 4-11: Representation of the mono- and triple (tripod)-anchor probes immobilised onto an 
electrode surface. 
 
As depicted in Figure 4.12, the stability of the tripod-anchored probe was evaluated and 
compared to the analogous mono-anchored system. Figure 4.12A shows the assessment of 
their shelf life when the probes were stored at 4 °C in PBS for 30 days and periodically 
monitored with the SWV signal. An increased storage stability of tripod-anchored probes is 
clearly observable, as the signal loss was only about 25% after 30 days, whereas the signal 
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loss obtained for mono-anchored probes was about 55-60%. They were also evaluated in terms 
of thermal stability. For this purpose, they were immersed in PBS at 40 °C and the SWV signal 
was monitored over a time period of 2 hours (Figure 4.12B). Again, the stability of tripod-
anchored probe was observed to be higher than mono-anchored probe. Furthermore, both 
anchor types were assessed in PBS containing 2 mM dithiothreitol (DTT) which is another 
thiol group-anchoring molecule often present, with the aim of challenging the anchors through 
competitive binding onto the electrode surface. Tripod-anchored probes again showed a 
greater stability, whereas the registered signal from mono-anchored probe was seen to 
continuously decrease. Overall, one can easily rely on multi-anchored strategy by considering 
these reproducible results that exhibited improved stability of tripod-anchor over mono-anchor 
under all tested conditions as well as similar multiple anchor studies reported for various 
applications [252]–[254]. However, the synthesis of tripod-anchored probes (Section 3.2) is 
challenging compared to the mono-anchored ones and unfortunately, they could not be 
obtained in large yields which hindered its use for most of the following performance 
characterisations of the protease sensors. Therefore, mono-anchored probes have been used 
instead unless otherwise is stated.  
 
Figure 4-12: Percentage signal change registered for tripod- (red) and mono (blue)-anchored probes 
when (A) stored in 1x PBS at 4 °C for 30 days; (B) immersed in 1x PBS at 40 °C for 2 h; and (C) 
immersed in 1x PBS containing 2 mM DTT at room temperature. Average data and error bars are 
typically from 3 individual SAM sensing layers. Adapted from [197]. 
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4.4 Analytical Performance of Gold Macroelectrodes  
After the sensing probe was optimised, quantitative trypsin detection was evaluated and the 
analytical performance of a developed electrochemical sensors was assessed initially using 
gold macroelectrodes by Dr. Eva Gonzalez-Fernandez [7]. The optimised sensing probe (MB-
tagged, PEG-6 spacer, T-SAM and mono-anchored) was therefore immersed in 1x PBS 
solutions containing varying trypsin concentrations (0.1–100 nM) for 70 mins. The addition 
of trypsin enzyme (at time t=0) caused the expected changes in signal for the macroelectrode 
when interrogated by SWV (Figure 4.13). This change was then plotted as a percentage signal 
decrease (Figure 4.14) as before as in Section 4.3. In addition to the varying trypsin 
concentrations incubated with substrate-modified probe, a negative control experiment was 
also performed by incubating the control-modified probe with 100 nM trypsin. As presented 
at the same figure, this negative control signal can be subtracted from the other data recorded 




Figure 4-13: Typical background-subtracted SWV curves for a SAM-functionalised probe substrate 
immobilised onto Au macroelectrode registered for 100 nM trypsin at different incubation times (0, 5, 
15, 35 and 60 min) in 1x PBS. Adapted from [7]. 
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Figure 4-14: Top: Plot of % signal change vs time for SAM-functionalised probe immobilised onto Au 
macroelectrodes immersed in varying trypsin concentrations in PBS (0, 0.1, 0.5, 1, 5, 10, 25, 50, 100 
nM for substrate probe and 100 nM for the negative control probe, containing D-amino acids). All data 
represent the average (and standard deviations) from (typically) 3 functionalised electrodes. Bottom 
left: The data recorded for the negative control subtracted from the others. Bottom right: Natural 
logarithm of A(%), after 70 min plotted against the concentration of trypsin. The straight line 
corresponds to the best linear regression fit (lnA =−0.21 [trypsin/nM] + 4.46; r2= 0.87). The points of 
[trypsin]= 50 and 100 nM were not included in the fit due to that A(t)=0 and having large replicate error 
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As expected, there was no statistically significant difference between the control and the blank 
(0 nM trypsin) experiments, expect a small, negligible decrease in the signal due to the loss of 
SAM. On the other hand, there was a marked difference between them and the lowest trypsin 
concentration (0.1 nM) used, which confirms the high sensitivity and selectivity of the sensing 
platform. In addition, it is worth noting that the higher the trypsin concentration in solution, 
the faster the % signal decrease. At low trypsin concentrations (up to 25 nM), there was a 
proportional relationship between the enzyme concentration incubated and the natural 
logarithm of the percentage signal decrease. However, it was seen that it reaches a saturation 
point at the concentrations above 25 nM. Given that this system has been shown to follow 
Langmuir kinetics, this is to be expected at relatively low concentrations of trypsin compared 
to the Michaelis constant, where the proportion of surface covered by the trypsin-protein 
complex is expected to be low and the resulting rate of proteolytic cleavage is determined by 
this and is proportional to the concentration of trypsin.  
It is satisfying that, as predicted by the method previously developed [7], [8], A(t) can be 
defined as the percentage of signal left to change at time t, and calculated as;  
 
    A(𝑡) =
 (% SC at 𝑡)  −  (% SC as 𝑡 →  ∞)
(% SC at 𝑡 = 0)  −  (% SC as 𝑡 →  ∞ and [E]  →  ∞)
× 100%            (4.1) 
 
as % SC is the percentage signal change registered and [E] is the trypsin concentration. As 
plotted in Figure 4.14 Inset, the natural logarithm of A(t) is shown to be proportional to the 
trypsin concentration, [E] which is the confirmation of the first-order kinetics with respect to 
the trypsin concentration. It is also confirmed that this linear dependency is seen at only lower 
concentrations up to 25 nM, as it curved and reached saturation (for A(t)=0), with large 
replicate errors, at higher concentrations, 50 and 100 nM. This linear relationship allowed an 
estimation of the LoD as 250 pM for this Au macroelectrode-based sensor platform. This low 
LoD value is quite consistent with the values obtained using electrochemical, colorimetric and 
fluorescence-based techniques reported in literature [255]. It also successfully covers the 
clinically relevant range for trypsin levels in normal (5-15 nM) and chronic pancreatitis 
conditions (34-85 nM) [256], [257]. Additionally, the response of the sensor platform was 
evaluated upon exposure to enzyme followed by the enzyme inhibitor, Glycine wax, to further 
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confirm whether the source of the registered decrease was really due to selective enzyme 
cleavage.  
Figure 4.15 shows the immersion of the probe into 1x PBS solution containing 100 nM trypsin 
and corresponding % signal decrease, represented as the increase in fraction of product, fp with 
time. It shows the expected first order kinetics due to the trypsin cleavage. However, red line 
with triangles shows the inhibition of the cleavage reaction when initially it was immersed into 
the 1x PBS solution containing 100 nM trypsin, and then the introduction of 200 nM trypsin 
inhibitor (Glycine wax) after 10 min, where an almost stable signal registered afterwards. The 
hindering of the kinetics due to the enzyme inhibition in this way establishes the specificity of 
the sensor platform against the target enzyme. 
 
Figure 4-15: Fraction of products (fp or θ) vs time plot for probe immobilised-Au macroelectrodes 
responses upon addition of 100 nM trypsin (brown circles) or upon initial addition of 100 nM trypsin 
100 nM (at time t=0), followed by the addition of trypsin inhibitor (200 nM Glycine wax) into the 1x 
PBS solution (at time t=10 min) (red triangles). Trypsin is denoted by the yellow sector symbol whereas 
the green triangle denotes trypsin inhibitor.  
 
4.5 Analytical Performance of Platinum Macroelectrodes 
In order to evaluate and compare the analytical characteristics offered by the gold and platinum 
macroelectrodes in protease sensing, platinum macroelectrode surfaces were identically 
modified with the mixed SAM as described in Section 3.4.2.1. They were then immersed in 
buffer (1x PBS) solutions containing varying concentrations of trypsin (1-100 nM) and the 
electrochemical signal was interrogated by SWV with time. Figure 4.16 shows typical SWV 
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signals obtained from the probe immobilised onto a Pt macroelectrode over a time period of 
60 mins. The decrease in the signal (SWV peak height) is clearly observable after the addition 
of the enzyme (at time t=0). Also, the amount of this decrease observed per unit time (5 min) 
is higher initially after the enzyme addition (which means the higher amount of cleavage at 
the beginning), whereas it declines over time. In comparison to the typical SWV peaks 
obtained for the Au macroelectrode (Figure 4.13), it was found to be similar, in terms of the 
peak potential, height and also the approximate amount of decrease in signal after 60 min 
incubation with 100 nM trypsin. As only peaks obtained at 0, 5, 15, 35 and 60 min are given 
for Au macroelectrode, unlike Pt macroelectrode where all peaks are plotted in the figure, it 
seems like there was a difference in the amount of signal decrease per unit time. However, it 
was not the case when all of them has been analysed comparatively. It was again similar as 
observed in Au macroelectrodes, where the amount of the cleavage was found to be lowered 
with time again. This was quite advisable considering the cleavable probe amount has the 
highest level when enzyme is added, whereas this amount reduces over time and less amount 
of cleavable probe remains on the electrode surface, resulting in the experienced convergence. 
  
 
Figure 4-16: Typical background-subtracted SWV curves for a SAM-functionalised probe substrate 
immobilised onto Pt macroelectrode registered for 100 nM trypsin at different incubation times between 
0 - 60 min (with intervals of 5 min) in 1x PBS. 
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Figure 4.17 shows the signal decrease amounts registered for probe-immobilised Pt 
macroelectrodes immersed in varying trypsin concentrations in 1x PBS for 92 min. This 
incubation time was slightly different than the one (70 min) used for Au macroelectrodes. 
However, this difference is not considered as significant because the percentage signal 
decrease was found to be constant after a while, due to the fact that all cleavable probes on the 
electrode surface were successfully cleaved. It should be noted that the percentage signal 
decreases registered for Pt macroelectrodes did not varied too much than Au macroelectrodes 
(for same concentrations incubated). There was a slight difference in terms of standard 
deviations observed in Au and Pt macroelectrodes. They were found to be larger in Pt 
especially for higher concentrations, which might be attributed to the poorer reproducibility. 
However, there is not any inspected confirmation of the reason for this. Apart from that, there 
was again a proportional relationship between the natural logarithm of the percentage signal 
decrease and trypsin concentrations, and the kinetics was shown to follow the Langmuir model 
as similar to Au macroelectrode findings. Again, it is shown by plotting the ln A(t) vs trypsin 
concentration, [E] as depicted in Figure 4.17 Inset, where this relationship was fitted to a linear 
fit. Using this observed linear dependency of ln A(t) to concentration, LoD for Pt 
macroelectrode-based trypsin sensor was determined as 2.5 nM for sensing up to 25 nM. 
Although this value is significantly higher than the earlier reported value obtained using Au 
macroelectrodes (250 pM), there is not any evidence to be convinced that it was caused by a 
fundamental distinction between Au and Pt as electrode material. Moreover, these LoD values 
are only estimations reached after a limited number of measurements/replicates per each 
concentration. Therefore, it is quite possible that they are vulnerable to variations in SAM 
probe formation or measurement conditions. In order to make sure that they completely reflect 
the actual reaction, enough measurements should be performed. Furthermore, taking 
additional concentrations (0.1 and 0.5 nM) tested for Au (unlike Pt macroelectrodes) into 
account might have been the main reason which has led to increasing the measurement range 
and corresponding different estimated value.  
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Figure 4-17: Plot of % signal change vs time for SAM-functionalised probe immobilised onto Pt 
macroelectrodes immersed in varying trypsin concentrations in PBS (0, 1, 5, 10, 25, 50, 100 nM for 
substrate probe and 100 nM for the negative control probe, containing D-amino acids). All data 
represent the average (and standard deviations) from (typically) 3 functionalised electrodes. Inset. 
Natural logarithm of the adjusted signal, A(%), after 92 min plotted against the concentration of trypsin. 
The straight line corresponds to the best linear regression fit (lnA =−0.075 [trypsin]/nM + 4.498; r2= 
0.96). The point of [trypsin]=50 nM was not included in the fit due to having large replicate error 
compared to the other concentrations.  
 
4.6 Further Optimisations of Microelectrodes  
As significance of the design of the probe itself, all SAM-based components added to the probe 
solution plays an important role for the enzyme accessibility as well as electron transfer 
between the redox tag and electrode [258], [259]. It is also known that mass transport 
properties are different for macro- and microelectrodes. Enzyme cleavage and SAM film 
formation are normally faster for microelectrodes; however, it is valid only if they are under 
mass transport control. Therefore, optimising the self-assembled monolayers on electrode 
surfaces are vital, as the changes in surface chemistry and morphology have too much 
influence on diffusional properties. In addition, the optimal conditions should be used to avoid 
any possible undesired interaction between the charged/uncharged species or steric effects. 
For this purpose, further optimisations on microelectrodes were made in terms of backfilling 
substances (MCH) and third component (DT) molecules, keeping the same probe design, 
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concentration (40 µM) and protocols used for electrode preparation. Figure 4.18 shows both 
percentage signal decrease due to trypsin cleavage after 900 min as well as the initial probe 
signal before trypsin addition for Pt microelectrodes overnight-incubated with 40 µM probe + 
DT with varying concentrations of 50, 150, 300 and 600 µM.   
 
Figure 4-18: Registered % signal decrease (after trypsin incubation for 900 min) and initial currents 
(before any enzyme addition) for Pt microelectrodes following overnight incubation with 40 µM probe 
+ DT in various concentrations (50, 150, 300 and 600 µM). All data represent the average (and standard 
deviations) from 3 replicates. SWV data used for the preparation of this figure can be found in 
Appendix-4.   
 
% Signal decrease and initial currents registered were the same within experimental error for 
all DT concentrations. As given in Section 4.3.2, this was unsimilar to the macroelectrodes 
where increasing the DT concentration increased the percentage signal loss (for concentrations 
below 150 µM). This disparity in microelectrodes might be attributed to the possible formation 
of more close-packed probe layer immobilised on the surface prior to DT addition, thus leaving 
a limited space for DT molecules to get attached onto the surface, which might result in a less 
importance of the changes in concentrations above a threshold. As a result, 150 µM was 
selected as optimum DT concentration for further microelectrode experiments, because it at 
least has the highest mean value both in initial signals and % signal decrease registered.  
In addition to the concentration of DT molecules used, backfilling MCH molecules were also 
optimised in terms of treatment duration. The backfilling molecules are of great significance 
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and thus required for SAM-based electrochemical biosensing [260]. Otherwise, the sensing 
layer can include some defects/pinholes on the surface, which would be exposed to any 
undesired interaction such as non-specific binding. Furthermore, sizes and numbers of these 
pinholes on the surface may alter SAM reorganisation process [261]. All these can induce 
detrimental changes in the electrochemical signal, which should be avoided. The optimised 
backfilling treatment used for macroelectrodes was 1 h in 1 mM ethanolic solution of MCH. 
Because its common concentration used in literature is 1 mM [154], [262]–[264], this was kept 
same but only the effect of treatment (incubation) time was analysed. Figure 4.19 shows 
comparative initial currents registered for non-treated and treated Pt microelectrodes with 1 
mM MCH with varying treatment times (10, 30, 60, 1440 min) for both B-SAM (40 µM probe) 
and T-SAM (40 µM probe + readily optimised 150 µM DT) structures. Clearly, it suggests 
increasing MCH incubation time caused a decrease in the SWV signal registered for both B-
SAM and T-SAM configurations. It is, of course, interesting that there was almost no signal 
for T-SAM configuration after overnight MCH treatment, whereas still some remaining redox 
activity was observed for B-SAM.  
 
 
Figure 4-19: Comparative initial currents registered for non-treated and treated microelectrodes with 1 
mM MCH using different treatment times for both B-SAM (40 µM probe, represented with dark 
columns) and T-SAM (40 µM probe + 150 µM DT, represented with light columns) configurations. All 
data represent the average (and standard deviations) from 9 functionalised electrodes. 
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It can be hypothesised that more diluted surface in T-SAM configuration, as previously 
discussed, can deliver more space to backfilling molecules which could be thermodynamically 
preferred over probe molecules, accordingly reorganised and replaced them overnight. 
However, when all probes were assessed also in terms of the % signal decrease after trypsin 
addition, these were observed to be in similar range within experimental errors. Since even 
well-ordered SAM layers are known to have surface defects [265], the backfilling and 
corresponding passivation of the pinholes are crucial for sensitivity purposes. Therefore, the 
shortest time tested for treatment, 10 min, was selected as optimal duration and used for the 
rest of the microelectrode work, although no evidence of treatment time-dependent change in 
the % signal decrease was observed so far. 
 
4.7 Analytical Performance of Platinum Microelectrodes  
After above mentioned optimisations in backfilling MCH and third component DT molecules 
have been completed, platinum microelectrode surfaces were modified with the mixed SAM 
using optimised concentrations and durations, then monitored with SWV in real time. Figure 
4.20 shows typical SWV signals registered for the probe immobilised Pt microelectrode over 
a time period of 900 mins. The first difference to note was the amount of the signal, which 
was in the range of nanoamps (nA), whereas the signal recorded for macroelectrodes was 
usually in microamps (µA) range. This was expected and consistent with the electrode 
dimensions. As similar to Au or Pt macroelectrodes, the signal decreased after 100 nM trypsin 
addition (at time t=0). However, the decrease was explicitly slower for microelectrodes, 
compared to macroelectrodes. As seen in the figure, it was only around ~20-25% after an hour. 
In order to further investigate this, the electrodes were immersed into 1x PBS solutions with 
varying concentrations of trypsin, to check whether the response is similar. As depicted in 
Figure 4.21, the percentage signal decrease was slow for all trypsin concentrations incubated. 
In addition, microelectrodes were found to show different behaviour in terms of the amount of 
signal decrease. The maximum percentage signal decrease registered for Au and Pt 
macroelectrodes was, for example, ~35% (Figure 4.14, after 70 min) and ~55% (Figure 4.17, 
after 92 min), respectively, upon the addition of 100 nM trypsin. However, it was increased 
up to ~80% (after 900 min) for Pt microelectrodes. This observation was also valid for other 
high concentrations such as 25 and 50 nM. This means a change in the amount of the cleavable 
probes as well, which is not similar to macroelectrodes where no change of the proportion of 
cleavable/uncleavable probe amount was observed with increasing [E].  
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Figure 4-20: Typical background-subtracted SWV curves for a SAM-functionalised probe substrate 
immobilised onto Pt microelectrode registered for 100 nM trypsin at different incubation times between 
0 - 900 min (with intervals of 60 min) in 1x PBS. 
 
Figure 4-21: Plot of % signal decrease vs time for SAM-functionalised probe immobilised onto Pt 
microelectrodes immersed in varying trypsin concentrations in 1x PBS (0, 1, 5, 10, 25, 50, 100 nM for 
probe substrate and 100 nM for the negative control probe, containing D-amino acids). All data 
represent the average (and standard deviations) from (typically) 3 functionalised electrodes. Inset. 
Natural logarithm of A(%), after 900 min plotted against the concentration of trypsin. The straight line 
corresponds to the best linear regression fit (lnA =−0.030 [trypsin/nM] + 4.354; r2= 0.84). The point of 
[trypsin]=50 nM was not included again in the fit due to having large replicate error compared to the 
other concentrations. 
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Microelectrodes have been reported many times to show enhanced diffusional kinetics due to 
hemispherical diffusion compared to the linear diffusion observed for macroelectrodes as also 
given in Section 2.5.3 [266]. Therefore, it is clear from these observed cleavage rates that this 
difference in rate of proteolytic cleavage is not as a result of the rate of trypsin diffusion. Given 
that the rate must therefore be determined by surface reaction, it is likely that this difference 
results from the macro- and microelectrode surfaces having a different SAM structure and/or 
probe or target surface disposition.  It was previously noted that macro- and microelectrodes 
might differ from each other regarding the deposition and disposition of SAMs on their 
surfaces, which could affect the resulting properties such as electron transfer [267]. Although 
the trypsin cleavage reaction is not under diffusional control, such differences could arise from 
differences in diffusional rates during SAM film formation (as previously noted in Section 
4.6), and differences in uniformity of diffusion to macro and microelectrode surfaces when 
under diffusional control. Given this, it is interesting that there is a difference in the observed 
initial SWV peak potentials between macro and microelectrodes of around 70 mV which 
indicates a difference in average redox environment and overall film structure.  
In spite of these variations in the rate and the cleavage amount, the proportional relationship 
between the natural logarithm of ln A(t) and trypsin concentration revealed that the cleavage 
kinetics is still first order (Figure 4.21 Inset). LoD for microelectrodes was again determined 
using this linear dependency and found as 2.9 nM which is a quite close value to the one 
obtained using Pt macroelectrodes. Although this is a single point measurement on only three 
electrode replicates and is therefore likely to be a conservative estimate of the LoD value, the 
calculated linear response range and values are in good agreement with those reported in the 
literature [215], [229], [268]–[270], and still successfully covers the clinically relevant range 
for trypsin levels.    
 
4.8 Kinetic Analysis of Proteolytic Cleavage 
Although single time point analysis and linear calibration is a facile method, time-dependent 
analysis of multiple data points is likely to be more robust and sensitive, and when combined 
with Michaelis-Menten kinetic analysis, which models the non-linearity of the response with 
[E], analysis should be possible over a wider trypsin concentration range. The measured % 
signal changes for varying trypsin concentrations were therefore analysed as a function of time 
using the previously established Michaelis-Menten kinetic model for similar heterogeneous 
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enzymatic assays [7], [215], [228], [271]. According to this model, the % signal change, A, is 
expressed as a variation in the fraction (θ(t) = 1 - A(t)) of cleavable peptide which has been 
cleaved at any time, t. Data for each trypsin concentration are then fitted to the equation [7]: 
 
 
                                                          𝜃 = 1 −  𝑒−𝑘𝑒𝑓𝑓𝑡                                                   (4.2) 
 
 
where θ is the fractional cleavage of the substrate on the surface, keff is the effective rate 
constant and t is the time. Although good fits were obtained to this equation for the Pt 
macroelectrode system, consistent with previous observations on Au macroelectrodes [7], this 
was not the case for the Pt microelectrode system. Inspection of Figure 4.21 indicates that this 
is likely due to an increase in the fraction of cleavable probe with increasing [E], as shown by 
the increasing maximum % signal change as t → ∞. All data were therefore fitted to equation 
4.3, which includes the additional concentration-dependent variable, a, which is the fraction 
of cleavable peptide that can be cleaved at each trypsin concentration, [E], (with a → 1 and 
equation 4.3 → equation 4.2 as [E] → ∞ and at all [E] for macroelectrodes):  
 
 
                                           𝜃 = 𝑎[1 − 𝑒−𝑘𝑒𝑓𝑓𝑡]                                                   (4.3) 
 
 
This simple equation was shown to fit well to all data and generally enabled the extraction of 
both a and keff values for each trypsin concentration (both Figure 4.22, for which a = 1 and 
equation 4.3 collapses to equation 4.2, and Figure 4.23). The only exception was for the lowest 
[E] in Figure 4.23, where over this measurement time range the product tkeff was sufficiently 
small for equation 4.3 to become effectively linear and only a combined constant akeff could 
be determined.  
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Figure 4-22: Calculated fractional cleavage, θ, vs time plots for data for Pt macroelectrode cleavage 
data from Fig. 4.17. The data points (from bottom to top) correspond to immersion in varying trypsin 
concentrations in 1x PBS (namely 1, 5, 10, 25, 50 and 100 nM), whilst each line shows the best fit to 
equation 4.2. 
 
Figure 4-23: Calculated fractional cleavage, θ, vs time plots for data for Pt microelectrode cleavage 
data from Fig. 4.21. The data points (from bottom to top) correspond to immersion in varying trypsin 
concentrations in 1x PBS (namely 1, 5, 10, 25, 50 and 100 nM), whilst each line shows the best fit to 
equation 4.3 from which values of a = 0.39, 0.39, 0.58, 0.59, 0.76 and 0.98 respectively have been 
obtained. 
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For the estimation of kcat (enzyme turn-over number) and KM (Michaelis-Menten binding 
constant) values, these extracted keff values were plotted as a function of trypsin concentration 
(Figure 4.24 and 4.25) and fitted to the Michaelis-Menten enzyme cleavage model using the 
equation:  
                                      𝑘𝑒𝑓𝑓 = 𝑘𝑐𝑎𝑡 / (1 + 𝐾𝑀 / [E])                                           (4.4) 
 
This non-linear fitting enabled the estimation of the values of kcat and KM as 0.035 min-1 and 
19 ± 3 nM for Pt macroelectrodes and, 0.0075 min-1 and 15 ± 3 nM for Pt microelectrodes, 
respectively. Although there are significant differences in kcat values, the calculated KM values 
are comparable to each other and also to previously reported values by Anne et al. (~17 nM) 
[215] and also Au macroelectrode finding (28 ± 3 nM) [7]. All estimated values for Au and Pt 
macroelectrodes and Pt microelectrodes are presented in Table 2. Although kcat values 
estimated for Au (0.102 min-1) and Pt (0.035 min-1) macroelectrode platforms were also found 
to be different, there is not enough evidence of any significance in this difference considering 
that they showed similar KM values, SWV peak potentials, peak currents, current densities and 
thiol bonding strength.  
 
 
Figure 4-24: Effective rate constant, keff, as a function of the bulk trypsin solution concentration. Data 
represented by dots correspond to the experimental data obtained from the fits to the data in Fig. 4.22 
and the solid red line shows the fitting processed according to equation 4.4. 
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Figure 4-25: Effective rate constant, keff, as a function of the bulk trypsin solution concentration. Data 
represented by dots correspond to the experimental data obtained from the fit to the data in Fig. 4.23 
and the solid red line shows the best iterative fit to equation 4.4. 
 
Table 4-1: Summary of the extracted kinetics and SAM-based surface coverage-related values. 
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These comparable KM values suggests that there is little difference between the 
thermodynamics of the trypsin binding to the probe substrate to form the enzyme-substrate 
complex in all cases. However, the markedly lower kcat value indicates significantly lower 
kinetics of the reaction of this enzyme-substrate complex on the SAM-functionalised 
microelectrodes. This indicates that the catalytic efficiency (kcat/KM) of the enzyme is lower 
for this surface, and that although absolute and relative enzyme-substrate association and 
dissociation rates appear similar (which given the size and multiple interactions of the enzyme 
with the surface is likely to be reflective of more general enzyme-SAM surface association 
and dissociation) unlike the enzyme substrate reaction rates (which are likely to reflect 
differences in probe accessibility). Therefore, the rationale for slower proteolytic cleavage 
observed is lower probe accessibility to the enzyme active site at the microelectrode surface, 
which would result in lower probe reactivity. It is possible that this (and the fact that a < 1, 
equation 4.3 for microelectrodes) is due to the relative inaccessibility of the enhanced 
proportion of probe nearer the electrode edge, due to the dramatic increase in the amount and 
importance of edge per unit area on decreasing from the macro to the microelectrode 
dimension, as illustrated in Figure 4.26. This is in addition to the uncleavable subset of the 
immobilised peptides at all [E] for both electrode types, previously attributed to electrode 
roughness and probe orientation variation as sources of local site inaccessibility. 
 
 
Figure 4-26: Representation of the dissimilar behaviour observed for macro- and microelectrodes due 
to the differences in the peptide film structure formation and their effect on the cleavage rate. 
 
 
  101 
In order to further investigate and confirm the idea that SAM probe formation and structure 
on macro- and microelectrode surfaces is dissimilar, SAM surface coverage (Γ) for Au and Pt, 
macroelectrodes and microelectrodes, was calculated using the equation [176]:  
                                                              𝑖p =
𝑛2 𝐹2
4𝑅𝑇
𝑣𝐴𝛤                                                               (4.5) 
where ip is the peak current, n is the number of electrons transferred per mole of reaction (n=2 
for methylene blue), F is the Faraday constant, R is the universal gas constant, T is the 
temperature, v is the scan rate and A is the surface area of electrode. In order to achieve this, 
cyclic voltammograms were recorded with various scan rates (Figure 4.27) and registered peak 




Figure 4-27: Cyclic voltammograms (CVs) recorded with varying scan rates of B-SAM probe-
immobilised Au macro-, Au micro-, Pt macro- and Pt microelectrodes. 
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This linearity is also consistent with this electrochemical signal, due to surface-bound redox 
species, the MB-tagged peptide-based probes [197]. It was followed by the estimation of the 
surface coverage from the slopes of ip – v dependence using the above formula. These were 
calculated as 2.38 x 10-11 mol cm-2 for Au macroelectrodes, 4.00 x 10-11 mol cm-2 for Au 
microelectrodes, 2.11 x 10-11 mol cm-2 for Pt macroelectrodes and 3.94 x 10-11 mol cm-2 for Pt 
microelectrodes. Apparently, there are around a 2-fold larger values for microelectrodes 
compared to macroelectrodes, suggesting that more redox-active SAM probe exists per unit 
area on microelectrodes than on macroelectrodes. In addition, the average interchain spacings 
were estimated from the relation (d=1/NΓ)1/2 (where d is the interchain spacing, N is the 
Avogadro constant and Γ is the surface coverage) [215] and found as 2.64 nm for Au macro-, 
2.03 nm for Au micro-, 2.81 nm for Pt macro- and 2.05 nm for Pt microelectrodes. This might 
be another strong rationale for slower cleavage observed in microelectrodes, if peptide-chains 
are closely located, interpeptide interactions take place and the space for enzyme accessibility 
is thus further limited.  This was also demonstrated by Wain et al. showing that SAM peptide 
chains can experience a restricted motion and reorganisation due to enhanced intermolecular 
interactions between the chains [177], [259]. 
 
Figure 4-28: Linear correlation between ip (anodic+cathodic) and scan rate for Au macro-, Au micro-, 
Pt macro- and Pt microelectrodes. 
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4.9 Characterisation of Response for Potential Interferents  
In order to assess the selectivity of the macroelectrode and microelectrode-based 
(miniaturised) trypsin sensor, the modified electrodes were exposed to solutions containing 
potential interferents. Experiments for the selectivity assessment of Au macroelectrodes were 
performed previously by Dr. Eva Gonzalez-Fernandez [7].  
The interferents, used in the assessment, consisted of BSA (100 nM), casein (100 nM), 
dopamine (1 nM) and Ca2+ (1 mM) for macroelectrodes (Figure 4.29) whereas of BSA (100 
nM) and casein (100 nM) for microelectrodes (Figure 4.30). These interferents were 
specifically preferred for the selectivity studies, because BSA is a common protein used for 
the characterisation of non-specific binding [272], casein has a comparable size (~24 kDa) to 
trypsin and it is being used as substrate in protease assays [273], dopamine is an important 
substance for many physiological conditions and also it has been found to be related to tumour 
angiogenesis and growth [274], and Ca2+ signalling is very significant for tumour progression 
and thus monitoring of the anti-cancer therapy processes [275].  
 
Figure 4-29: Comparative % signal decrease registered for SAM-functionalised macroelectrodes after 
70 minutes upon the addition of trypsin (100 nM) or non-specific binding proteins; BSA (100 nM), 
casein (100 nM), Ca2+ (1 mM) and dopamine (1nM) for both substrate- (orange columns) and control-
modified (cyan columns) sensing layers. Average data and error bars are typically from 3 individual 
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Figure 4-30: Comparative % signal decrease registered for SAM-functionalised microelectrodes  after 
900 minutes upon the addition of 100 nM trypsin or non-specific binding proteins; BSA and casein for 
both substrate- (orange) and control-modified (cyan) sensing layers. Average data and error bars are 
typically from 3 individual SAM sensing layers. 
 
Both figures show the % signal decrease recorded from both the substrate (orange) and the 
control (cyan)-modified electrodes upon the addition of either the non-specific substances or 
the target enzyme trypsin. Because dopamine and Ca2+ have shown only a negligible effect on 
the signal decrease, they were not used as interferents to microelectrode response. However, 
BSA and casein were chosen as models for evaluating the potential for interference in real-
world samples arising from non-specific binding of proteins and had an expected effect on the 
signal decrease recorded for the macro- and microelectrodes. This was expected because it is 
known that there are driving interactions between the peptide chains and proteins, which are 
governed by energetical pathways and functional conformations [276].  
Although there was a significant amount of signal decrease recorded for BSA or casein, no 
statistically significant difference between the substrate and control probe responses were 
observed, which confirms that the signal decrease in both cases was most likely due to non-
specific binding, occurring, presumably due to the reduction in probe flexibility that hinders 
the redox tag - electrode interaction and therefore, the redox activity. This is in contrast to, the 
maximum signal decrease of ~36% (for macroelectrodes) and ~80% (for microelectrodes) 
recorded for substrate-modified surfaces upon the addition of trypsin, which was markedly 
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and statistically different to the relatively smaller response of the control-modified probe 
surface.  
Additionally, another selectivity test was performed which both macro- and microelectrodes 
were incubated with one of the non-specific binding protein and the target enzyme trypsin at 
the same time. As illustrated in Figure 4.31, both macroelectrode and microelectrode were 
immersed in 1x PBS solutions including a non-specific protein (BSA or casein) and the target 
enzyme, trypsin, at the same time in order assess the sensor selectivity in complex 
environments. Macroelectrode-based sensor exhibited a clear trypsin selectivity in the media 
consisting of casein in addition to trypsin. However, contrarily, trypsin selectivity of the 
microelectrode-based system was higher in the media including BSA as non-specific protein. 
Although casein had a larger effect than BSA on miniaturised system, contrary to 
macroelectrodes, this can be explained by the more close-packed conformation of SAM layer 
on microelectrodes, which might be more prone to casein (~24 kDa) than BSA (~66 kDa) due 
to casein’s smaller size. Still, this highlights the fact that the proposed microelectrode-based 
sensing system is highly selective towards trypsin, and that a combination of substrate and 
control measurements offering potential for direct measurements in real-world samples 
containing proteins. 
 
Figure 4-31: Comparative % signal decrease registered for SAM-functionalised Au macro- and Pt 
microelectrodes (after 70 min for macro and 900 min Pt micro) for upon the addition of 100 nM trypsin 
+ non-specific binding protein; BSA or casein for both substrate- (orange) and control-modified (cyan) 
sensing layers. Average data and error bars are typically from 3 individual SAM sensing layers. 
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4.10  Effect of Temperature on SAM-functionalised 
Microelectrode Performance  
It is known that temperature has an important role on the functional activity characteristics of 
most enzymes [277]. Therefore, the kinetics of proteolytic trypsin cleavage was determined 
on the microelectrode-based sensor not only at room temperature (25 °C) but also at the 
clinically relevant normal body temperature (37 °C). Figure 4.32A depicts the comparative 
signal decrease registered for both control- and substrate-modified microelectrodes at these 
temperatures with time. For both temperature cases, it is clearly seen that the signal decrease 
for the trypsin-cleavable substrate-modified electrodes is higher than the control-modified 
electrodes, which again demonstrates the trypsin selectivity of the sensor.  
A higher rate of signal decrease (~30% after 200 min) was observed for the control-modified 
surfaces at 37 °C, compared to that (~10% after 200 min) registered at 25 °C, indicative of an 
enhanced detachment and loss of probe from the surface at these elevated temperatures. This 
is an additional process also present in the substrate-modified surfaces which, like trypsin 
cleavage, results in probe signal loss shown by subtracting the time dependent control-
modified electrode response from that of the substrate-modified electrode. This was then 
converted to fractional cleavage, θ and A(t) following the same process as previously detailed 
in Section 4.8, but in this case normalised to the signal for these data as t → ∞ at this value of 
[E] (Figure 4.32B). This shows the expected characteristic change in signal with time due only 
to probe loss arising from trypsin cleavage, as shown by the good fit to equation 4.3 (which is 
equivalent to equation 4.2, as this normalisation by definition fixes a as 1 in equation 4.3) 
(Figure 4.32B).  This fit gives keff  = 0.082 ± 0.004 min-1 at 37 oC, which is around four-times 
larger than the 0.021 ± 0.002 min-1 obtained at 25 oC. Using these values and the modified 
Arrhenius equation;   
     𝑙𝑛 (
𝑘𝑒𝑓𝑓,   𝑇2
𝑘𝑒𝑓𝑓,   𝑇1









)            (4.6) 
where keff is the effective rate constant, for T1 or T2 which are temperatures in Kelvin, R is the 
universal gas constant and Ea is the apparent activation energy of the reaction. Ea for this 
system was estimated as 87.2 ± 6.9 kJ/mol. This estimated value is comparable to the one 
determined for the BSA-trypsin model system, Ea = 64.8 kJ/mol [278], which also shows that 
reliable and consistent data can be recorded using this sensor platform. In addition, the 
enhancement in kinetics with increasing temperature is consistent with previously reported 
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work [279] and indicates the potential for markedly faster trypsin measurement in vivo on 
implanted microelectrodes.   
    
Figure 4-32: (A) Comparative signal decrease vs time curves registered for the miniaturised sensor 
upon the addition of 100 nM trypsin in 1x PBS at 25 °C (pink) and 37 °C (black) for both control- 
(triangle) and substrate-modified (circle) microelectrodes. (B) Calculated fractional cleavage, θ, vs time 
plots for control-subtracted substrate data from (A). The data points correspond to temperatures of 25 
°C (magenta) and 37 °C (black) whilst the green dotted lines show the best iterative fits to equation (1) 
with keff = 0.021 ± 0.002 min-1 and 0.082 ± 0.004 min-1 respectively.   
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In addition to the enhancement in kinetics by controlling temperature, it should be noted that 
that uncontrolled temperature of the measurement environment might also influence the signal 
amount registered. Figure 4.33 illustrates the long-term stability of the tripod-anchored probes 
which have been immobilised on Pt microelectrodes. In order to investigate the effect of 
ambient temperature in the long-term stability of the probe-modified electrodes, two identical 
commercial Pt microelectrodes were modified with tripod-anchored substrate probes and 
interrogated with SWV for ~3 days (66 hours) after immersion into 1x PBS solution, without 
addition of any enzyme or other non-specific proteins. The temperature was recorded using a 
commercial data logger over the course of measurements. As depicted in Figure 4.33A, there 
was some difference in the initial signals registered for electrode-1 (~7.9 x 10-10 A) and 
electrode-2 (~4.6 x 10-10 A), although similar responses/currents were recorded during their 
electrochemical cleaning and then they were identically modified at the same time.  However, 
it was not surprising as there was frequently a variation in the signals registered for identically 
prepared electrodes, which is attributed to the ambiguous nature of SAM formation. However, 
it is always possible to overcome this issue, by reporting the change in the signal as percentage, 
instead of its actual value, as presented in Figure 4.33B. By this means, lower deviations can 
be secured between the replicates. That is why the change in the signal has been reported as 
percentage value for all analyses presented through this thesis. 
 
 
Figure 4-33: Long-term time-temperature-dependency of SWV signal recorded for probe-immobilised 
electrodes: A) SWV signal vs time and B) % signal change vs time registered for tripod-anchored probes 
immobilised onto two individual Pt microelectrodes (electrode-1 given in black circles and electrode-2 
given in red circles), for ~3-day measurement. Blue dotted lines and arrows illustrates the transition 
points between signal increase-decrease fluctuations and corresponding times. 
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As explicitly produced by both identical electrodes, there were time-dependent fluctuations in 
the recorded signal. It was revealed that the signal consistently decreased at night and then 
increased during the day. It should be remarked at this point, the signal increase (during the 
day) was lower than the decrease (at night) for both electrodes, which resulted in an overall 
decrease of around 15%.  
There was no external stimulator under ambient laboratory conditions except the temperature, 
which could result in these fluctuations. Therefore, the corresponding temperature data, which 
were recorded using the data logger placed inside the Faraday cage, was compared to the 
variations in the percentage signal. Although the data logger could not be located inside the 
buffer solution because of its non-waterproof characteristic, it was found that there is only a 
negligible difference between the buffer solution and the Faraday cage medium. Figure 4.34 
shows a good correlation between the temperature and % signal decrease was observed and 
this confirmed that even the tripod-anchored probes which was previously characterised and 
found to have an improved stability against thermal, chemical and storage conditions [197], 
can face some issues related to stability/durability on electrode surfaces under uncontrolled 
measurement conditions. This exhibits the significance of controlled measurement parameters 
and it should be regarded as a motivation for the enhanced electrode development. 
 
Figure 4-34: Long-term time-temperature-dependency of SWV signal recorded for probe-immobilised 
electrodes: % signal change vs temperature (oC) recorded over time using data logger for tripod-
anchored probes immobilised onto Pt microelectrodes for ~3-day measurement. Average data and error 
bars are from 2 individual SAM sensing layers (electrode-1 and electrode-2). 
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4.11  Summary 
In this chapter, the miniaturisation of a peptide-based electrochemical biosensor platform for 
protease detection using platinum microelectrodes is presented in comparison to the 
macroelectrode-based sensing. Using a previously developed detection mechanism based on 
the signal change due to the proteolytic cleavage of a peptide sequence followed by the 
removal of the redox tag by the enzyme, trypsin, some background work focusing on the probe 
optimisation has been step-by-step summarised. Then, analytical quantitative performances 
obtained for gold macro-, platinum macro- and platinum microelectrodes were evaluated, 
especially concentrating on the effect of miniaturisation on sensor performance. The ability of 
the proposed miniaturised electrode to support efficient trypsin detection was assessed and 
compared to the previously reported gold and new platinum results registered for 
macroelectrodes. These comparisons demonstrated the feasibility of using microelectrodes for 
these platforms as comparable analytical performance has been observed in terms of target 
accessibility and specificity, as well as insensitivity to the non-specific adsorption of proteins. 
The proposed system was also shown to give a quantitative response across the entire 
measured concentration range and fit well to a Michaelis–Menten surface cleavage model 
which enabled the estimation of global kcat and KM values. A LoD value of 2.9 nM was 
determined confirming that this sensing platform operates in a clinically relevant range for 
trypsin and suggests that this approach can be further applied to a wide range of proteases. The 
insensitivity of the sensor system to two potential interferent proteins shows its potential for 
measurement in complex media. The increase in temperature enhanced the kinetics and 
resulted in faster trypsin detection, although it caused a slight decrease in the surface stability 
of the probe. However, it is worth noting that the undesirable need for control data subtraction 
arising from the observed enhancement of probe loss at normal body temperature can be 
addressed by the use of a stronger tri-branched thiol anchor. Some important subjects for next 
chapters will be investigating the translation of these findings to electrode-on-silicon chips (in-
house made) and the different methods which could be utilised for probe immobilisation onto 
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5.1 Introduction  
The background and main motivations of the biosensor miniaturisation were given in detail in 
Section 2.2.2. As part of this evolution, advancements in fabrication techniques have led to 
research activities in the miniaturising of the components of electrochemical devices such as 
electrodes. The advantageous reasons for this transition to smaller transducers are their higher 
sensitivity and selectivity as well as integration with electronics and their construction as 
implantable biosensors to enable in vivo measurements [280]. Also, decreasing electrode 
dimensions from mm to the µm or nm range offers enhancements such as increasing signal-
to-noise ratios. Analyte LoDs which are measured using miniaturised electrodes are enhanced 
or at least comparable to those obtained using commercial macroelectrodes [281]. That is why 
both micro- and nanoelectrodes are being used in a wide range of applications in many fields 
of analytical sciences today.  
Reproducible microelectrode fabrication has improved over time due to the emerging 
photolithographic methods used in the semiconductor industry. These improvements have 
been extremely important in producing high-fidelity and reproducible electrodes with well-
defined shapes and dimensions [282]. This has enabled microelectrodes to be fabricated with 
various geometries such as cylinders, discs, cones, bands and hemispheres. Among all these 
different geometries, metal disc electrodes which are encapsulated in insulator materials (such 
as glass/plastic) are the most favoured because of their ease of production and established 
quantitative analytical response [283]. Some examples of areas where microelectrodes have 
been used are sensors [284], biosensors [285], scanning electrochemical microscopy (SECM) 
[286], microfluidic devices [287] and liquid chromatography [288]. As a local example, the 
IMPACT team at the University of Edinburgh (Section 2.2.1) has recently measured dynamic 
intestinal oxygenation changes, in real-time, in a rodent model using a miniaturised oxygen 
sensor which consists of a three-electrode cell with a platinum working and counter-electrodes 
and a silver/silver chloride reference electrode on a silicon chip [109].  
Following these successes, there has been a need for the preparation of more sensitive, new 
generation electrodes which could be able to detect very small members of molecules, and this 
constitutes the main driving force for the development of nanoelectrodes [289]. They offer 
even more advantages over microelectrodes in terms of improved mass transport, signal-to-
noise ratio and sensitivity as detailed in Section 2.5.3. In addition, they do not typically include 
surrounding materials unlike glassy commercial bulk electrodes which restrain their use in 
defined spaces, and which is a vital limitation for localised in vivo measurement 
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compatibilities. It has been also suggested that they are more preferable platforms than 
commercial macroelectrodes because of enhancing accessibility to analytes, and not being 
limited by time-dependent planar diffusion [283]. Reproducible and robust nanoelectrode 
fabrication is more challenging and is not fully established, but they have been widely used 
and sufficiently well-understood. They are much more sensitive to even small variations in 
their geometry, size, shape and surface chemistry [289]. Therefore, a person who targets a 
particular nanoelectrode application should be careful and specific when considering the 
fabrication process.  
There are various methods existing for fabrication. The first type of nanoelectrode was 
fabricated as a nanoband (with widths between 2 - 50 nm and lengths between 0.5 - 1 cm) in 
1987, by Au/Pt metal evaporation [290]. Typical nanoelectrode preparation techniques include 
photolithographic fabrication, electroless/electrochemical metal deposition, templated 
production, laser-assisted pipette pulling and many others [291]. In templated production, 
nano-porous solid structures can be used as templates for the deposition of metallic layers 
which can then serve as nanoelectrodes and nanoelectrode ensembles where their dimensions 
can be controlled by the pore sizes [291]. Some examples of previously employed templates 
include polycarbonate and polyester membranes [292] [293], anodic aluminium oxide [294], 
zinc oxide [295], carbon nanotubes [296] and tetraethoxysilane sol-gel films [297]. In parallel 
with these expanded production practices, there are many different applications within the 
range of nanoelectrode utilisation such as the detection of neurological diseases by using 
neurochemical sensors [298], hypertension monitoring [299], DNA [300] and glucose [301] 
detection as well as in vitro analysis of the cell medium for reactive oxygen and nitrogen 
species [302]. Moreover, the Mount Research Group at the University of Edinburgh has also 
developed experience in the photolithographic fabrication and fundamental understanding of 
analysis of microcavity nanoband edge electrode arrays (MNEE) which offer similar but 
enhanced reproducible steady-state response to nanoelectrodes [187], [203], [303]–[306].  
Of course, there are some possible drawbacks with downscaling in electrode dimensions. 
These include (i) smaller amounts of current generated, (ii) potential of (liquid) probe/sample 
evaporation during preparation/analysis because of their reduced volumes if nanolitres used 
and (iii) the risks of inaccessibility of analyte resulting from geometrical restrictions [283]. In 
order to resolve these problems, most of the micro- and nanoelectrode architectures are 
fabricated in arrays, instead of individual electrodes. Thus, they can generate higher signals 
by combining each array response in parallel as well as reducing evaporation and 
inaccessibility risks owing to the enlargement in the sensing (array of electrode) region. 
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However, it is important in this case to preserve the enhanced mass transport characteristics 
while multiplying the number of electrodes. Controlling and finding the optimum 
interelectrode spacing is quite significant here, to avoid any overlapping of diffusion layers 
whilst maximising signal. Therefore, photolithography is typically easier compared to the 
templated production such as utilisation through pores which makes it hard to control.   
Although there are some examples of the use of microelectrodes [228] and nanoelectrodes 
[307] in peptide-based protease sensing, the literature still lacks a systematic study of the 
effects of miniaturisation. Peptide-based sensing probes used throughout this work have been 
attached onto electrode surfaces as SAMs. Considering that the characteristics of SAMs might 
have deleterious effects on the biosensors performance [308] and the influence may be much 
more important on a miniaturised system than on a commercial macro-scale sensor, 
understanding the miniaturisation effects in terms of SAM formation and the effects on 
resulting response is crucial.  
This chapter seeks to address these questions, by investigating how an electrode type or 
dimension effects the preparation and performance of a peptide-based electrochemical 
protease sensor. As a follow-up of the work on sensor miniaturisation using commercial bulk 
microelectrodes in Chapter-4, this will cover various established platinum in-house built 
designs (as thin films on a silicon substrate) such as single microelectrodes with thin (TT) and 
superthin (STT) contact tracks, microelectrode arrays (MEA), microcavity nanoband edge 
electrode arrays (MNEE) and macro-scale metal films. It will analyse any observed difference 
between all these electrode designs or dimensions in terms of electrochemical response against 
either common redox agents (bare electrodes) or trypsin enzyme (target protease) (SAM 
probe-modified electrodes). Altogether, the aim of this chapter will be to produce a systematic 
study of these effects to inform the sensing strategies based on miniaturised electrodes.  
 
5.2 Thin Track and Superthin Track Single Microelectrodes  
In order to translate findings achieved for commercial platinum microelectrodes given in the 
previous chapter to in-house built platinum electrodes, initially two designs were fabricated 
and characterised in terms of cleaning, preparation and protease detection performance. They 
were single disc microelectrodes of varying diameters, with thin (TT) and superthin (STT) 
contact tracks. Although there is no different fabrication process step involved in their 
production, they might be expected to show different track resistances (which should be 
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greater for STT compared to the TT microelectrodes) between the electrodes and the contact 
pads, due to having this particular contact track arising from the different masks used for 
photolithography during fabrication. However, differences between them in terms of 
characterisation (as bare electrodes) and performance (as functionalised biosensors) should 
not be expected, because exposed electrode surfaces are expected to be identical. Their 
fabrication process chain and all other details of involved steps are given in Section 3.3.2 and 
Appendix-1.   
 
5.2.1 Cleaning  
Comprehensive cleaning of electrode surfaces is very important in electrochemistry, to achieve 
reproducible and consistent measurements. That is why a fresh electrode surface which is free 
of any residue is needed before any individual measurement. Typically, a three-step cleaning 
process is used for commercial (plastic or glass insulator-encapsulated) macro- or 
microelectrodes, consisting of  
(i) concentrated acid treatment  
(ii) mechanical polishing with alumina slurries 
(iii) electrochemical cleaning in a dilute acidic solution  
as these have been shown to avoid any impurities on an electrode surface [309]. Specifically, 
applying a cycle of potentials repetitively in electrochemical cleaning in acidic solutions was 
reported to activate the surface due to the formation and reduction of metal oxide films, local 
pH changes (oxidation/reduction) as well as the mechanical act of the bubbles of gases 
produced, H2 and O2 [182]. Unfortunately, some of these steps such as mechanical polishing 
or concentrated acid treatment are inappropriate for microfabricated thin film electrodes as 
they are sensitive to rough treatment and strong acid/base solutions [310]. For example, only 
a thin (~500 nm) silicon nitride layer is formed as the passivation layer in TT and STT single 
microelectrodes, which might be easily cracked or worn when mechanically polished. Besides, 
immersing them into concentrated acids for 10 min might change their surface chemistry 
significantly and irreversibly. Therefore, electrochemical cleaning was considered the best 
option to clean a microfabricated electrode surface.  
Cyclic voltammograms (CVs) of platinum TT and STT single microelectrodes of various sizes 
recorded in 0.1 M sulfuric acid are shown in Figure 5-1. Each individual CV shows the 20th in 
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a set number of repetitive CV scans and for a specific type (TT or STT) and diameter (20, 50 
or 100 µm) disc electrode. In general, each cleaning CV were seen to be comparable to each 
other in terms of previously seen characteristic features for commercial platinum 
microelectrodes (Section 3.4.1). The first significant feature to note is the oxygen formation 
(as surface-adsorbed and/or platinum oxide) peak around +1.55 V which increases for 
electrodes with successively larger areas, as expected. Interestingly, the oxygen formation 
peak of TT 100 µm electrode was not significantly larger than TT 50 µm and was not similar 
to STT 100 µm. However, there was the expected correlation between the electrode size and 
intensity of the oxygen reduction wave at ~0.30 V for both STT and TT microelectrodes.  
 
One possibility is that an electrode surface could be qualified as clean if there is no further 
change in the heights/areas of these characteristic peaks as the scans progress. Figure 5-2 
presents the 20th and 1000th CVs, in comparison, of a TT 20 µm microelectrode recorded in 
0.1 M H2SO4. It is seen that there is an almost three-fold difference in the height of oxygen 
evolution peaks obtained after 20th and 1000th scans, as well as an additional peak around +1.35 
V after 1000 scans. This can be attributed to the electrode roughness which increased with 
time. Because, the re-formation mechanism of Pt from Pt oxide results in an expansion and 
increase in Pt surface area. Adsorption is determined by this peak. However, it should be 
emphasised that oxygen reduction peak at ~0.30 V was similar even after 1000 scans. Because 
there was no increase in geometric (cross-sectional) area, which determines mass transport. 
Considering this dependency on the electroactive area of the electrode, the necessity for longer 
Figure 5-1: CVs of Pt A) superthin track (STT) and B) thin track (TT) microelectrodes of various sizes 
recorded in 0.1 M H2SO4 between -0.35 and +1.6 V at a scan rate of 100 mV.s-1. Each scan corresponds 
to the 20th cycle of electrochemical cleaning.  
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time cycling becomes questionable. In addition, keeping the electrode surface in acidic 
solution, even it is diluted, more than enough is a high potential of causing surface roughness 
to increase which would not be preferred for most of the probe-based biosensing applications. 
It should be also noted that 1000 scans take approximately 11 h to complete at a scan rate of 
100 mV.s-1, whereas 20 scans take 13 minutes. This makes 20 CV scans more preferable for 
electrochemical cleaning and thus typically applied for the rest of the study, because a clean 
electrode with constant surface roughness was intended.  
 
 
Figure 5-2: Comparative cleaning CVs of Pt TT 20 µm recorded after 20 (black line) or 1000 (red line) 
scans in 0.1 M H2SO4 between -0.35 and +1.6 V at a scan rate of 100 mV.s-1.  
 
5.2.2 Characterisation  
The best way to characterise a clean bare electrode is to obtain a cyclic voltammogram using 
a common redox agent which can be reduced and oxidized reproducibly on an electrode 
surface. The shape of the recorded voltammograms using micro- or nanoelectrodes which have 
much smaller sizes typically differ from the ones obtained for macroelectrodes which are in 
the mm range. Usually a characteristic sigmoidal shape is obtained for micro- or 
nanoelectrodes whereas peaks are obtained for macroelectrodes. The reason for this difference 
and its relation to mass transport and diffusion are explained in Section 2.5.3.  
E (V) 
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Cyclic voltammograms for commercial bulk and STT platinum microelectrodes of varying 
diameters recorded in 5 mM potassium ferri/ferrocyanide in PBS at a scan rate of 100 mV.s-1 
is given in Figure 5-3. As clearly seen, there is the expected correlation between current and 
electrode size. Also, the current obtained for 30 µm-diameter STT electrodes is the same with 
the commercial bulk electrode which has a diameter of 25 µm, which shows that in-house built 
electrodes can present similar electrochemical performances to commercially-available 
electrodes.  
 
Figure 5-3: CVs of various Pt microelectrodes of different diameters recorded in 5 mM potassium 
ferri/ferrocyanide in 1x PBS between 0 and +0.5 V at a scan rate of 100 mV.s-1: A) STT (10, 20, 30, 50 
and 100 µm) and B) commercial (25 µm) and STT (20 µm and 30 µm). 
 
When STT and TT microelectrodes were compared, it was observed that they exhibited the 
same responses within experimental errors, in terms of voltammogram shape and currents 
registered. This was also consistent with the electrochemical cleaning observations. This was 
attributed to identical electroactive areas of comparable STT and TT microelectrodes. In 
addition, characteristic waves were observed for all electrodes and most of the sizes except 
STT 50 and 100 µm. This was already expected for microelectrodes due to hemispherical 
diffusion and enhanced mass transport. The reason why voltammograms of STT 50 and 100 
µm showed peaks instead of waves was their larger electrode areas compared to others, which 
resulted in partially macroelectrode response at these scan rates. 
In order to check how the current responses and CV shapes change with respect to the scan 
rate, STT 100 µm was subjected to the cyclic voltammograms recorded at varying scan rates 
of 10, 50, 100, 200, 300, 400 and 500 mV.s-1, as depicted in Figure 5-4. Again, mostly peaks 
were observed only except the voltammogram recorded at 10 mV.s-1 which was more like a 
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sigmoidal response. It was expected because of that slower scan rates promotes the 
hemispherical (radial) diffusion and steady-state behaviours to be seen, whereas the linear 
(planar) diffusion is favoured under higher scan rate conditions [184]. In addition, the 
investigation of the dependence existing between the recorded peak current and the scan rate, 
revealed that the mass transport for STT 100 µm was dominated largely by planar diffusion.  
 
To make a quantitative evaluation using these electrodes, Saito equations [283], [311] (Section 
2.6.1) were used to calculate the experimental diffusion coefficient of potassium 
ferri/ferrocyanide in 1x PBS, for a disc-shaped (used for in-house built STT) and hemisphere-
shaped (used for commercial) microelectrodes, respectively;  
          𝑖𝐿 = 4𝑛𝐹𝐷𝐶𝑟                     (5.1) 
 𝑖𝐿 = 2𝜋𝑛𝐹𝐷𝐶𝑟                     (5.2) 
where n is the number of electrons (which is equal to 1 for ferri/ferrocyanide), F is the Faraday 
constant, D is the diffusion coefficient (cm2/s), C is the concentration (mol/cm3) for redox 
molecule (ferri/ferrocyanide) in the solution and r is the radius (cm) for the electrode. Using 
these two equations (Equation 5.1 for in-house built and Equation 5.2 for commercial bulk 
microelectrodes), experimental diffusion coefficients of potassium ferri/ferrocyanide were 
Figure 5-4: : CVs of STT 100 µm recorded with varying scan rates (10, 50, 100, 200, 300, 400 and 500 
mV.s-1) in 5 mM potassium ferri/ferrocyanide in 1x PBS between 0 and +0.5 V. 
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found to be 6 x 10-6 cm2/s for STT 10 µm, 6 x 10-6 cm2/s for STT 20 µm, 6 x 10-6 cm2/s for STT 
30 µm, 8 x 10-6 cm2/s for STT 50 µm, 10 x 10-6 cm2/s for STT 100 µm and 7 x 10-6 cm2/s for 
commercial (25 µm) microelectrodes. In comparison to its literature value reported as D = 7 x 
10-6 cm2/s at ambient temperature [312], it can be suggested that all gave the comparable results 
to the previously estimated value with little differences which most likely resulted from the 
variations in uncontrolled temperature of measurement environment.  
All these demonstrate that in-house built single microelectrodes exhibit expected characteristic 
features which are comparable to commercial microelectrodes. Therefore, they are ready for 
performance characterisation in the detection of proteases.   
 
5.2.3 Performance in Protease Detection  
5.2.3.1 Experimental  
In order to evaluate the analytical performance offered by the in-house built single 
microelectrodes in protease sensing, four individual electrodes (STT 20 µm,  STT 50 µm, STT 
100 µm and TT 100 µm) were selected and modified with the mixed SAM layer as previously 
described. However, the mixed SAM probe layer was incubated on the electrode surfaces by 
drop-casting in this case, instead of dip coating, because of that the electrode geometry was 
created as a Pt thin film on a planar Si chip which is significantly larger in area than 
commercial bulk microelectrodes (See Section 3.3). Also, by this means, probe solution 
volumes could be reduced, saving probes for future trials and thus allowing more experiments. 
In preliminary tests, it was found that the probe solution prepared in ethanol, as used for 
commercial electrodes (Section 3.4.2.1), evaporated over time during an overnight incubation, 
leaving a dried liquid mark on the in-house built electrode surfaces. This was not observed for 
commercial electrodes, because they were dip coated into solution inside parafilm-sealed 
tubes, but this would lead to excessive consumption of probe for in-house electrode designs, 
as these designs are not cylindrical, the electrode is not located at the bottom of the chips and 
thus would require more solution to fill the tube to cover the whole electrode surface during 
dip coating. Therefore, the probe solutions were prepared in 1x PBS, instead of ethanol, to 
avoid this evaporation. Control tests on commercial microelectrodes showed that the SWV 
signals recorded for the electrodes incubated with probe solutions prepared in PBS were in a 
similar current range to the electrodes prepared with ethanolic solutions, confirming that 
change of the solvent had no apparent effect on the formation of self-assembled monolayers 
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in this case. There was not any other change in protocol except this. The molecules used and 
the concentrations present in the mixed SAM solution used for commercial microelectrodes 
(Section 4.6) were kept the same for these electrodes.  
5.2.3.2 Response 
Figure 5-5 shows the percentage signal changes for STT 20 µm, STT 50 µm, STT 100 µm and 
TT 100 µm electrodes after they were SAM modified with either the substrate or the control 
probe, immersed in buffer (1x PBS) solution containing 100 nM trypsin and interrogated by 
SWV with time. It is clearly noticeable with that none of the electrodes modified with the 
control probe gave the expected stability with time. The initial rapid signal decrease for the 
control-modified STT 20 µm and TT 100 µm was ~90-100%, whereas it was around 30% for 
STT 50 µm and STT 100 µm which increased with time, up to ~60-90%. Unexpectedly, the 
signal decrease observed for control-modified STT 20 µm, STT 100 µm and TT 100 µm was 
higher than for substrate-modified analogues. Although the expected response (the signal 
decrease recorded for control-modified electrodes was lower than substrate-modified ones) 
was observed for STT 50 µm, the difference after 900 min was only around 15-20%.  
Figure 5-5: Plots of % signal change vs time upon addition of trypsin 100 nM (at time = 0) for SAM-
functionalised substrate (black circles) and control (orange circles) probes immobilised onto Pt 
microelectrodes: A) STT 100 µm, B) STT 50 µm, C) STT 20 µm and D) TT 100 µm. SWV data used 
for the preparation of this figure can be found in Appendix-4. 
 
  122 
This was very low in comparison to the difference (~70%, Figure 4-21) obtained when using 
a commercial Pt microelectrode and these, of course, raises an issue with the 
robustness/stability of the sensor system when utilising these types of electrodes.  
In order to understand the underlying problem, a similar experiment was designed after 
preparing and conditioning the electrodes. This time no trypsin was added into the 1x PBS 
solution. As illustrated in Figure 5-6, there was again an almost immediate decrease in the 
signal recorded for the control-modified STT 100 µm. Though it was not as immediate, and 
more gradual, it was still significant at around 50-60% for the control-modified STT 50 µm 
and TT 100 µm. Also, the total decreases recorded for three electrodes when modified with 
the substrate probe were found to be between 40% and 60%. Given this is not correlated with 
enzyme cleavage, the most likely reason is loss of the probes from the surface. The behaviour 
observed for STT 20 µm was dissimilar to the others. The signal decreases shown for both the 
control-modified and the substrate-modified analogue STT 20 µm electrodes fluctuated over 
time, but did not drop significantly. In fact, in this case, even an increase in the signal was 
observed for a time course of ~200 min for the control-modified electrode, which was very 
likely due to the ongoing reorganisation of self-assembling structures on the surface.  
Figure 5-6: Plots of % signal change vs time with no addition of trypsin for SAM-functionalised 
substrate (black circles) and control (orange circles) probes immobilised onto Pt microelectrodes: A) 
STT 100 µm, B) STT 50 µm, C) STT 20 µm and D) TT 100 µm. SWV data used for the preparation of 
this figure can be found in Appendix-4. 
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The comparative analysis of two experiment sets demonstrated that the signals did not go down 
only because of the protease cleavage. In a nutshell the major signal stability problem arose 
either from the probe or the electrode surface, given that the real expectation for this test 
performed without an enzyme was to see a stable, constant signal, independent of SWV 
interrogation time.  
Figure 5-7 shows the optical images taken from STT 20 µm, STT 50 µm, STT 100 µm and 
TT 100 µm electrode surfaces respectively, after experiments which included the 900 min-
trypsin incubation. As can clearly be seen in the figure, there were some different features on 
the surfaces, and it was thought that they might have played a role in the durability problems 
encountered. First, the upper side of the electrode region of STT 20 µm showed some metal 
loss, which was spread in smaller pieces. For STT 100 µm, although the electrode itself has 
not been damaged, there was a thin delamination on the perimeter of the insulator, which might 
have expanded the electrode size and it thus gave a macroelectrode response some time later 
even if it was not at the time when images taken. STT 50 µm and STT 100 µm electrodes also 
showed some minor hollows in little speckles, however it can be seen they were already 
existing even prior to use, in Figure 3-9. They are thought to be inevitable features which are 
sporadically observed after the etching process in microfabrication. In addition, some fibre-
shaped features have been found on STT 50 µm and TT 100 µm surfaces.  
Figure 5-7: Optical microscope images of Pt microelectrodes: A) STT 20 µm, B) STT 50 µm, C) STT 
100 µm and D) TT 100 µm following the immobilisation with SAM-functionalised probes, incubation 
with 100 nM trypsin for 900 min and electrochemical cleaning in H2SO4 afterwards. 
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As these electrodes were cleaned electrochemically before SAM probe deposition, and then 
washed with PBS and water after trypsin experiments, they cannot be dust or individual probe 
molecules either, considering the low resolution of the current optical microscopy. Because 
they were located on the insulator just outside the electrodes, it is likely that some of them 
might be clusters of thiol-based residues, which could not be electrochemically cleaned and 
thus accumulated over time. Briefly, some of these effects may have happened during initial 
electrochemical cleaning, and some of them during SAM formation. All these can positively 
contribute to the thought of electrode-related adverse effect on SAM probe stability.  
In order to fully characterise the performance of in-house electrodes in protease sensing and 
investigate the advantages and drawbacks, electrode types tested were broadened using 
different alternatives. IMPACT miniaturised three-electrode on-chip design was one of these 
alternatives. As illustrated in Figure 5-8A and 5-8B, it consists of all the working, the reference 
and the counter electrodes (in order from inside to outside) patterned on the chip. There was 
no major difference in the fabrication protocols of this three-electrode chip and single 
microelectrodes. Only the working electrode (WE, with a diameter of 50 µm) was used for the 
characterisation, using an external Pt counter and an external Ag/AgCl reference electrode as 
usual, to make a fair comparison between the performances of electrodes characterised within 
the scope of this chapter. Therefore, the reference electrode was patterned but not fabricated 
on this chip, although it could be successfully fabricated for in vivo applications by first silver 
plating and then chlorination processes [109]. Besides, mixed SAM probe solution was drop-
cast on all electrodes inevitably since there was no any protecting layer on top of the reference 
and counter electrodes. It did not pose any problem in this case as only WE was used. 
However, in a real implanted biosensor application, counter and reference electrodes should 
be protected by coating and patterning a solution-etchable layer (photoresist etc.) on top of 
them prior the probe immobilisation and then removed and activated afterwards, not to alter 
surface chemistry of the reference electrode and/or block the counter electrode. Cyclic 
voltammograms recorded in 0.1 H2SO4 for electrochemical cleaning of the electrode, prior to 
immobilisation with the probe, were consistent in comparison to the characteristic 
voltammogram of a commercial Pt microelectrode, given in Figure 3-11. The two-fold 
differences between their diameters (25 µm for commercial microelectrode and 50 µm for this 
electrode) lead to an increase in the oxygen evolution peak at ~1.55 V to nearly 4-fold, as 
expected. Figure 5-8D shows the performance of the WE of this device for protease sensing, 
by concentrating on the analysis of the substrate-modified and the control-modified analogue 
with incubation with 100 nM trypsin (added at time = 0), as well as a substrate-modified 
analogue without the addition of trypsin. The signal decrease for the substrate-modified 
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electrode after incubation with trypsin for 900 min was found to be 85%, whereas it was around 
60% for the control-modified analogous. This difference clearly offers the selectivity of the 
substrate-modified electrodes against trypsin. However, the recorded signal decrease for the 
control sample was again above the expectation. It was significant to understand if this was 
due to either a degree of non-specific binding of trypsin enzyme to D-amino acids in the 
control probe or a recurring stability issue. The additional data gathered without any trypsin 
showed a signal decrease of ~40% for a substrate-modified electrode and revealed that the 
effect of the stability problem was more severe than non-specific binding, although non-
specific binding also should be borne in mind as a point in question since the decrease (60%) 
recorded for control probes with enzyme found to be higher than 40%.  
 
Figure 5-8: Conformance testing of the working electrode (WE) of the miniaturised three-electrode 
system on-chip with usual electrode preparation protocol and trypsin sensing. A) Macroscopic image 
of the miniaturised three-electrode system on-chip with WE of 50 µm-diameter. B) Optical microscope 
images showing the region for the electrodes on the chip. C) Electrochemical cleaning CV of WE in 0.1 
M H2SO4 between -0.35 and +1.6 V at a scan rate of 100 mV.s-1. D) Percentage signal change registered 
upon addition of trypsin 100 nM for substrate (black circles) and control-modified (red circles) probe 
immobilised electrodes, as well as substrate-modified probe immobilised electrodes with no addition of 
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The characterisation of this different electrode type e.g. WE of the miniaturised three-electrode 
system on-chip in terms of the response against trypsin showed that the experience of stability 
issue was not only for the STT or TT single microelectrodes as a one-off, production batch-
induced issue. Also, it cannot be attributed to the electrode size as well, because it was 
experienced for various diameters of 20, 50 and 100 µm. Instead, this should be considered as 
a serious problem which needs to be resolved to successfully translate SAM-based biosensing 
into the silicon-on-chip technologies.   
 
5.2.4 Effect of Increasing Anchor Strength: Tripod-Anchored Probes  
As previously reported [197], [253], [313] and also discussed in Section 4.3.5, multiplied 
anchors can improve the stability/durability of probe molecules on electrode surfaces. For this 
reason, the effect of using a tripod-anchored analogous probes instead of the mono-anchored 
ones was investigated on STT 50 µm, STT 100 µm and TT 100 µm electrodes, as shown in 
Figure 5-9. The data labelled here as mono-anchor were discussed in Figure 5-6. This 
experiment was also performed without an enzyme, to focus solely on potential stability 
improvements and avoid any effect of non-specific binding or proteolytic cleavage. In all three 
individual electrodes, the tripod-anchored probes provided slightly improved stability in 
comparison to the mono-anchor materials. Still, there was a similar immediate decrease of at 
least ~20% in the signals registered for all three electrodes. This further confirmed and 
established the stability problem even if the anchoring capabilities of the probe structures have 
been enhanced. It is also worth noting that the signal decrease recorded for tripod-anchored 
probe was observed over different time points, which were ~200 min for STT 50 µm and TT 
100 µm, and ~400 min for STT 100 µm. The decreases after these time points were negligible 
for the tripod-anchored probes, whereas the decreases in the signals were continuous until the 
final time points for the experiments for the mono-anchored probes. Interestingly, the signal 
recorded for TT 100 µm went down over ~200 min and then increased after this time. This 
can be explained by the orientation and/or re-organisation of the anchor(s) in the multi-dentate 
probe onto the surface, which might have inhibited the electron transfer between the methylene 
blue and the electrode for a while. This may have resulted in the signal decreasing until a time 
point when stabilisation on the surface was complete and the electron transfer was recovered. 
In addition to these, comparison of the responses observed for TT 100 µm and STT 100 µm 
revealed a significant variation between the electrodes, whereas they are expected to be 
identical.  
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Although some of the above-mentioned results taken from tripod-anchored probes might be 
seen as promising, the recorded signal decreases for the in-house electrodes were still higher 
than commercial microelectrodes when they were modified with the same tripod-anchored 
probes. Figure 5-10 shows that the signal decrease observed for commercial microelectrodes 
was only around 10% after 800 min SWV interrogation and were almost stable after 50th min 
over the same experiment. This suggests that they can be used effectively to enhance the 
stability on the commercial electrodes, but not effectively on the in-house built electrodes. 
Given the fact that more or less stability problems were experienced regardless of the 
improvements in the probe, it was established that the source of the problem is substantially 
electrode-based and further advancements/changes in their fabrication are needed to overcome 
these drawbacks. 
Figure 5-9: Percentage signal change registered for mono- (cyan) and tripod (orange)-anchored probes 
when immobilised onto A) thin track (100 µm-diameter), B) superthin track (100 µm-diameter) and C) 
superthin track (50 µm-diameter) electrodes and interrogated with SWV in 1x PBS for 800 min to check 
and compare the stability.  
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5.2.5 Effect of Increasing Platinum Film Thickness  
In the previous section, it was emphasised that the stability of SAM-based probes was found 
to be better for commercial bulk electrodes, compared to the in-house built, thin film 
electrodes. Considering they are significantly different in terms of the amount and metal layer 
thickness of the Pt electrode material; this difference was proposed to be an important 
parameter effecting the stability/durability of the electrodes. Therefore, thicker films with a Pt 
layer thickness of 200 nm were fabricated in-house and characterised, as an alternative to TT 
or STT microelectrodes (which include a Pt layer of 50 nm-thickness).  
As depicted in Figure 5-11A, these electrodes were fabricated by depositing adhesion (Ti) and 
electrode metal (Pt) blanket layers onto Si chips (with dimensions of 35 mm x 7.50 mm x 0.55 
mm). They are named as “Pt blanket films” for the rest of this work. In contrast to the TT and 
STT microelectrodes, the size of the electrode region was not defined, because they were not 
patterned (using photolithography) or coated with an insulator silicon nitride layer in order to 
simplify the fabrication process.  
Figure 5-11B shows that all three identical Pt blanket replicates consistently exhibited 
characteristic Pt features when they were electrochemically cycled (cleaned) in 0.1 M sulfuric 
acid. A sharp metal oxide reduction peak near +0.4 V (instead of the typical oxygen wave 
Figure 5-10: Percentage signal change registered for tripod-anchored probes when immobilised onto 
commercial bulk microelectrodes (black line and circles), compared to the stability of thin track and 
superthin track microelectrodes shown in Figure 5-9, and interrogated with SWV in 1x PBS for 800 
min. 
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characteristic of microelectrodes) and hydrogen absorption/desorption peaks below 0 V 
illustrate typical macroelectrode characteristics, as expected. After each was successively 
cleaned in this way, they were modified with the tripod-anchored probes overnight by drop-
casting (approximately the same area of ~1 cm2) for each film. They were then assessed in 
terms of the SWV signal stability over time. There were only small and negligible difference 
between the recorded initial currents obtained (for the three replicates), confirming that the 
similar sizes of surface area (drop-cast) with the probe solutions. Figure 5-11C shows 
percentage signal changes registered for these probe-modified three individual replicates 
(green, blue and purple triangles) when interrogated with SWV in 1x PBS for 800 min. The 
signal decrease recorded was around 75-80% after 800 min, similar for all three replicates. For 
ease of comparison, they are plotted together with the previously presented data (Figure 5-10) 
showing the response of commercial (black circles) and average in-house TT and STT 
microelectrodes (red squares). This clearly reveals that the probe stability on the Pt blanket 
film surfaces were no better and made worse. Thicker films could be expected to cause the 
layer to act more like bulk metal as in commercial macro- or microelectrodes, instead of a 
microfabricated thin films. However, these results showed that thickness was not the main 
reason of stability problem.   
When the film surfaces were analysed with an optical microscope afterwards, it was interesting 
that many fractures and cracks were present on all three electrodes (Figure 5-11D). It should 
be noted that these features were observed across the whole blanket film, not just the probe-
modified region. Given the surfaces were found not to include any of these features when they 
were optically monitored after fabrication, prior to use, this might indicate surface re-
organisation due to stress based on insertion into solution.  This is consistent with the observed 
positive correlation between the internal stress and the Pt deposit thickness (up to the values 
~500 nm Pt on ~2500 nm Cu substrate) which has been reported in literature, after 
electrodeposition of Pt onto Ni or Cu surfaces [314]. It was also shown that the structural 
damage (cracks) on the Pt deposits were produced by this increased internal stress, which was 
suggested as being due to the strong forces at the substrate surface with corresponding 
formation of strain and fracture in the deposited material [314]. Another study [315] suggested 
that 150 nm-thick Pt films e-beam evaporated onto silicon oxide substrates showed tensile 
stresses of 230 MPa at a deposition rate of 0.1 nm s-l and 847 MPa at 0.7 nm s-1, due to the 
correlation between the deposition rate and the size of intergranular porosities, resulting in an 
increase in internal stress. The lack of the passivation layer on top of the Pt film should be also 
considered as they were shown to be able to reduce the substrate stress [316]. Therefore, it is 
suggested that that these effects might have together provoked the formation of surface 
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cracking following the fabrication, during immersion into solution and either electrode 
cleaning or stability measurements. 
 
5.2.6 Effect of Annealing Platinum Films  
In the previous section, it was thought that fabrication of thicker platinum films might have 
led to an increase in the internal film stress and this might have caused the formation of surface 
cracking as presented in optical microscope images and an increased propensity for probe loss 
through metal debonding. Post-annealing of thin films is a commonly used technique to alter 
film microstructure [317]. This also helps to reduce internal film stress and control surface 
morphology (roughness) when applied under optimised conditions [318].  
Figure 5-11: Stability of tripod-anchored probes on 200 nm-thick Pt blanket films (electrodes).               
A) Macroscopic image of the 200 nm-thick Pt film coated on SiO2/Si chip (35 mm x 3.75 mm). B) 
Electrochemical cleaning CVs of three individual films in 0.1 M H2SO4 between -0.35 and +1.6 V at a 
scan rate of 100 mV.s-1. C) Percentage signal change registered for tripod-anchored probes when 
immobilised onto three individual 200 nm-thick Pt films (green, blue and purple triangles) and 
interrogated with SWV in 1x PBS for 800 min. compared to the stability of commercial bulk (black 
circles) and in-house built TT and STT (red squares) which were given in Figure 5-10. D) Optical 
microscope image of the probe-immobilised region of the film has shown many fractures and cracks 
following the stability tests given in C).  
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In order to investigate whether post-annealing might reduce stress and increase SAM film 
stability, two sets of Pt blanket films, each including three identical replicates of 50 nm-thick 
Pt layer, were fabricated and one set was post-annealed, for 10 hours at 500 oC in N2. This was 
followed by the established mono-anchored probe immobilisation step (Section 3.4.2.1) and a 
comparative investigation of the stability in 1x PBS over time.  
As shown in Figure 5-12A, the deposited materials and their thicknesses used in two sets were 
slightly different. The Pt blanket films used in the annealed set included a thicker adhesion Ti 
layer compared to the other set, as well as an additional Si3N4 insulator layer. This can be 
accounted for by the fact that this set of Pt blanket films (which were then exposed to 
annealing) were already available as they had been previously fabricated for a different 
application. However, it was presumed this should not make any substantial difference 
between the two sets as the top Pt layer thickness is similar for each set. To confirm this, 
optical images obtained before and after probe immobilisation on both unannealed and 
annealed blanket films did not exhibit any variation or any kind of surface defects, such as 
delamination (Figure 5-12B).     
Figure 5-12: Stability of mono-anchored probes on unannealed (UA) vs annealed (A) 50 nm-thick Pt 
blanket films (electrodes). A) Cross-sectional schematic diagrams (not to scale) of the layers with 
thicknesses for unannealed and annealed films. (B) Optical microscope images of both unannealed and 
annealed films before or after, mono-anchored probe immobilisation.  
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Figure 5-13 presents the percentage signal change registered for mono-anchored probes 
immobilised onto unannealed and annealed Pt blanket films (each consisting of 3 replicates) 
which were immersed to 1x PBS and interrogated for 500 min. There is a clear difference 
between the responses of these unannealed and annealed films. A significant immediate signal 
decrease, around 90%, was registered for all unannealed blanket films just after 250 min they 
have been placed into buffer solution. This signal loss was comparable but quicker than the 
amount of signal loss registered for unannealed 200 nm-thick Pt blanket films with tripod-
anchored probes, as given in Figure 5-11. Also, in both experiments, a perfect consistency 
between the replicates of unannealed blanket films was experienced and this further confirms 
the recurrence and reproducibility of the stability problem, regardless of the fabrication batch 
or the nature of the probe.  
Interestingly, the stability of mono-anchored probe molecules immobilised onto annealed 
films was found to be very different. The signal initially rose which was attributed to the 
ongoing reorganisation of the film up to a time point (~100-150 min). This suggested that the 
post-annealing has decreased the rate of signal loss, although the annealing protocols were not 
optimised and there were some variation between the replicates in terms of the amount and the 
rate of experienced probe loss. However, this increased signal due to film reorganisation is 
balanced by SAM film loss, which limits the potential of post-annealing to recover film 
stability.  
Figure 5-13: Percentage signal change registered for mono-anchored probes when immobilised onto 
three individual of each unannealed (black, red and blue circles) or annealed (green, purple and yellow 
triangles) 50 nm-thick Pt films and interrogated with SWV in 1x PBS for 500 min. 
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As consistent with the experienced stability issue, platinum microelectrodes has been also 
found to be susceptible to chemical and morphological changes when they were exposed to 
electric fields (6 Vpp/175 µm AC and ±3 V/175 µm DC field) in various biological buffer 
solutions such as PBS, HEPES or Tris buffered saline [319]. These changes consisted of 
platinum oxidation, dissolution, re-deposition as well as potassium and/or chloride formation 
depending on a buffer solution used, and these changes were observed to be more effective 
under DC electric fields than in AC fields [319]. Another study revealed that the products of 
the dissolution/corrosion can have some cytotoxic effects in the long term, focusing on the Pt-
induced death of murine fibroblast (NIH 3T3) and human neuroblastoma (SH-SY5Y) cell lines 
[320]. This is not surprising when it is considered that cisplatin is widely used to treat cancer 
[321].   
Luckily, there have been a few successful attempts to avoid (or minimise at least) this 
drawback of platinum. For example, de Haro et al. reported that the lower rate of dissolution 
(7.8 ng/C) was obtained for electroplated Pt microelectrodes, whereas it was observed to be 
38.8 ng/C for thin film microelectrodes, with this improvement attributed to the good adhesion 
of electroplated Pt onto substrate Pt thin film due to an initial surface pre-treatment process 
[322]. Also, Park et al. showed that the Pt microelectrodes with fractal designs exhibited better 
charge transfer characteristics than the ones with circular designs, but they suffered from a 
significantly faster neurostimulation-induced Pt dissolution [323]. However, a single layer of 
graphene coating was shown to decrease the dissolution rate by almost ~97% without 
deteriorating the charge transfer [323]. As a relieving finding in addition to these, platinum 
dissolution was observed to be slower in solutions including proteins, which inhibit any release 
and/or accumulation into tissues and thus promoting their use for in vivo biosensing 
applications [324].  
Although some efforts e.g. using stronger anchoring, increased film thickness, post-annealing, 
have been given to improve the SAM film (probe) stability on platinum thin film single 
microelectrodes, the problem could not be resolved entirely. It was thought that this might 
have resulted from the employed cleaning method based on electrochemical 
oxidation/reduction in the acidic solution that might have led to increased Pt surface 
roughness. Therefore, the feasibility of its replacement with a simpler and less aggressive 
cleaning technique was investigated in the next sections, using the arrays of microelectrodes 
(MEA) and microcavity nanoband edge electrodes (MNEE) in order to increase the set of data 
and resulting currents.  
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5.3 Microelectrode Arrays (MEAs)  
In addition to the single microelectrodes analysed in the former section, arrays of 
microelectrodes were also produced, cleaned and assessed. For this purpose, two electrodes 
with a similar size (20 µm) and shape (circular) to commercial electrodes were selected. As 
presented in Figure 5-14B and C, they have the same diameter and shape, but different 
interelectrode spacings (2D and 4D) to characterise the effect arising from the interelectrode 
distance on sensor performances. Accordingly, they will be abbreviated as MEA 20µm-2D 
and MEA 20µm-4D from now on (Section 3.3.3 and Figure 5-14A).   
Figure 5-14: A) Cross-sectional schematic diagram (not to scale) with constituent materials layer 
thicknesses of a microelectrode array (MEA) with an electrode diameter/edge length of 20 µm and the 
separation of 2D (40 µm) as well as optical microscope images of B) MEA 20µm-2D and C) MEA 
20µm-4D.   
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5.3.1 Cleaning  
As suggested in the previous section, typical electrochemical cleaning in dilute acidic solutions 
(0.1 M H2SO4) was not successful to result in high fidelity reproducible SAM probe films on 
in-house built Pt thin film single microelectrodes. This stability problem was most likely due 
to loss of probes with weakened bonding to roughened electrode surfaces because of the 
progressive effect of formation and re-reduction of Pt oxide at positive solvent limit. Because 
microfabricated electrodes are already sufficiently clean, there is no need for such an 
aggressive cleaning technique. Therefore, an alternative method, electrochemical reduction 
[325]–[327] which has been shown to break gold-sulphur bonds, leading to the reductive 
desorption of SAM-based molecules from the substrate and thus cleaning the electrode surface 
could be used. Moreover, this method was not limited to gold electrodes, as it has been shown  
to be extendable to platinum and palladium substrates as well [328]. These redox reactions for 
reductive thiol desorption and the oxidative thiol adsorption can be given respectively, where 
RSH shows free thiol molecules and RS–M shows metal surface-adsorbed thiol molecules 
[329]:  
(i) RS–M + e - ⟶ M + RS -  
 
(ii) RSH + M ⟶ RS–M + H+ + e - 
 
If such a cleaning protocol was to be effective, it would also be useful to see it such cleaning 
was effective for electrode arrays. Therefore, microelectrode arrays, MEA 20µm-2D and MEA 
20µm-4D, were assessed in terms of the usefulness of the reductive cleaning method. Figure 
5-15 shows typical CVs (1st, 20th, 40th, 60th, 80th and 100th scans) recorded for MEA 20µm-
2D after modified with mono-anchored SAM probe and then cycled between -1.1 and +0.25 
V vs Ag/AgCl reference electrode, at a scan rate of 100 mV/s in 1 mM potassium 
ferri/ferrocyanide and 0.1 M KCl. As expected, the first CV scan recorded after the overnight 
modification of the electrode with the probe solution showed inhibition of the redox reaction 
of the ferri/ferrocyanide redox couple due to the blocking SAM layer on the electrode surface. 
However, it can be seen in the succeeding cycles, the redox reaction of the external agents was 
reinstated and the currents increased, confirming the desorption of thiols from the surface. The 
importance of using a fresh buffer solution and replacing it after each 10 min intervals was 
mentioned in other studies, because the process is reversible and re-adsorption of thiols (which 
desorbed from the surface and released into the buffer) can take place at oxidative potentials 
[201]. However, the buffer replacement was avoided in this work, limiting the oxidative 
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potential at only +0.25 V, instead of +0.45 V which was the oxidative potential limit used in 
the previous work. No evidence of SAM re-adsorption was seen within the potential range 
used for this study. 
 
 
Figure 5-16 presents voltammograms of MEA 20µm-2D and MEA 20µm-4D electrodes 
before and after this reductive electrochemical cleaning process. For both electrodes, as 
expected there is a clear difference which is compared to the uncleaned condition, even after 
20 cycles of reductive cleaning. Although this is further improved with 80 more cycles, it was 
seen there was little difference between the voltammograms of MEA 20µm-2D registered after 
20 and 100 cycles, unlike MEA 20µm-4D. This means that even a few cycles of 
electrochemical reduction can be sufficient to generate a fresh surface for an array of 
electrodes. A statistical evaluation of the registered currents revealed that all electrodes found 
in arrays can be successfully cleaned after sufficient time of cycling depending on the extent 
of SAM coverage and number of electrodes (depending on electrode size and interelectrode 
spacing). The most significant advantage of this cleaning technique over electrochemical 
Figure 5-15: Reductive electrochemical removal of SAM-functionalised probes: Typical CVs (1st, 
20th, 40th, 60th, 80th and 100th scans) of a MEA 20µm-2D recorded between -1.1 and +0.25 V at a 
scan rate of 100 mV.s-1 in an aqueous solution of 1 mM potassium ferri/ferrocyanide and 0.1 M KCl. 
E (V) 
 
  137 
cleaning with acidic solution, is an opportunity of real time monitoring of the electrode surface, 
as enabled by the external redox agent present in the buffer solution. This also enables better 
quantitative control on electrode morphology, as the cycling can be stopped when the 
monitored limiting current reaches the target value of a clean electrode determined by previous 
experiments.  
 
5.3.2 Characterisation of Clean MEAs  
Typical clean cyclic voltammograms of MEA 20µm-2D and MEA 20µm-4D are given in 
Figure 5-17A. There was around 2.5-fold difference in limiting currents, which were found to 
be higher for MEA 20µm-2D. This was the expected correlation, because 2500 individual 
electrodes are patterned on MEA 20µm-4D design, whereas MEA 20µm-2D consists of 6889 
individual single microelectrodes (See Appendix-2). The ratio of electrode number (the 
number of electrodes found in MEA 20µm-2D design divided by the number of electrodes 
found in MEA 20µm-4D design) is 2.76 which is slightly higher than the observed difference. 
Although, both array devices showed the expected sigmoidal, or near sigmoidal response 
characteristic of the hemispherical diffusion (Section 2.6.1), it was seen that MEA 20µm-4D 
had a more sigmoidal shape, compared to the MEA 20µm-2D which has a more peak-like 
response at this scan rate (100 mV.s-1). This is consistent with the fact that the individual 
electrodes are closer to each other for MEA 20µm-2D, which results in an overlap of the 
neighbouring diffusion layers.   
 Figure 5-16: Reductive electrochemical removal of SAM-functionalised probes: CVs of a A) MEA 
20µm-2D and B) MEA 20µm-4D recorded between -0.1 and +0.5 V at a scan rate of 100 mV.s-1 in an 
aqueous solution of 1 mM potassium ferri/ferrocyanide and 0.1 M KCl vs Ag/AgCl reference electrode, 
before reductive cleaning (black line) or after 20 cycles of reductive cleaning (red line) or after 100 
cycles of reductive cleaning (blue line).  
E (V) E (V) 
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Figure 5-17B therefore shows cyclic voltammograms of MEA 20µm-2D recorded at varying 
scan rates of 10, 50, 100, 200, 300, 400 and 500 mV.s-1. It was seen that a progressively more 
peak-like shape occurred at lower scan rates, which was especially observable for 10 mV.s-1. 
This was not surprising as it is known that the decrease in the scan rate causes the diffusion 
fields of the array electrodes to overlap and, correspondingly, resulting in the mass transport 
to each electrode becoming less efficient. At higher scan rates, however, this overlap is not 
seen due to the limited diffusion time, and each electrode in the array is able to respond as an 
individual microelectrode. This lays emphasis on the selection of the fastest scan rate (which 
should be enough to promote electrodes to respond individually) while a target limiting current 
is to be determined for an array [201]. In order to make a quantitative evaluation for MEA 
20µm-2D, Equation 5.1 was used to determine the experimental diffusion coefficient of 
ferri/ferrocyanide redox couple. The limiting current, iL of an individual microelectrode in the 
array was calculated by dividing the total limiting current obtained at the fastest scan rate (500 
mV.s-1) by the number of electrodes (N=6889). The diffusion coefficient was found to be D = 
6 x 10-6 cm2/s, which was very close to the literature value of 7 x 10-6 cm2/s [312], consistent 
with the variation in temperature. This confirms that the electrodes located in these fabricated 
MEAs are electroactive and they exhibit quantitative performance under redox conditions, thus 





Figure 5-17: A) Typical CVs of a MEA 20µm-2D (black line) and MEA 20µm-4D (red line) recorded 
between -0.1 and +0.5 V at a scan rate of 100 mV.s-1 in an aqueous solution of 1 mM potassium 
ferri/ferrocyanide and 0.1 M KCl. B) CVs of a MEA 20µm-2D with varying scan rates (10, 50, 100, 
200, 300, 400 and 500 mV.s-1) using the same buffer solution and conditions. 
E (V) E (V) 
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5.3.3 Performance in Protease Detection  
In order to evaluate the analytical performance of MEAs in protease sensing, MEA 20µm-2D 
and MEA 20µm-4D were modified with the mixed SAM layer by drop-casting as previously 
described (See Section 3.4.2.1). In order to assess them in terms of trypsin selectivity, MEA 
20µm-2D was modified with the substrate probe, whereas control probes were immobilised 
onto MEA 20µm-4D; and then they were replaced for the second analogous experiment to 
check whether an interelectrode spacing has any effect on the performance.  SWV peaks (right, 
Figure 5-18) registered for both control and substrate probe modified arrays were analysed 
using a simple MATLAB code (Appendix-3) this time, whereas the peaks were normally 
analysed by fitting to a Gaussian curve in the Origin software. Because, Gaussian fitting has 
been found to be significantly time consuming for a large number of scans. Therefore, the 
MATLAB code was created to simply find a background for the given peak and then calculate 
the peak height. Reassuringly, the peak height values obtained using both methods were 
compared and found to give the same results with experimental errors. Consequently, the SWV 
data obtained were analysed using the MATLAB code, unless other peak parameters (such as 
full width at half maximum, FWHM) were needed for analysis. As an initial SWV signal, 
MEA 20µm-2D (6889 electrodes) device gave ~2 µA whereas it was around 0.5 µA for MEA 
20µm-4D (2500 electrodes). The currents given by a single microelectrode in both arrays were 
thus found to be comparable to the currents (~10-10 A)  registered with single microelectrodes 
(with comparable diameters).  
Figure 5-18 shows the percentage signal change for both arrays immersed in buffer solution, 
1x PBS before and after the addition of 100 nM trypsin (at time t=100 min). The most 
significant finding to note here was the improved stability of the microelectrode arrays for 
probe molecules. Until the time when enzyme was added into solution, both substrate and 
control modified arrays showed a similar and more stable background than TT and STT 
microelectrodes, only decreasing by ~10%. This was of course significant considering the 
major stability problem experienced with single TT and STT microelectrodes, which 
sometimes caused at least ~50% signal decrease within the first 100 min. This improvement 
can be attributed to the feasibility of reductive cleaning used for MEAs.  
Following trypsin addition at 100 min, the signal was monitored for a further 175 min and a 
clear signal decrease of 70% was recorded for substrate-modified MEA 20µm-2D while 
control modified MEA 20µm-4D device still did not present any significant signal change 
afterwards. There was only a little change which was attributed to the background decrease 
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due to the stability, because the rate of this decrease was similar to the one which was observed 
before enzyme addition. This background signal change recorded with control probes was then 
subtracted from the trypsin-induced signal change recorded for substrate modified electrode. 
Afterwards, the effective rate constant was calculated as detailed before (Section 4.8) and 
found to be 0.01864 ± 0.00047 min-1. Despite being a bit lower than the one recorded for 
commercial Pt macroelectrode (0.02854 ± 0.00120 min-1), surprisingly it was 3-fold faster than 
the one estimated for commercial Pt microelectrode (0.00617 ± 0.00013 min-1).     
Figure 5-18: Top: Plot of % signal decrease vs time for SAM-functionalised mono-anchored probe 
immobilised onto Pt microelectrode arrays (Substrate-modified: MEA 20µm-2D, Control-modified: 
MEA 20µm-4D) upon the addition (at time t = 100 min) of 100 nM trypsin in 1x PBS. Inset. Calculated 
fractional cleavage, θ, vs time plot for the control-subtracted substrate data, where its fit to equation 
4.3 gives a keff value of 0.01864 ± 0.00047 min-1. Bottom: Typical SWV curves and their peak height 
calculations using a MATLAB code for SAM-functionalised i) substrate and ii) control-modified 
probes immobilised onto MEAs at different incubation times (between 0 - 275 min) with 100 nM 
trypsin are also given.   
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In order to assess whether the estimated rate constants are reproducible, the arrays were again 
cleaned with electrochemical reduction until the target limiting currents were obtained. They 
are then modified with probe, but the other way around this time; MEA 20µm-4D was 
modified with the substrate probe and MEA 20µm-2D was modified with the control probe. 
Initial signals were again comparable, confirming the reproducibility of reductive cleaning for 
creating a fresh electroactive surface. Although there has been a quite similar and stable 
background (~5%) for both arrays until trypsin addition (at time t = 100 min), the rate of 
trypsin cleavage was notably slower, with a decrease of 60 – 65% after 900 min of incubation 
(Figure 5-19). This was also presented by the keff value for this experiment, which was 
estimated as 0.00344 ± 0.00064 min-1. It was interesting because this rate was too slow to be 
affected by mass transport, and there should have thus been no difference. There might have 
been some differences between these two electrodes such as (i) the amount of cleavable 
substrate probe molecules (anticipated to be higher for MEA 20µm-2D due to the larger total 
area) and (ii) possible macroelectrode-like behaviour for MEA 20µm-2D, arising from the 
overlapping of diffusion fields. However, any of them was typically expected not to affect the 
rate.  
 
Figure 5-19: Plot of % signal decrease vs time for SAM-functionalised mono-anchored probe 
immobilised onto Pt microelectrode arrays (Substrate-modified: MEA 20µm-4D, Control-modified: 
MEA 20µm-2D contrarily to given in Figure 5-18) upon the addition (at time = 100 min) of 100 nM 
trypsin in 1x PBS. Inset. Calculated fractional cleavage, θ, vs time plot for the control-subtracted 
substrate data, where its fit to equation 4.3 gives a keff value of 0.00344 ± 0.00064 min-1. 
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To make sure that the rate of trypsin cleavage specific to this MEA 20µm-4D was 
reproducible, the same array device was reductively cleaned, modified with the substrate probe 
and incubated with varying trypsin concentrations (0, 25 and 100 nM) at ambient (25 oC) and 
body temperature (37 oC). As depicted in Figure 5-20, the array-based platform gave different 
amounts of percentage signal change for varying concentrations. Also, it was seen to be quite 
stable when incubated with only buffer solutions, which did not include any trypsin (0 nM). It 
was interesting that the stability was even seen to be higher this time, compared to the previous 
experiments presented in Figure 5-18 and 5-19. This confirms the trypsin sensitivity of the 
array-based sensor platform. Also, increasing the temperature up to 37 oC resulted in an 
increase in the rate in shorter time period, losing its effect in longer terms. Most likely, this 
increase was lower than ~4-fold which was obtained for commercial microelectrodes. It is also 
worth noting that the standard deviations for the replicates of the experiment performed at 37 
oC were the lowest compared to all other data obtained at 25 oC. This offers further improved 
consistency regarding clinical measurement conditions.  
 
Figure 5-20: Plot of % signal decrease vs time for SAM-functionalised mono-anchored substrate-
modified probe immobilised onto Pt microelectrode arrays (MEA 20µm-4D) immersed in varying 
trypsin concentrations in 1x PBS: 0 nM (blue circles), 25 nM (green circles) and 100 nM (at 25 °C, 
black circles or at 37 °C, red circles). All data represent the average and error bars from 3 functionalised 
electrodes. 
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5.4 Microcavity Nanoband Edge Electrode Arrays (MNEEs) 
Although nanoelectrodes have attracted significant interest in lots of fields in the recent years 
[291], their use in protease detection is very limited. Existing works have mainly focused on 
the utilisation of nanoelectrode arrays for understanding the proteolytic activities of cathepsin 
B and/or legumain in buffer solutions, tissue and cancer cell lysates [84], [235], [307], [330]. 
However, their fabrication were based on the encapsulation of vertically aligned carbon 
nanofibers (VACNFs) into SiO2 substrates, and they are not thus convenient platforms for 
SAM molecules which requires a thiol bonding to immobilise onto the substrates. This  
necessitates for Au- or Pt-based nanoelectrodes which can allow metal-thiol bonding.  
Therefore, two types (i. in-house built and ii. commercially available) of microcavity Pt 
nanoband edge electrode array (MNEE) devices were used to characterise their performance 
in protease sensing. For both commercial and in-house MNEEs, electrochemical reductive 
cleaning was successfully used and achieved reproducible surface cleanliness similar to MEA 
findings.  
5.4.1 NanoFlex MNEEs  
The first type of MNEE electrodes was commercially available and supplied by NanoFlex Ltd, 
UK with a brand name of CAVIARE™ (CAVIty ARray Electrode). This array includes square 
(30 x 30 µm) cavities with a 50 nm Pt band at the edges, as shown in Figure 5-21B and C.  The 
type used here consisted of dual contact pads where both connected to the array of electrodes 
in the same way, but only one of the contact pads was used for connection. Figure 5-21A 
presents two individual identical NanoFlex MNEEs drop-cast with the solution of substrate 
probe molecules. 
Figure 5-21: A) Macroscopic image of two individual and identical (left: Electrode-1, right: Electrode-
2) NanoFlex Microcavity Nanoband Edge Electrode (MNEE) arrays incubated with 40 µM of probe 
solution by drop-casting. Optical microscope images show B) the array of 10 x 10 electrodes and C) a 
single microsquare cavity of 30 µm x 30 µm and a 50 nm Pt nanoband at the edge of the cavity. 
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As depicted in Figure 5-22(i), limiting currents and redox reaction of both MNEEs were 
significantly enhanced after successfully cleaned via 100 cycles of reductive cleaning between 
-1.1 and +0.25 V. This was as anticipated, as any production-induced adsorbates were 
reductively desorbed from the Pt nanoband surface. However, the shapes of the 
voltammograms were slightly different from each other, which were found to be interesting as 
they are identical electrodes and the same behaviour was expected. 
 
 
Figure 5-22: Using NanoFlex MNEE arrays for trypsin sensing. i) Electrochemical reductive cleaning 
with 100 cycles of CVs between -1.1 and +0.25 V at a scan rate of 100 mV.s-1 in an aqueous solution 
of 1 mM potassium ferri/ferrocyanide and 0.1 M KCl.  ii) Plot of % signal decrease vs time for SAM-
functionalised mono-anchored probe immobilised onto NanoFlex MNEE arrays (both Electrode-1 and 
2 substrate-modified) upon the addition (at time = 0 min) of 100 nM trypsin in 1x PBS. iii) Plot of % 
signal decrease vs time for second performance characterisation with SAM-functionalised mono-
anchored probe immobilised onto NanoFlex MNEE arrays (Control-modified: Electrode-1, Substrate-
modified: Electrode-2 this time) upon the addition (at time = 0 min) of 100 nM trypsin in 1x PBS, with 
calculated fractional cleavage, θ, vs time plot (Inset) for the control-subtracted substrate data, where its 
fit to equation 4.3 gives a keff value of 0.00490 ± 0.00041 min-1.  
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These devices were then immobilised with substrate probe molecules exhibited ~60-65% 
signal decrease over 900 min, after the addition of 100 nM trypsin (at time t=0 min) (Figure 
5-22(ii)). Although the registered decreases in the percentage signals obtained from both 
replicates were similar after 900 min, the initial response of Electrode-2 was markedly 
different than Electrode-1. A difference was also seen in variation in their initial peak currents, 
recorded as 87 nA for Electrode-1 and 44 nA for Electrode-2. 
In order to estimate the efficient rate constant and analyse whether they were similar to the 
ones recorded for microelectrode arrays, they were modified with the substrate (Electrode-2) 
and control (Electrode-1) probes. Closer values were obtained as initial signals this time, 
which are 95 nA for Electrode-1 and 73 nA for Electrode-2. A clear difference between the 
percentage signal decreases calculated for control (~20%) and substrate modified (~60%) 
nanoelectrodes was seen after 900 min incubation of 100 nM trypsin (Figure 5-22(iii)). In 
addition, the effective rate constant was calculated as 0.00490 ± 0.00041 min-1 for this 
cleavage - not much different from the keff reported for MEAs (0.00344 ± 0.00064 min-1, where 
substrate: MEA 20µm-4D, control: 20µm-2D). This simply suggests that commercial Pt 
MNEEs were sensitive against trypsin and this motivated the fabrication of similar architecture 
MNEE devices in-house.  
 
5.4.2 In-house MNEEs  
After it was seen that the commercial MNEE sensing platform has shown successful probe 
deposition and trypsin cleavage (sensitivity), corresponding MNEE devices were fabricated 
in-house in SMC (as detailed in [201]) as an alternative to commercially available version, 
and then characterised in terms of protease detection, as similarly. Again, two designs, MNEE 
20µm-1D and MNEE 20µm-2D, due to fact that they are comparable with previously analysed 
electrodes in terms of size and shape, were selected for characterisations, although it is possible 
to fabricate them in any size and any shape.   
 
5.4.2.1 Characterisation  
Cyclic voltammograms of MNEE 20µm-1D and MNEE 20µm-2D recorded between -0.1 and 
+0.5 V at varying scan rates in an aqueous buffer solution of 0.5 mM ferrocene methanol 
(FcMeOH) and 0.1 M KCl are given in Figure 5-23. There is an about 2-fold difference when 
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MNEE 20µm-1D and MNEE 20µm-2D are compared in terms of the limiting currents 
obtained in their CVs recorded at the same scan rate. Again, similarly to the comparison of 
MEA devices, this was consistent with the ratio of electroactive area (Appendix-2, MNEE 
20µm-1D: 15625 cavities and MNEE 20µm-2D: 6889 cavities) on the arrays. The 
voltammogram shapes were observed to be more sigmoidal compared to the MEAs and single 
microelectrodes, due to the enhanced hemispherical diffusion. When CVs taken at 10 mV.s-1 
are compared, MNEE 20µm-1D seems slightly less sigmoidal than in MNEE 20µm-2D, which 
again attributed to the overlapping of the diffusion fields. This, of course, disappeared at faster 
scan rates for both devices, as overlapping of the diffusion fields at neighbour electrodes does 
not exist. The experimental diffusion coefficient of ferrocene methanol was calculated at fast 
scan rate using the equation [192];   
       𝑖𝐿 = 0.956𝑛𝑁𝐹𝐷𝐶𝑟                    (5.3) 
where n is the number of electrons (which is equal to 1 for ferrocene methanol), N is the 
number of electrodes in the array, F is the Faraday constant, D is the diffusion coefficient 
(cm2/s), C is the concentration (mol/cm3) for redox molecule in the solution and r is the radius 
(cm) of an individual electrode in the array. 
The diffusion coefficient was found to be D = 6 x 10-6 cm2/s using both MNEE 20µm-1D and 
MNEE 20µm-2D. These given values are the same as each other and the literature (D = 7 x 
10-6 cm2/s) [331] within experimental error. 
 
 
 Figure 5-23: A) Typical CVs of in-house built A) MNEE 20µm-1D and B) MNEE 20µm-2D recorded 
between -0.1 and +0.5 V at varying scan rates (10, 50, 100, 200, 300, 400, 500 and 600 mV.s -1) in an 
aqueous solution of 0.5 mM ferrocene methanol and 0.1 M KCl. 
E (V) E (V) 
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5.4.2.2 Performance in Protease Detection  
Both MNEE 20µm-1D and MNEE 20µm-2D devices were cleaned using the same 
electrochemical reduction method prior to the probe immobilisation. Afterwards, MNEE 
20µm-1D was modified with the substrate probe, whereas control probes were immobilised 
onto MNEE 20µm-2D. The initial SWV signals were observed as ~0.7 µA for MNEE 20µm-
1D and ~0.4 µA for MNEE 20µm-2D. The ratio was consistent with the number of electrodes 
in the arrays, and these signal amounts were significantly higher than single microelectrodes 
tested up to now. The current densities of probe modified TT & STT single microelectrodes, 
MEAs and MNEEs were calculated for further analysis, and given in Table 5-1. They were 
also compared to the commercial Pt single microelectrodes. In-house STT single 
microelectrodes gave similar values within experimental errors to the commercial 
microelectrodes. The current density values calculated for all STT single microelectrodes 
(20µm, 50µm and 100µm) were found to be the same with each other. In addition, the current 
densities of MEAs also found as smaller than expected. They were observed to be same with 
STT single microelectrodes within errors. The highest current densities were recorded using 
MNEE devices, by almost 10-fold superior numbers than other in-house built devices. This is 
a significant finding that MNEE electrodes can offer the best signal-to-noise ratio for SAM-
based redox probes of all the miniaturised electrodes in this study.   
When MNEE 20µm-1D (substrate) and MNEE 20µm-2D (control) were incubated with 100 
nM trypsin (added at time t=0 min) for 900 min, this resulted in a clear difference between 
substrate- and control-modified electrodes, as shown by Figure 5.24. The control probe only 
showed a decrease around 25%, where the change for substrate probe was found as ~70%. 
These signal decreases were observed to be quite reproducible when other tests were carried 
out. The effective rate constant was calculated as 0.01302 ± 0.00127 min-1 for the cleavage 
(Figure 5-24 Inset). This value was found to be comparable with the first keff, 0.01864 ± 
0.00047 min-1, reported using MEAs (where MEA 20µm-2D: substrate modified and MEA 
20µm-4D: control modified). Also, it is worth noting that it was ~2-fold faster than commercial 
Pt microelectrodes (0.00617 ± 0.00013 min-1). On the other hand, all keff values reported, 
through this chapter, estimated for MEAs as well as commercial and in-house MNEEs have 
been smaller than the values given by Au and Pt commercial macroelectrodes (See Table 4-
1). This further confirms the suggestion of similar and valid findings for all tested miniaturised 
electrodes, in terms of SAM film variations compared to macroelectrodes, partial 
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inaccessibility of enzyme and slower proteolytic cleavage, in accordance with the discussion 
in Section 4-8.  
 
 Figure 5-24: Using in-house built MNEE arrays for trypsin sensing. Plot of % signal decrease vs time 
for SAM-functionalised mono-anchored probe immobilised onto in-house built MNEE arrays 
(Substrate-modified: MNEE 20µm-1D and Control-modified: MNEE 20µm-2D)  upon the addition (at 
time = 0 min) of 100 nM trypsin in 1x PBS. Inset. Calculated fractional cleavage, θ, vs time plot (Inset) 
for the control-subtracted substrate data, where its fit to equation 4.3 gives a keff value of as 0.01302 ± 
0.00127 min-1. 
Table 5-1: Summary of calculated current densities for various Pt electrodes. 
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5.4.2.3 Issues with Reproducible Measurement using MNEEs  
Although MNEE devices have displayed encouraging performance for protease sensing, some 
issues were experienced during the measurements and they might constitute future challenges 
if not addressed. Therefore, the problems and possible solutions were investigated, in 
collaboration with Mr. Daniel Dewar under the programme of EPSRC Vacation Bursary 
Undergraduate Project.  
The first challenge experienced by MNEE-based sensors was due to the sensitivity of 
nanoelectrodes to the presence of O2 in buffer solution. As depicted in Figure 5-25, in most of 
the cases, there is an elevation at the lower potential side of the background due to the O2 
reduction, whereas it should be ideally a Gaussian curve which is centred around ΔE1/2  of the 
usual potential range for methylene blue. The same situation is sometimes faced during the 
microelectrode measurements as well, due to the improved sensitivity of miniaturised systems. 
The presence of this elevated background requires longer analysis times, as background 
subtraction is usually needed prior to fitting of the data according to Gaussian distribution.    
 
Moreover, the background does not remain constant and changes over the course of 
experiments due to the same reason. Figure 5-26A shows SWV data consisting of 240 
individual scans recorded with 5 min intervals for an experiment performed overnight, without 
the addition of the enzyme. As illustrated in Figure 5-26B, five individual scans recorded at 
varying times of the experiment course were selected from data set and plotted, in order to 
Figure 5-25: A) Ideal SWV curve of a methylene blue-tagged probe where clear Gaussian distribution 
is centred around ΔE1/2 of the usual potential range for methylene blue. B) However frequently 
observed SWV response of the probe immobilised onto MNEE arrays shows an elevation at the lower 
potential side due to the reduction of oxygen in PBS solution.  
E (V) E (V) 
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exhibit the drastic background change at negative end of the potential window. This drawback 
of MNEE devices hinders the possibility of automated analysis (peak fitting) of all data using 
the same algorithm and thus significantly effects the time and effort spent for the extraction of 
the real MB redox peak.   
 
A SWV scan recorded over a wider potential window (from -0.7 V to +0.1 V) can show the 
peak corresponding to O2 reduction at -0.6 V and this illustrates how an increase in the amount 
of this peak effects the background of the MB redox peak (Figure 5-27). As also depicted in 
the same plot, degassing of the solution with an inert gas such as N2 or Ar can decrease this 
background considerably. Because degassing results in a decrease in the amount of O2 
dissolved in the buffer solution, which accordingly provides an easier and reliable data 
analysis. However, this can only be a temporary solution which can be benefited for bench 
measurements. Because the future work aims these sensing platforms to be implanted into the 
body, there is a need for other approaches which can be applicable from a lab-on-a-chip 
technology, as degassing cannot be a final answer in this case.    
Changing the SWV sweep direction was used as another method in order to decrease the 
amount of background change due to O2 reduction. SWV scans are normally scanned towards 
the reductive side, where the sweep goes from 0 V to -0.4 V. The potential is held at 0 V for 
two seconds to ensure that the MB is returned to the oxidised state prior to its later reduction. 
However, applying a potential of -0.4 V and then sweeping the potential towards 0 V was 
Figure 5-26: A) Typical SWV data (240 scans with intervals of 5 min) which belongs to the substrate-
modified probe immobilised onto a MNEE array for an experiment performed overnight, where no 
enzyme was added.  B) Five selected SWV curves over this long experiment period demonstrates how 
the oxygen background varies over time.  
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found to reduce the amount of background change over the course of measurements (Figure 
5-28). The reason is attributed to the possible depletion of reducible O2 near the electrode 
surface, which is most likely due to holding the potential at -0.4 V initially, which should be 




















Figure 5-27: Typical SWVs with an extended potential window (-0.7 to +0.1 V) for substrate-
modified probe immobilised MNEE 20µm-1D before and after degassing 1x PBS solution with N2.  
E (V) 
Figure 5-28: A) Typical SWVs performed in the reductive direction (from -0.05 V towards -0.4 V), 
with the potential being held at -0.05 V for 2s before starting the sweep, compared to the B) SWV 
curves scanned in the oxidative direction (from -0.4 V towards -0.05 V), with the potential being held 
at -0.4 V for 2s before starting the sweep, and it has been observed that magnitude of the background 
decreased dramatically for curves scanned in the oxidative direction.  
E (V) E (V) 
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5.5 Summary  
In this chapter, further miniaturisation of the peptide-based protease sensing platform was 
investigated. This was approached by translating commercial (conventional) bulk macro- and 
microelectrodes to in-house built Pt thin film electrodes on silicon chips. These electrodes 
have been grouped with respect to their size and structure and then individually assessed, as 
single microelectrodes, microelectrode arrays (MEAs) and microcavity nanoband edge 
electrode arrays (MNEEs). The cleaning procedures and characterisation were primary 
features which have been discussed for each group, before the evaluation of their performance 
in trypsin detection, together with encountered problems and possible solutions.  
Investigation of superthin track (STT) and thin track (TT) single microelectrodes discovered 
a major stability problem which significantly limited the detection of trypsin. Optical 
microscope images of electrode surfaces presented several defects and evidences of metal 
removal, consistently with the experienced problem. Although the effects of different 
treatments such as using probes with stronger anchors (tripod-), increasing the metal film 
thickness and post-fabrication annealing were assessed, any of them could not completely 
recover the in-house single microelectrode stability. An increased surface roughness due to 
the electrochemical oxidation and reduction in the acidic cleaning solution was thought to be 
responsible for the problem, because of the possible Pt surface reconstruction after oxide 
formation and removal. Therefore, acidic cleaning was replaced with a less-aggressive 
reductive cleaning technique, which was found to increase MEAs stability and reproducibility. 
Although MEA findings revealed very promising advances in protease sensing (i.e. easier and 
reproducible cleaning, improved probe stability, rapid sensing depending on an array structure, 
enhanced consistency) compared to in-house single microelectrodes, the addition of other 
concentrations and the characterisation of non-specific binding should be included in future 
work, for complete analytical evaluation. Also, similar cleavage rates and significantly 
enhanced electrode current densities were obtained using MNEEs, although some additional 
drawbacks related to increased background due to O2 reduction were found. As a result, in-
house fabricated electrodes can be designed and used as suitable platforms for the development 
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6.1 Introduction  
Self-assembled monolayers (SAMs) have long been an interest of many researchers because 
of their ready formation and their successful employment in several applications, as detailed 
in Section 2.4. Typical SAM structures consist of functionalised tails and thiol head groups 
which can strongly bind to Au/Pt substrate atoms, as previously illustrated in Figure 2-9. The 
mechanism and kinetics of SAM formation have also attracted attention. It has been found that 
the initial adsorption and subsequent re-organisation processes and kinetics can be affected by 
changes in parameters such as temperature, bulk solution concentration, type and chain length 
of SAMs, and substrate surface cleanliness, morphology and chemistry [147]. This is why, 
although SAM formation has been widely studied and is established, deconvolution of the 
effects of surface processes and the resulting SAM film structural variety can quite easily 
become challenging. SAMs are commonly deposited using incubation of a clean gold substrate 
with an organic-based solvent including SAM-forming molecules. It is often found that initial 
adsorption rapidly results in 80-90% of surface coverage within second to minutes, dependent 
on concentration, with further coverage continuing at a slower rate thereafter [332]. For 
example, an evaporated Au film surface was seen to be almost completely covered with 
dodecanethiol (2 µM in hexane solution) within the first 5 min [333]. In another study [11], 
the initial and fastest step of SAM formation was related to the strong chemisorption of the 
headgroup onto the substrate surface, which is followed by chain straightening in a 3-4 times 
slower second step and further chain re-organisation in a 35-70 times slower final step. 
Therefore, it has been claimed that typical high fidelity SAM coverage can take hours and 
even days [334].  
Controlling SAM adsorption kinetics and mechanism as well as decreasing these required 
timescales is considered vital in order to enhance their applicability and to create 
preferentially-patterned substrates [335]. Given that the gold metal surfaces typically have 
uncontrolled potentials (and hence surface charges and energies), fixed by the likely variable 
redox composition and potential of the SAM deposition solution, this has led to studies focused 
on potentiostatic (potential-controlled) selective SAM adsorption and desorption. For 
example, Riepl et al. have performed capacitive monitoring of SAM thiols (mercapto-
hexanoic acid and octadecanethiol) which were found to be chemisorbed onto Au 
microelectrode arrays at +0.3 V vs SCE, but only physisorbed when the applied electrode 
potential was -1.4 V after 100-200 min [336]. In similar work, +0.4 V vs SCE applied over 5 
min was found to result in the best film integrity when forming a n-dodecanethiol SAM [337]. 
Ma et al. deposited C16 RS SAMs onto Au substrates from a 5 mM solution in only 15 min 
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applying potentials between +0.2  and 0.6 V vs Ag/AgCl [338]. In addition to these thiol 
studies, the effect of potential in controlling SAM adsorption/desorption and film formation 
was also studied when using different types of SAM head groups (thiol, dithiolane, thioester, 
disulfide and thiosulfanate) [339] and different substrates (Au, Pt and Pd) [328].  A 
combination of applied anodic and cathodic potentials was found to enable the selective 
deposition of one of two different redox tag (ferrocene)-labelled SAM molecules from the 
same bulk solution each onto two individual electrodes [329]. This was then extended to the 
immobilisation of single-stranded DNA on Au surfaces by employing potential pulses for 15 
min [340].   
Accordingly, the proof of concept work presented in this chapter aims to analyse the 
applicability and feasibility of an active, potential-controlled technique in creating enhanced 
probe-modified surfaces in comparison to the ones provided by passive overnight incubation.  
  
6.2 Effect of Potential on SAM Probe Deposition  
Commercially available (Metrohm Dropsens UK, Section 3.3) screen-printed electrodes 
(SPEs) were used for the experimental work in Chapter 6 and Chapter 7. Due to the differences 
between the commercial SPEs (formed from a screen printed gold ink) and in-house 
microfabricated electrodes (formed from deposition of pure platinum films), some significant 
differences for these SPEs in e.g. electrode material composition and/or distribution, 
electrochemically-active area, surface cleanliness might be expected. This has been observed 
previously [341], and in order to mitigate this, the SPEs were cleaned using the protocol 
developed in [341]. This involved cycling the potential (performing 10 cyclic voltammograms) 
between 0 and +1.6 V at 100 mV/s in 0.1 M H2SO4. Although the size of the peaks per unit 
area in these cleaning CVs were sometimes different across SPE batches and compared to 
microfabricated electrodes, they were found to be similar and self-consistent within the same 
SPE batch following cleaning. Still, in order to avoid any remaining issues which may arise 
from such peak size variations, the changes in the resulting signals were always defined as the 
normalised percentage, where possible, instead of the actual current values. This followed the 
approach in [341] and was thought to be reasonable as such percentage changes should be 
insensitive to any differences in electro-active area.    
In order to measure the effect of applying a potential to the gold working electrode when 
depositing SAM-functionalised probe, 100 µl of 40 µM mono-anchored substrate probe 
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(Section 4.2) in 1x PBS was drop-cast onto a horizontally oriented and electrochemically-
cleaned (see Section 3.4.1 for protocol) Au screen printed three electrode system with a Au 
working electrode of 4 mm-diameter whilst a constant DC potential was applied for 10 min 
using a chronoamperometry (See Section 2.6.3). The internal Ag pseudo reference electrode 
and Au counter electrode were used as this volume was sufficient to ensure coverage of all 
three electrodes and electrochemical control. Although the reference potentials of pseudo REs 
are typically unknown and highly dependent on the solution, the difference between the 
internal SPE pseudo RE used here and an external Ag/AgCl (3M KCl) was measured as only 
~18 mV in 1x PBS. After 10 min, each electrode was immersed in 1x PBS solutions to washing 
off any weakly or non-adsorbed SAM molecules. In order to analyse the amount of adsorbed 
SAM probe at each applied potential, they were then interrogated with SWV in 1x PBS in the 
established potential range for peak methylene blue detection (-0.4 V – 0 V, See Section 3.4.3) 
because each SAM-functionalised substrate probes in the SAM was covalently attached to a 
methylene blue redox-tag.  
Figure 6-1 shows the resulting methylene blue SWV average peak currents registered for 3 
replicates, versus applied electrode potential (vs the internal Ag pseudo RE). Although these 
average peak current values unexpectedly seemed to show an increasing trend when shifting 
the applied potential to more cathodic potentials, the variation reflected in the error limits was 
found to increase markedly at and below 0V, such the difference in average values were not 
statistically significant. These larger deviations can be attributed to variation caused by 
physisorption at these negative potentials, which would be consistent with the literature 
findings [329], that thiol SAMS were typically observed to be physisorbed at cathodic 
potentials, instead of chemically adsorbed. This is consistent with the fact that the most 
negative potential applied was chosen to be -1.0 V since it was shown that -1.1 V resulted in 
the reductive cleaning of the electrode surface of SAM molecules (See Section 5.3.1). In 
contrast, the peak currents were found to be similar and with much reduced experimental errors 
between +0.2 V and +0.6 V. This we attribute to a region where stronger adsorption, 
potentially chemisorption is occurring. Moreover, at larger anodic values e.g. +0.8 and +1.0 
V, there was a progressive decrease in the signal obtained. Only negligible signals were 
registered, consistently for all replicates, which was most likely due to Au oxidation resulting 
in the progressive change of the surface to Au-O and decrease in SAM sorption strength. 
Consistent average peak current values and high reproducibility within the replicates obtained 
at +0.2, +0.4 and +0.6 V therefore indicate that this potential range is preferable for potential-
controlled SAM probe deposition.  
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As well as determining surface coverage from the relative number of probe molecules 
electrochemically detectable, given the relatively short deposition time, the degree of surface 
electrode blocking is another related parameter which should be characterised, as this should 
be independent of probe orientation and electrode accessibility. In order to do this, an electrode 
coverage test was carried out by using the soluble redox couple ferri/ferrocyanide. Figure 6-2 
shows cyclic voltammograms of bare and probe-modified (overnight passive incubation, -1.0 
V, +0.2 V and +0.6 V) electrodes recorded in 5 mM potassium ferri/ferrocyanide in 1x PBS 
between potentials of -0.2 and +0.5 V at a scan rate of 100 mV/s. The bare electrode showed 
the expected and characteristic macroelectrode response for a reversible redox reaction. For 
all probe-modified electrodes, although there were also oxidation and reduction peaks which 
are indicative of electrode redox reaction, they were decreased in height and more separated. 
This confirms that SAM-functionalised probe molecules have not completely passivated the 
electrode surface but clearly affected the reversibility of the electron transfer reaction. This 
effect was largest for the probe deposited with the potential at +0.6, followed by the non-
potential controlled overnight incubation, -1.0V and +0.2 V. Although this data on its own 
does not establish an optimum deposition method, since more surface coverage might not 
indicate the best orientation and performance for trypsin cleavage, it is interesting that 
Figure 6-1: The dependence of the methylene blue SWV peak current on the electrode potential applied 
to the Au SPEs over 10 min of SAM probe deposition. All data points typically represent the average 
and standard deviation for 3 replicates. 
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potential controlled deposition at +0.6 V for 10 minutes produces a greater response than 
overnight, non-potential controlled functionalisation.   
 
6.3 Trypsin Sensing Performance of Deposited SAM Probes 
The best way to understand the feasibility of potential-assisted deposition technique was to 
perform an experiment to analyse the trypsin sensing performance of deposited probes. Figure 
6-3 presents background-subtracted SWV curves registered for overnight deposited and 
potential-controlled (at +0.2 V) deposited probes before addition of the enzyme as well as the 
percentage signal decrease against 100 nM trypsin registered for the overnight incubated 
probes in comparison to the potential-assisted deposited probes at -1.0 V and +0.2 V. It is 
interesting that the variation in percentage signal decrease between the replicates of overnight 
incubated probes was higher than the short time potential-controlled SAM deposition. Also, 
higher SWV peak height registered for 10 mins at +0.2V compared to overnight with non-
potential control is worth noting. These confirm that a more reproducible SAM film has 
resulted in a more reproducible trypsin performance. It is interesting that the mean percentage 
signal decreases for all of these data were found to be the same within experimental error.  
Figure 6-2: Cyclic voltammograms at electrodes which are bare (black), and have undergone overnight 
non potential controlled SAM deposition (red) and potential-assisted SAM deposition (at -1.0 V: blue, at 
+0.2 V: green, at +0.6 V: purple) in 5 mM potassium ferri/ferrocyanide in 1x PBS between potentials of 
-0.2 and +0.5 V at a scan rate of 100 mV/s. 
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That’s why the fractional cleavage (Figure 6-3 Inset) of the probes and the effective rate 
constants were calculated using equation 4.3 and found to be 0.0083 ± 0.0002 min-1 for 
overnight incubation, 0.0085 ± 0.0002 min-1 for -1.0 V and 0.0083 ± 0.0001 min-1 for +0.2 V 
applied potential. It has been found that these calculated effective rate constants were the same 
with each other (within experimental errors) as in their average percentage signal decreases 
recorded. This suggested that the extent of the probe molecules deposited onto electrode 
surface might not be much effective on the cleavage rate, unless the surface is dilute enough 
so as not to hinder either redox tag-electrode interactions or trypsin binding and proteolytic 
cleavage. As a result, non-potential deposition runs overnight and produces more variation, 
whereas potential-controlled technique takes ten minutes and results in less variation with 
similar cleavage kinetics. These findings thus confirmed the feasibility of using potential-





Figure 6-3: Characterisation of the trypsin sensitivity after potential-assisted probe deposition onto Au 
SPEs in comparison to overnight incubation: A) Background-subtracted SWV curves registered for 
overnight deposited and potential-controlled (at +0.2 V) deposited probes before addition of the 
enzyme. B) Percentage signal change registered for overnight deposited (No potential, black squares) 
and potential-controlled deposited probes (at -1.0 V for 10 min: red circles or at +0.2 V for 10 min: blue 
triangles) after the addition of 100 nM trypsin at time = 0 in 1x PBS. All data points typically represent 
the average and standard deviation for 3 replicates. Inset: Calculated fractional cleavage, θ, vs time 
plots for the same data.   
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6.4 Summary  
Potential-controlled SAM deposition technique was investigated in a comparative manner to 
the commonly used probe incubation method. Preliminary proof of concept results revealed 
that potential-controlled deposition can provide faster SAM immobilisation onto surfaces, 
more reproducible SWV peak currents and same biosensing performance. All probes deposited 
on the electrode surfaces via applied potentials (between +0.2 and +0.6) under the shorter 
deposition times were found to be redox-active, trypsin-accessible and cleavable to the same 
extent as those prepared using the usual overnight incubation, which clearly highlights the 
usefulness of this proposed technique. Combination of this method and reductive cleaning can 
selectively functionalise individual electrodes in an array on the 10 minute timescale, which 
will open a way for practical SAM deposition and selective functionalisation with different 
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7.1 Introduction  
The applicability of electrochemical biosensors integrated with wearable [342], [343] or 
implantable [344], [345] platforms for the detection of many different analytes, both in vitro 
and in vivo, has attracted widespread attention owing to the many advantages detailed in 
Section 2.2. However, foreign body response is still a major challenge for implantable 
electrochemical sensing devices. Specifically, if an implanted device needs to be used for long 
periods of time, biofouling can cause the sensor transducer (electrode) surface to become 
passivated by fibrous capsules and non-specific proteins (See Section 2.3.2). This significantly 
limits the potential of in vivo electrochemical biosensing in complex biological media [127].   
Accordingly, there is growing research interest in order to avoid biofouling by minimising 
material-tissue interactions and/or protecting the implantable sensing systems. Some of these 
are shown in Figure 2-8, and include a variety of approaches based on polymers, hydrogels, 
SAMs, MEMS and even fluidic systems [346].  
Polymers have been widely used in medical devices and implants due to their easily-
controllable chemical, electrical and thermal properties [347]. Mostly because of this ease of 
control, they are often synthesised/fabricated as biocompatible materials unlike other 
alternatives such as the metals and ceramics used in packaging. Also, polymers are typically 
soft materials due to their lower Young’s modulus values and thus can be fabricated in any 
size or shape on demand [348]. There are different groups of polymers which can be coated 
on electrode surfaces to minimise biofouling, largely by reducing interactions between the 
electrode surface and proteins/cells [138]. For example, hydrophilic polymers like 
polyethylene glycol (PEG) form a hydration layer which has been found to act as a physical 
barrier for protein adsorption [349]. Also, zwitterionic polymers  were shown to have some 
additional advantages over hydrophilic polymers, such as the ability to form stronger hydration 
layers, biodegradability and lower immunogenicity [350]. Conducting polymers can be also 
used to reduce biofouling [351]. For example, polypyrrole (PPy) and polyaniline (PANI), 
when combined with PEG, were shown to significantly enhance the fouling resistance against 
BSA adsorption [352]. Another study suggested the development of an antifouling 
electrochemical dopamine sensor, where glassy carbon electrodes were modified with a 
conducting polymer, poly(3,4-ethylenedioxythiophene) (PEDOT) doped with a water 
insoluble ionic liquid, 1-ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide [353]. 
This enabled the detection of dopamine with a LoD of 33 nM in the presence of several 
proteins and in human serum. Despite not being studied as commonly as other types, 
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hydrophobic polymers might also hold significant potential for antifouling coatings. Xue et al. 
showed that fluorinated methacrylate molecules fabricated on poly(ethylene terephthalate) 
(PET) fabrics via surface-initiated atom transfer radical polymerization, with alterations of 
their wettability based on polymerisation time, were effective in improving surface antifouling 
properties [354]. In addition to these approaches, there are other polymeric coatings like 
Nafion [355], polyvinyl chloride (PVC) [356], poly(1,3,5-tris(3-indolcarbonyl)benzene) 
(PTICBL) [357] and copolymers of a poly(vinylidene fluoride) (PVDF) and poly(oxyethylene 
methacrylate) (POEM) [358] who act as selective membranes by allowing only the target 
analytes to permeate to the electrode surface and blocking the transport of other non-specific 
macromolecules, thus minimising the onset of biofouling. 
Recently, Montiel et al. reported delayed activation and the enhancement of the anti-biofouling 
characteristics of bare and enzyme (glucose oxidase)-embedded carbon paste electrodes 
through coating the surfaces with biocompatible, methacrylate-based pH-responsive transient 
polymers [359]. The capability of these polymeric coatings was characterised in undiluted 
blood and saliva samples in terms of the delayed activation and the anti-biofouling 
enhancement of glucose sensing [359]. This approach was then translated into sensing in other 
biologically relevant media such as gastric (pH ~ 1.5) and intestinal (pH ~ 6.5) fluids [360].   
Based on these advancements, the development of such transient polymeric coatings could be 
applicable to other biosensing platforms. Therefore, in this chapter, the delayed activation and 
anti-biofouling characteristics of Eudragit® S100 (Evonik Industries) commercial pH-
responsive polymers coated on gold screen printed electrodes (Au SPEs) were investigated. 
Building on the desirability of compatibility with the new pH [361] and protease (trypsin) 
sensor system developed in this thesis (Chapter 4), enabled by self-assembled monolayer 
(SAM)-functionalised recognition probe system studies, results will be presented concerning 
the optimisation and performance of these coatings both on bare and SAM-functionalised 
electrodes, along with a discussion of the applicability of this work to in vivo biosensing. 
 
7.2 pH-Activated Polymeric Coatings:  Eudragit® 
Poly(meth)acrylate-based polymer formulations have been commercialised, produced and 
distributed under the Eudragit® brand of Evonik (Nutrition & Care GMBH) Industries since 
1954 [362]. They are used for drug release, mainly for three types which are: (i) immediate, 
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(ii) delayed and (iii) time-controlled (sustained), which are controlled by the formulation 
(chemical structure) of the respective polymer as shown in Figure 7-1.  
 
 
Eudragit® L and S type polymers (L12,5 / L 30 D-55 / L100-55 / L100 / S 12,5 / S100 / FS30 
D) which provide delayed release are typically preferred for the drugs targeted toward 
gastrointestinal (GI) systems, as the stomach is a highly acidic environment which would 
decrease the efficiency of some drugs if they were not protected [363]. Also, as delivery to 
different locations in the GI system might be required for targeted clinical purposes, a family 
of Eudragit® polymers has been produced which achieve delayed release by becoming 
activated and dissolving above a specific pH value; e.g. Eudragit® L100-55 (powder form) and 
Eudragit® L30 D-55 (aqueous dispersion form) dissolve in the duodenum above pH 5.5, 
Eudragit® L100 (powder form) and Eudragit® L12,5 (organic solution form) dissolve in the 
jejunum around pH 6.0-7.0, Eudragit® S100 (powder form), Eudragit® S12,5 (organic solution 
form) and Eudragit® FS30 D (aqueous dispersion form) dissolve in the ileum above pH 7.0 
[362]. Here Eudragit® S100 (powder form) was selected for the studies found in this chapter 
with PBS used as a buffer solution for majority of the experiments since its pH of 7.4 was 
already high enough to cleave the polymer, leading to activation and dissolution.  
 
Figure 7-1: Chemical structures of Eudragit® polymers and their enabling of various types of drug 
release. Adapted from [362].   
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Eudragit® S100 (molecular weight, MW ~ 125 kDa) is a solid, anionic copolymer consisting 
of methacrylic acid and methyl methacrylate in a ratio of approximately 1:2, (Figure 7-2) 
[364].  
 
The mechanism behind the pH-dependent dissolution of Eudragit® S100 polymers was 
explained by Nguyen et al. as occurring in five main steps [365]: 
i. H2O and  -OH diffuse into the polymer matrix and form a gel layer 
ii. polymer chains in the gel layer become ionised  
iii. chains start to disentangle from the gel layer and move to the polymer-bulk solution 
interface 
iv. polymer chains at this interface are further ionised  
v. disentangled polymer chains diffuse from the interface and dissolve into the bulk 
solution. 
Accordingly, the main reason behind the pH-responsivity of Eudragit® S100 polymer is the 
presence of weakly acidic carboxyl groups which are initially uncharged in the acidic 
environments and then become charged at values greater than their pKa ~ 4 and start to 
disentangle and diffuse into bulk solution, as suggested by Vinner et al. and illustrated in 
Figure 7-3 [366]. In addition, in higher pH values, the hydrolysis product of ester groups can 
produce negatively charged carboxylate groups, which can enhance the rate of disentangling.  
Figure 7-2: Chemical structure of Eudragit® polymer. The ratio (x:y) of methacrylic acid and methyl 
methacrylate units is approximately 1:2 for Eudragit® S100, whereas n shows the degree of 
polymerization. Counter ion, M, can be a sodium or a potassium ion found in PBS. Adapted from [364].  
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7.3 Characterisation of Polymer Dissolution  
The protocol of polymer modification on bare or probe-modified Au SPEs was detailed in 
Section 3.5. Briefly, 10 μL of Eudragit® S100 polymer powder was dissolved in isopropanol 
(IPA) at specific concentrations (8, 16 or 32% (w/v)) and was drop-cast onto a modified or an 
unmodified (bare) electrode surface, either as a single layer or successive deposition of 
consecutive layers (1-layer, 2-layers or 3-layers) of 10 μL following evaporation. After the 
solvent IPA was evaporated at room temperature, polymer-coated electrodes were incubated 
in solution (5 mM ferri/ferrocyanide in 1x PBS for bare electrodes, or 1x PBS for probe-
modified electrodes, or DMEM-FBS mixture for anti-biofouling characterisation) and 
subjected to electrochemical characterisation with time using CV and/or SWV measurements 
in order to monitor the dissolution of the coated polymer layers. 
In order to check whether polymer modification of electrodes was achieved, a polymer layer 
integrity test was performed by recording CVs between -0.1 and +0.4 V at a scan rate of 100 
mV/s in 5 mM ferri/ferrocyanide in 1x PBS (Figure 7-4). Comparison of the bare and polymer-
coated electrodes showed a significant difference in their responses. The expected complete 
hindrance of the redox reaction of the external redox agent (ferri/ferrocyanide) was observed 
with the polymer-coated electrodes, whereas characteristic (peaked) voltammogram responses 
were obtained for the uncoated bare electrode. This confirmed the successful modification and 
integrity of the blocking polymer layer coated on these electrode surfaces. It is therefore 
expected in the following characterisations that all probe-modified electrodes coated with even 
a single layer of transient polymer should exhibit a zero current initially, since the redox 
environment underneath the blocking layer will not be solvated before polymer dissolution 
starts to take place.  
Figure 7-3: Mechanism for Eudragit® S100 dissociation due to weakly acidic functional groups, 
followed by electrostatic repulsion and polymer swelling. Adapted from [366].  
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When the modified electrode is immersed into a solution which has a higher pH value than a 
specific activation pH of the polymer, e.g. 1x PBS with pH 7.4, dissolution should be 
immediately initiated by diffusion of water and hydroxyl ions directly into the polymer matrix 
and the change of the solid polymer layer into a gel, by the established mechanism mentioned 
above. This should promote the progressive and time-dependent activation of passivated 
(blocked) electrode surfaces until each is completely exposed.  
Figure 7-5 shows the voltammograms of a gold SPE coated with a single layer of 16% 
Eudragit® S100 subjected to potential cycles between -0.1 and +0.5 V at a scan rate of 100 
mV/s after immersion in 5 mM potassium ferri/ferrocyanide in 1x PBS at different 
measurement times between 0 - 180 min at intervals of ~18 min. As expected, the first scan (0 
min) registered following the immersion of the polymer-coated electrode into redox solution 
did not show any peaks attributable to a redox reaction at electrode surface. However, there 
was a clear difference between the first and second voltammogram recorded after 18 min, 
which shows redox reaction occurring at electrode surface due to transport of 
ferri/ferrocyanide redox couple to the underlying electrode surface, most likely through pores 
formed due to polymer layer dissolution. This redox current then increased with the time which 
the electrode was incubated in this solution. After 3 hours of incubation, the shape and current 
Figure 7-4: CVs of Au SPE recorded in 5 mM potassium ferri/ferrocyanide in 1x PBS, before (black) 
and after (red) coated with a single layer of 16% Eudragit® S100. CVs were recorded between potentials 
of -0.1 and +0.4 V at a scan rate of 100 mV/s. 
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magnitudes of the voltammograms were still not the same as the response observed for the 
bare electrode in Figure 7-4; the oxidation and reduction voltammogram peak current heights 
were around 35 µA after 3 hours of dissolution, compared to ~175 µA for the bare surface. 
Considering that peak current is proportional to electrode area, it can be suggested that only 
~20% of the area of polymer-coated electrode was activated in this case. Also, more widely 
separated peaks in comparison to the bare electrode were seen due to resistance and this 
suggested that the holes were not completely exposed and the electrode surface was not fully 
activated. However, less resistive film was generally and progressively obtained due to the 
solvent (and redox couple) ingress. Of course, it should be noted that these two individual 
electrode surfaces might not be identical. In addition, there is a significant possibility that 
polymer coating might be non-uniform due to the simple nature of drop-casting method. 
Furthermore, it was mentioned before (Section 4.10) that SAM-functionalised probes also 
exhibited some variations in SWV peak currents, likely caused by the differences in their 
surface conformations. In order to avoid variations based on any of these, the redox current 
was monitored until it reached a stable value which is expressed as 100%, and then the relative 
change (% signal change) were evaluated and plotted versus time, in most of the subsequent 
experiments unless otherwise stated.  
  
Figure 7-5: CVs of Au SPE coated with a single layer of 16% Eudragit® S100 recorded in 5 mM 
potassium ferri/ferrocyanide in 1x PBS at different incubation times between 0 - 180 min (with intervals 
of ~18 min). CVs were recorded between potentials of -0.1 and +0.5 V at a scan rate of 100 mV/s. 
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In order to check the pH specificity of Eudragit® S100 polymer coatings, two Au SPEs were 
identically modified with Probe-1 as detailed in Section 3.4.2.1 and Section 7.4, before they 
were coated with three consecutive layers of 16% Eudragit® S100 and then subjected to SWV 
characterisation between 0 and -0.4 V (the methylene blue redox potential window) in PBS 
solutions (i) pH 5.6 and (ii) pH 7.4 for 1000 min. As illustrated in Figure 7-6, there was not 
any redox signal at all observed for the electrode immersed at pH 5.6, whereas the current for 
the other electrode immersed in pH 7.4 continuously increased over 1000 min. This was 
consistent with the previous findings where it was reported that any combination (of L100-
S100 mixtures in w/w such as 1:1, 2:3, 1:4, 1:5, 0:1) including 50% or more S100 coating did 
not release any amount of tested model drug, mesalazine in pH 6.5 phosphate buffer [367]. 
Eudragit® S100 was already shown to dissolve above pH 7.0 and is employed for drug release 
in the colon for the treatment of particular diseases such as ulcerative colitis, Crohn's disease, 
and irritable bowel syndrome [368]; this result further confirms that its activation/dissolution 
is highly specific to the pH value.  
  
 
Figure 7-6: SWV peak current vs time registered for Au SPE modified with Probe-1 and then coated 
with three layers of 16% Eudragit® S100 when incubated in PBS at pH 5.6 (red) and at pH 7.4 (blue) 
for 1000 mins.  
 
  170 
7.4 Applicability to SAM Biosensor Probes   
This chapter has been aimed at enhancing the anti-biofouling characteristics of the protease 
(trypsin) and pH sensor systems, in which SAM-functionalised recognition probes were 
employed. Therefore, these two different sensing probes (Probe-1 for pH sensing or Probe-2 
for trypsin sensing) were also used here to optimise and characterise the performance of 
polymeric coatings with respect to integration and feasibility of use with SAM-based 
biosensors (Figure 7-7). The details of the procedures used for chemical synthesis can be found 
elsewhere [7], [361]. Typically, Probe-1 was employed in the experiments performed for 
polymer coating optimisations (Section 7.5), because it is already shown in the previous 
chapters that the tripod-anchor was more robust and stable as an anchor than the mono-anchor. 
However, Probe-2 was also used, in order to test the feasibility of the approach for trypsin 
sensing, which can be found in Section 7.6.2.    
 
 
Figure 7-7: Chemical structures of the probes used for pH (Probe-1) and trypsin (Probe-2) sensing. 
Probe-1 contains methylene blue (blue) as the redox tag, PEG-4 as the spacer and tripod anchor (red) 
[361]. As detailed in Section 4-2, Probe-2 contains methylene blue (blue) as the redox tag, attached to 
Phenylalanine-Arginine-Arginine (orange) as the peptide sequence and PEG-6 (green) as the spacer and 
cysteine (red) as the anchor. 
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Figure 7-8 shows SWV curves registered for an Au SPE which was modified with the pH 
sensing probe (Probe-1) by drop-casting overnight and then coated with a single layer of 16% 
Eudragit® S100, before immersion in 1x PBS solution for 150 min. As clearly seen, the SWV 
peak current (purple curve) was ~1.1 µA before the polymer layer was drop-cast. However, 
this decreased to zero as shown by the first scan after the polymer was coated on top of the 
probe-modified electrode surface. This confirmed that the polymer layer also completely 
blocked the SAM-modified surface and hindered the redox reaction of surface-bound redox 
tags in addition to the external redox couples found in bulk solution as observed for bare 
electrodes. This was attributed to the effects of the resistive surface layer in blocking the 
electron transfer by stopping counterion and proton transport to the MB from solution and 
stopping probe flexibility and bending towards the electrode surface.   
 
As expected, the signal then increased with time due to dissolution of the polymer layer but 
unlike previous experiments with redox species in solution,  the shape of the redox signal was 
restored and the blocking characteristics disappeared. It was seen that the registered signal 
almost returned to the initial, uncoated value within 150 min, suggesting ~95-100% 
dissolution. It was also observed the dissolution rate was faster initially and converged over 
time. A difference of ~30 mV in the SWV peak potentials between uncoated electrode and the 
Figure 7-8: SWV curves recorded for an Au SPE modified with the Probe-1 and then coated with a 
single layer of the 16% Eudragit® followed by its immersion in 1x PBS.  
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coated electrode (red line, after 30 min dissolution) suggests a clear difference in their redox 
environment. This difference in peak potentials disappeared when the polymer dissolved over 
time, which might be thus attributed to the local pH change or electron transfer alterations due 
to changes in the local solvation environment and/or conformational changes in SAM-based 
probes.   
 
7.5 Optimisation 
Dissolution time could change depending on factors such as the thickness of the coating layers 
and the concentration of the drop-cast polymer solution. The effects of these two factors on 
the transiency behaviour of polymeric coatings have been investigated previously, when bare 
carbon SPEs were drop-cast with a single layer (3 μL of 4, 8 or 16% (w/v)) or consecutive 
layers (3 μL of 16% (w/v)) of polymeric solution onto the electrode surface [359]. However, 
this had not been done for any SAM-modified sensor electrodes systems. Therefore, it was 
important to understand how thickness and concentration affected the polymer dissolution 
time and performance in this order to optimise and control these parameters for future in vivo 
SAM-based biosensor protection applications.  
 
7.5.1 Layer Thickness  
The influence of the thickness on polymer dissolution time was examined after modified Au 
SPE surfaces with Probe-1 were coated with a number of layers using 16% (w/v) solution. 
Figure 7-9 presents optical microscope images of a region of the coated area for each electrode 
(1-layer, 2-layer or 3-layer). As clearly seen in the figure, increasing layer thickness resulted 
in a more uniform polymer coating, which can be suggested by the reduced number of surface 
defects such as holes and hillocks. Although these images were taken from randomly chosen 
areas, it was confirmed that they were representative and comparable across the whole surfaces 
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Figure 7-10 shows the percentage signal changes vs time registered for these different Au 
SPEs modified with Probe-1 and the number of (1, 2, and 3) layers of the 16% coating. It can 
be easily seen that polymer dissolution (electrode activation) can be delayed by more than 20 
hours when using 3 layers of the polymeric coating, while one layer of coating exposes the 
sensor surface within 2-8 hours.  However, there is a significant variation between identically 
prepared electrodes, especially the ones coated with 1 or 2 layers. This was attributed to that 
the films included variable defects which were non-uniformly distributed on the electrode 
surfaces, as also represented by optical images above. This variability was, however, reduced 
for the electrode modified with three layers of the coating, most likely due to the filling of the 
defects in underlying films by the subsequent layers.    
Figure 7-9: Optical microscope images of Au SPEs drop-cast with consecutive layers (1-Layer, 2-
Layer and 3-Layer) using 10 μL of 16% (w/v)) of the Eudragit® S100 polymeric solution for each layer.  
Figure 7-10: The relationship between % signal change (referred to polymer dissolution time) and layer 
thickness, examined by the redox signal registered for Probe-1 modified Au SPEs coated with different 
numbers of layers (1, 2 or 3-L) of a 16% solution and immersed in 1x PBS over 1200 min and 
interrogated with SWV.  The averages and error bars are for three replicates. 
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7.5.2 Concentration  
The influence of the polymer layer concentration was analysed by employing different Au 
SPEs each identically modified with Probe-1 and then coated with single layers which contain 
different weight to volume percentages (8%, 16% or 32%) of the S100 polymer. Figure 7-11 
exhibits the dependency of the resulting polymer dissolution time on the concentration,  which 
seems to be an inversely proportional relationship as the volume drop-cast was fixed. 
Especially for the concentrations of 8% and 16%, exposure rate was observed to be linear 
within experimental errors, which might suggest that changing concentration is more 
controllable than multiple layer deposition. It was observed that the polymer layers coated 
from solution with concentration of 8% completely dissolved in only 30 minutes, with almost 
no variation between the responses of replicates. The signal decrease of around 20% after full 
exposure in 30 min was interesting and statistically significant, but was only experienced in 
this case. It may indicate longer term changes in redox probe environment in this solution 
alone, but more measurements would be required to confirm this. It was observed that although 
both 16% and 32% coatings were both fully exposed in around 3 hours the initial activation 
rate was markedly slower for 32%.  
 
Figure 7-11: The relationship between % normalised signal change (referred to polymer dissolution 
time) and concentration, examined by the redox signal registered for Probe-1 modified Au SPEs (three 
replicates for each) drop-cast with a single layer of Eudragit® solution in different concentrations (8%, 
16% or 32%) followed by immersion to 1x PBS over 3 hours and interrogation with SWV. The averages 
and error bars are for three replicates. 
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In addition, another three replicates were prepared with 32% coating and tested at 37 oC in 
order to understand whether temperature has an effect on the dissolution rate. Although the 
increase in temperature might have resulted in the enhanced dissolution rate in first 60 min, it 
was not as effective as expected in long time points, showing the same percentage signal 
changes within experimental errors. It is, however, worth noting that larger variations were 
seen between replicates compared to the ones characterised at 25 oC, particularly for early time 
points. In summary, these results were promising in terms of the potential to control polymer 
dissolution times (and corresponding extent of delay in sensor activation) by fine-tuning of the 
preparation/fabrication parameters.  
  
7.6 Biofouling Protection  
After demonstrating the ability to control delayed sensor activation, the anti-biofouling 
protection characteristics of these polymeric coatings were investigated. To achieve this, 
polymer-coated (or uncoated as a control) pH and trypsin sensors were prepared on Au SPEs 
and tested at 37 oC in Dulbecco's Modified Eagle Medium (DMEM) including 10% fetal 
bovine serum (FBS) which mainly consists of proteins such as BSA and growth factors, and 
is commonly used for in vitro biofouling characterisation [369]. The anti-biofouling protective 
properties (Figure 7-12) were evaluated by comparing electrochemical signal from polymer-
coated and uncoated samples with time, and then determining the pH or trypsin sensing 




Figure 7-12: Illustration of the determination of the anti-biofouling protection of the SAM-based 
sensors through the dissolution of the polymeric coatings.  
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7.6.1 pH Sensor Protection  
The development as well as in vitro and in vivo characterisation of MB-based pH sensors can 
be found elsewhere [361]. Briefly, the sensor was developed by depositing a SAM-
functionalised film of probe molecules (Probe-1) onto microfabricated three-electrode chips 
packaged with a biocompatible epoxy in order to monitor tumour microenvironment pH in 
real-time based on the established pH-specific variation of the redox behaviour of MB  [370]. 
In vitro test results exhibited a linear dependency between the peak potential of the MB 
reduction and the pH, giving -26 mV/pH; the expected Nernstian behaviour for a 2 e- / 1 H+ 
redox process. Some of the chips also included Nafion as a top layer on these probe-modified 
electrodes given that it is a widely used cation-exchange polymeric membrane. The use of 
Nafion resulted in a better pH sensitivity, showing larger than two-fold change in the 
calibration line, which was -68.0 mV/pH. This was attributed to Nernstian behaviour for a 2 
e- / 2 H+ redox process due to a shift in the pKa of reduced MB arising from the negatively 
charged nature of Nafion membrane. Although the sensor system also exhibited very 
promising results when tested in vivo through implantation into ovine pulmonary 
adenocarcinoma (OPA) cases, it was established that better anti-biofouling protection 
approaches are needed for long term measurements. This is why the feasibility of transient 
polymeric coatings were now investigated.  
Figure 7-13 shows the relative changes in the SWV peak current of the polymer-coated and 
uncoated pH sensors over 1100 min. The signal registered for the uncoated sensors decreased 
rapidly by 65-70% within this time range consistent with non-specific binding reducing the 
electrochemical signal, whereas the polymer coated sensors showed a signal which 
continuously and reproducibly increased with time, without ever decreasing. Because the 
polymer-coated sensors are not likely to anywhere near fully exposed at 1100 mins according 
to the finding (less than 10% of signal recorded for 3 layers after 1200 min) as shown in Figure 
7-10, the relative signal changes was normalised with respect to the final measured signal, 
instead of the expected 100% signal. This means that the polymer is still on top of the probe 
molecules without fully exposure but with some opened channels providing the redox 
interactions. While the dissolution is still occurring, the fact there was not any indication of 
signal decrease due to non-specific protein binding onto these coated surfaces on this timescale 
clearly suggests  enhanced anti-biofouling is provided by these transient polymeric coatings.   
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It was of course significant for protected and activated sensor systems to show comparable 
sensing performances after the polymer was dissolved. Therefore, another experiment was 
performed to check the pH sensitivity of the exposed sensors, using the same method as 
previously reported [361]. As shown in Figure 7-14A, Nafion-coated and uncoated pH sensors 
were placed in phosphate buffers with varying pH’s (5.8, 6.2, 6.8, 7.2 and 7.6) and interrogated 
with SWV. Afterwards, the peak potential of MB redox signal was plotted against pH to create 
a calibration line for pH response (Figure 7-14B). This resulted in pH sensitivities of 36 ± 2 
mV/pH for Nafion-uncoated and 39 ± 4 mV/pH for Nafion-coated sensors. It was interesting 
that Nafion did not show any significant difference in potential-pH sensitivity this time rather 
a difference in potential offset, and that the slope observed was midway between 2e– 2H+ and 
2e– 1H+ behaviour. Although there is not any evidence to confirm, this might be an indication 
of possible interaction between Nafion and Eudragit® S100 polymers which might have altered 
the redox behaviour of MB.     
 
 
Figure 7-13: % Signal changes registered for the polymer-coated (three consecutive layers of 16% 
Eudragit®) and uncoated pH sensors (Au SPEs modified with Probe-1) in DMEM inc. 10% FBS (pH = 
~7.2). The averages and error bars are for three replicates. 
 
 




Figure 7-14: Characterisation of the pH sensitivity after complete polymer dissolution. A) Square wave 
voltammograms registered for Nafion-coated pH sensors immersed in phosphate buffered solutions 
with varying pHs: 5.8 (black), 6.2 (red), 6.8 (blue), 7.2 (magenta) and 7.6 (green). B) Calibration line  
of MB redox (average of reduction and oxidation) potentials registered for Nafion-coated and uncoated 
sensors versus the solution pHs. All data points typically represent the average and standard deviation 
for 3 replicates and straight lines correspond to the best linear fits. 
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7.6.2 Trypsin Sensor Protection  
Similar to anti-biofouling characterisations performed for pH sensors, trypsin sensors were 
also prepared (modifying Au SPEs with Probe-2 and either coated with a single layer of 16% 
Eudragit® on top or uncoated for control) and subjected to SWV measurements in DMEM 
including 10% FBS. Figure 7-15 shows the relative changes in the SWV peak current of the 
polymer-coated and uncoated trypsin sensors over 250 min. The reason why less incubation 
time was used this time is that a single layer of polymer was coated instead of three consecutive 
layers in this case and it was shown in the optimisation section that ~3-4 hours would be 
enough to obtain an exposed surface (Figure 7-11). The signal registered for the uncoated 
sensors decreased by 70-75% after 250 min whereas a continuous increase was observed for 
the coated surfaces again. The signal decrease of ~60% obtained in first 100 min for uncoated 
sensors was consistent and similar for both pH and trypsin sensor experiments, suggesting that 
most of the non-specific protein adsorption takes place in this period. As expected, the signal 
registered for the polymer-coated trypsin sensors increased over 250 min although there are 
some variations between the replicates. These variations are similar in magnitude (Figure 7-9) 
and can again be related to non-uniformity of the single polymer layer, which might have 
caused an inhomogeneous dissolution of the layer surface. Even so, this further confirmed that 
dissolvable polymeric coatings also improve anti-biofouling characteristics of these sensors.    
 
Figure 7-15: % Signal changes registered for the polymer-coated (with a single layer of 16%  Eudragit®) 
and uncoated trypsin sensors (Au SPEs modified with Probe-2) in DMEM inc. 10% FBS. 
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As shown in Figure 7-16, the percentage signal decrease registered for the polymer coated 
trypsin sensor against 100 nM trypsin was measured and compared to a typical trypsin sensor 
response which was not coated with polymer. Although they presented comparable signal 
decreases of around 55% after ~90 min of incubation with 100 nM trypsin enzyme, it can also 
be seen that the rate was slightly slower and have more variation for the polymer-coated 
system. It was found to be 0.026 min-1 when calculated using the same method detailed in 
Chapter 4, whereas the typical uncoated sensor gave 0.058 min-1. Despite the fact that the 
polymer-coated sensors were left in 1x PBS for a day before this experiment to secure 
complete dissolution, some polymeric residues could be still present in close proximity to 
SAM-functionalised probe molecules, which might have resulted in this variation and reduced 
rate constant. In the future other trypsin concentrations should also be investigated in order to 
better understand the effect of polymer coating integrity and dissolution on the kinetics of 
protease cleavage on the exposed SAM film. 
 
Figure 7-16: Characterisation of the trypsin sensitivity after complete polymer dissolution. Percentage 
signal change registered for uncoated (Before, black line and data points) and polymer-coated (After, 
red line and data points) trypsin sensors after the addition of 100 nM trypsin at time = 0 in 1x PBS. All 
data points typically represent the average and standard deviation for 3 replicates. 
 
  181 
7.7 Summary  
In this chapter, the applicability of adding dissolvable pH-activated commercial polymeric 
coatings onto our already established trypsin and new pH sensors was evaluated in terms of 
their anti-biofouling characteristics. The enhancement in the anti-biofouling properties of both 
sensing platforms, particularly at short times within the first 100 mins was observed when they 
were tested in biologically relevant medium. The delay in sensor exposure and activation was 
found to be vital for avoiding the effects of rapid non-specific protein adsorption. By 
optimising the thickness and concentration of coated polymeric layers, delay times were 
shown to be increased to up to 20 hours with a potential of further increases. Analytical 
performance of polymer-coated SAM sensors (both pH and trypsin) were comparatively 
characterised before and after complete polymer dissolution. Although the sensitivity of 
Nafion-coated pH sensors apparently slightly decreased and the apparent rate constant for 100 
nM trypsin detection reduced, all sensor platforms were still redox-active and sensitive to the 
target analytes. Together, these promising findings offer potential for translation to in vivo 
biosensing. Future work will focus on ways to further increase and control delay times and to 
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8.1 Summary   
This thesis has presented research on the development and miniaturisation of an 
electrochemical peptide-based protease sensor along with a study to determine and potentially 
enhance anti-biofouling properties. The sensing principle was recently established and is based 
on the signal change due to the proteolytic cleavage by trypsin (a model protease used 
previously and in this study) of a SAM-functionalised peptide sequence, leading to the removal 
of the labelled redox tag, methylene blue.  
This biosensor platform was previously optimised and characterised by employing 
commercial Au macroelectrodes; however, the use of this metal is problematic when using 
microfabrication to design and fabricate integrated micro and nanoelectrode systems such as 
those studied in this thesis. As even trace gold is known to affect microelectronic device 
performance, gold is typically prohibited within microelectronic fabrication centres such as 
the Scottish Microelectronics Centre. Therefore, the first part of this research focused on the 
development of the same platform on commercial Pt macroelectrodes, building as far as 
possible on the gold surface optimisations which have been outlined in detail. The results 
indicated that both macroelectrode platforms behave comparably; they exhibit quite similar 
SWV peak potentials (~ -0.20 V), peak currents (3-4 µA) and current density values (~1 A/m2) 
which suggests no effect of changing the electrode metal in terms of SAM-functionalised 
probe film formation. This is important, and consistent with the fact that both Au-S and Pt-S 
bonds are strong. To assess the potential for sensor miniaturisation, this was then followed by 
the assessment of the protease sensing performance of these SAM films on both commercial 
Pt microelectrodes and Pt macroelectrodes. Despite a few further microelectrode-specific 
optimisations (regarding the treatment time of the backfilling MCH and concentration of the 
third component, DT), the probe design, probe concentration and protocols were kept 
unchanged. The characterisation and analysis of the response demonstrated that comparable 
analytical performance to Pt macroelectrodes was observed with commercial platinum 
microelectrodes, with respect to the trypsin accessibility and specificity, with a comparable 
KM of (15 ± 3 nM) from a Michaelis-Menten surface cleavage model, which suggests a 
comparable surface binding energy. It was interesting that there was less variations between 
electrode response compared to macroelectrodes, which suggests more reproducible SAM 
probe film formation and conformation for microelectrodes. In addition, microelectrode-based 
sensing system gave a quantitative response covering the clinically relevant trypsin 
concentration range for both normal and disease states. However, the kinetics of enzyme 
cleavage, also analysed according to the Michaelis-Menten model was found to be kcat (0.0075 
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min-1) at 25 oC, which is lower than that observed on Pt macroelectrodes of kcat (0.035 min-1).   
Although this proteolytic cleavage rate was significantly slower for microelectrodes at room 
temperature, it was observed to be markedly increased at the normal body temperature (37 oC) 
applicable to implantation. Some interesting differences were found between macroelectrode- 
and microelectrode-based platforms. The SWV peak potential for microelectrodes was found 
to be around -0.27 V which is ~70 mV lower than macroelectrodes. Comparable binding 
constants suggested that there should not have been any difference in the cleavage rates, unless 
the enzyme accessibility to probe molecules have been satisfied. Therefore, the differences in 
peak potentials and cleavage rates were attributed to the distinctions between macro- and 
microelectrodes in terms of SAM film structures. This was suggested by the lower catalytic 
efficiency (kcat/KM) observed for microelectrodes, likely resulting from less probe accessibility 
to the active site of the enzyme and thus leading to decreased probe reactivity, although 
absolute and relative enzyme-substrate association and dissociation rates appeared similar for 
both electrodes. This accessibility difference could be resulted from geometric and/or 
orientational reasons e.g. enzymes bound near microelectrode edge interact with less probe 
molecules which are able to interact with the active site. Furthermore, microelectrode-based 
sensing system was shown to be relatively insensitive to the adsorption of non-specific 
proteins, which opens up the prospect of measurement in complex biological media.  
In order to further develop the implantability of this biosensor platform and assess the effect 
of moving from micro to nanoelectrodes, Pt thin film electrodes were fabricated in-house on 
silicon chips. These included thin track (TT) and super thin track (STT) single 
microelectrodes, microelectrode arrays (MEAs) and microcavity nanoband edge electrode 
arrays (MNEEs). The addition of arrays for analysis was in order to increase the data set of 
electrodes for wider assessment and also to increase the overall currents through combining 
the response of many electrodes. For each group of electrodes, they were initially 
electrochemically-cleaned, characterised with external (freely diffusing in solution) redox 
couples and finally modified with sensing probes and analysed in terms of trypsin detection 
performance. Investigation of TT and STT single microelectrodes discovered a major stability 
problem which hindered proper trypsin detection, because signal decreases were observed for 
both substrate and control probes, even without added enzyme. Optical microscopy revealed 
some surface defects and metal loss, which correlating with the problem. In order to enhance 
the probe film stability, different treatments e.g. more strongly (tripod-) anchored probes, 
increasing the metal film thickness and metal film post-deposition annealing were tried. These  
could not completely recover the in-house microelectrode stability, although post-annealing 
in particular helped a little. The main underlying problem leading to this issue was attributed 
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to the increased surface roughness due to the electrochemical oxidation and reduction in the 
acidic cleaning solution, through surface reconstruction driven by Pt oxide formation and 
removal. This was confirmed by replacing this with a simpler reductive cleaning technique 
which also enabled real-time monitoring of the surface cleanliness through an external redox 
couple included in solution. Reductively cleaned MEAs then exhibited increased stability, 
reproducibility and comparable trypsin sensitivity. Comparable cleavage rates and enhanced 
electrode current densities were obtained using MNEEs, but the background due to O2 
reduction significantly increased which made the data analysis more difficult. Therefore, there 
was no additional advantage in using MNEEs, instead of MEAs. Overall, this systematic study 
confirmed the feasibility of in-house microfabricated electrodes as platforms for peptide-based 
SAM-functionalised probes and protease detection. 
Given the observed dependency of conditions on SAM film formation and response, and the 
likely effect of an electrode potential on this, it is interesting that later, promising results were 
obtained which showed that applying a controlled potential to the working Au electrode can 
promote more reproducible SAM probe film formation (compared to standard overnight 
incubation) in a shorter timescale of 10 min. Although all probes deposited at a wide potential 
range were observed to be trypsin sensitive with similar cleavage rates, slight anodic potentials 
(+0.2, +0.4 and +0.6 vs Ag pseudo RE) were seen to give more consistent and reproducible 
signals.   
The second aspect of this work was to focus on the creation of biofouling protection for the 
sensor platform. In order to achieve this, commercial biocompatible polymers developed for 
controlled release drug delivery purposes and triggered by pH selective dissolution, were 
assessed with a view to incorporating these into our biosensors. Two biosensors platforms 
were used; the trypsin sensor (detailed throughout this thesis) and recently developed pH 
sensor which employs the pH dependency of a thiol-terminated methylene blue redox tag as a 
SAM film. Initial experiments varying the thickness and concentration of the polymeric 
coatings showed the possibility of 20 hours and more delay in complete sensor exposure, and 
variation of the length and reproducibility of this delay with control of surface thickness and 
deposition method. Comparative evaluation of polymer-coated and uncoated trypsin and pH 
sensor samples in biologically relevant medium revealed the detrimental effects of non-
specific protein binding within first 100 mins on uncoated electrodes, which were found to be 
markedly reduced on polymer-coated sensors. Post-dissolution performance tests confirmed 
that both polymer coated sensor platforms were still redox-active and sensitive against trypsin 
and pH.  
 
  186 
Together, this PhD research has demonstrated progress towards the development, 
miniaturisation and biofouling protection of this peptide-based SAM-functionalised 
electrochemical biosensor system for trypsin, which has been demonstrated to be able to sense 
trypsin concentration across the whole clinically relevant range. In this way, the biosensor 
capabilities have been enhanced as a step towards implantation into solid tumours to monitor 
real-time changes in biomarker quantity and activity, which would lead to the personalisation 
of cancer treatment. Although this development was largely designed for protease (trypsin) 
detection here, the need for miniaturisation and protection is more universally applicable and, 
as the biofouling pH studies indicate, these results can be applied to other analytes. This 
emphasises a wider contribution to the biosensing field. Combining with the future work 
suggested below, this could enable the move to clinical trials and in vivo biosensing.  
 
8.2 Future Work   
8.2.1 Translation to Detection of Other Proteases  
Trypsin enzyme was chosen as a model protease in this work because it is widely studied 
enzyme with well-understood properties. Also, it plays vital roles in digestion and has links to 
some diseases including pancreatitis, cystic fibrosis and cancer. However, there are other 
significant proteases e.g. MMPs, caspases and cathepsins which have clear links to many 
cancer processes, as discussed in Chapter 2. Although there are several works in the literature 
showing their electrochemical peptide-based detection, most of these have employed 
macroelectrodes. Therefore, the miniaturisation strategy presented here could also be applied 
to detect these proteases, which can be enabled by changing the peptide sequence used here 
(Phe-Arg-Arg) to another sequence which is specific to a target protease. Of course, if the 
binding sequence were longer than three amino acids (and even if it weren’t), such changes 
might affect the SAM formation mechanism and structure as well as cleavage kinetics. In this 
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8.2.2 Enhancing the Development of Array-Based Sensing  
Although microelectrode arrays (MEA) and microcavity nanoband edge electrode (MNEE) 
arrays have been briefly shown to be convenient for protease sensing in addition, it would be 
useful if, as with the commercial screen printed electrode systems, they could be fabricated as 
a three-electrode system with on-chip reference (Ag/AgCl) and counter electrodes (Pt), 
because external electrodes could be used with a finalised implanted device. Following this, 
to assess the potential for multiparameter binding, potential-assisted deposition should be 
investigated for these array systems. If an array is divided into some parts including electrodes 
and these parts are connected to different individual working electrode contact pads, they can 
be separately and selectively modified with different types of probes (substrate vs control, or 
specific for different proteases) using potential-assisted deposition technique (e.g. by applying 
a negative potential for desorption/avoiding adsorption or positive potentials for adsorption).  
 
8.2.3 Controlling Surface Chemistry to Avoid or Promote Protein/Cell 
Adhesion 
Even if the biosensor is incorporated with pH-triggered dissolving polymeric coating, 
biofouling of electrodes and/or system surfaces can still occur, after complete coating 
dissolution, in the complex medium experienced by an implanted sensor. One aspect to 
consider is the altering and controlling the charge and wettability characteristics and thus 
cell/protein adhesion on these surfaces. Given that SAM molecules with varying 
functionalised end groups e.g. -OH, -NH2, -COOH, -CH3 can exhibit different surface 
wettability and charge, these can be used to enhance anti-biofouling properties of the biosensor 
systems. Specifically, the advancements in the potential-assisted SAM deposition technique 
can enable their selective patterning onto electrode surfaces and/or surrounding locations in 
order to control protein/cell surface attachment and biofouling which would be of benefit in 
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Step  Description  
 
Equipment  Recipe/Instructions  
1 Insulate wafer – SiO2   
1.1 Thermal oxidation (1000 nm 
SiO2)  
Furnace  WETOX14, 2.20 mins 
1.2 Measure layer thickness  Nanospec  Oxide on silicon program 
    
2  Deposit metal – Ti and Pt    
2.1 Deposit titanium ANS E-Beam 
Evaporation 
10 nm 
2.2 Deposit platinum ANS E-Beam 
Evaporation 
50 nm 
2.3  Inspect Microscope   
2.4  Inspect Nanospec Measure reflectance  
2.5  Inspect Dektak Measure step height  
2.6  Inspect 4-point probe Measure sheet resistance 
    
3 Photolithography – pattern 
metal  
  
3.1 IPA clean Solvent wet deck IPA, DIW, N2 dry 
3.2 Bake Hot plate 90 °C, 1 min 
3.3 Box Prime Wafers Wet Bench, HMDS box 10mins, HMDS Primer 
3.4 Spin on Photoresist Spin coater SPR 220 – 3/ 500 rpm, 5 s 
then 2500 rpm, 60 s 
3.5 Bake photoresist Hot plate 110 °C, 90 s 
3.6 Clean mask Solvent wet deck Acetone clean 
3.7 Inspect mask Microscope  
3.8 Expose wafer Karl Suss mask aligner Low vac contact, 12 s 
3.9 Develop Solvent wet deck 
MF26A developer, 1-1.5 
min 
3.10 Rinse & Dry DI gun, N2 gun  
3.11 Inspect  Microscope  
    
4 Etch metal    
4.1 Etch Pt/Ti JLS RIE 80 Prog 8 (Ar mill), 9 mins 
4.2 Measure SiO2 conductivity Multimeter  
4.3 Inspect Microscope   
4.4 Inspect Nanospec  
    
5 Resist strip    
5.1 ACT Rinse Ultrasonic bath 15 mins, 50 °C  
5.2 IPA Rinse IPA 5 min  
5.3 Rinse & Dry DI gun, N2 gun  
5.4 Inspect  Microscope  
    
6 Coat passivation    
6.1 500nm LPCVD SIRN Furnace SIRNFLAT, 5 hours 
6.2 Inspect Microscope   
6.3 Inspect Nanospec Measure thickness 
    
7 Photolithography – electrode 
and contact  
  
7.1 IPA clean Solvent wet deck IPA, DIW, N2 dry 
7.2 Bake Hot plate 90 °C, 1 min 
7.3 Box Prime Wafers Wet Bench, HMDS box 10mins, HMDS Primer  
7.4 Spin on Photoresist Spin coater 
SPR 220 – 3/ 500 rpm, 5 s 
then 2500 rpm, 60 s  
 












7.5 Bake photoresist Hot plate 110 °C, 90 s 
7.6 Clean mask Solvent wet deck Acetone clean 
7.7 Inspect mask Microscope  
7.8 Expose wafer Karl Suss mask aligner Low vac contact, 12 s 
7.9 Develop Solvent wet deck 
MF26A developer, 1-
1.5min 
7.10 Rinse & Dry DI gun, N2 gun  
7.11 Inspect  Microscope  
    
8 Etch electrode and contact   
8.1 Etch SiN JLS RIE 80 
Prog 25, 75W, CF4 - 
60/AR-4, ~25 mins 
8.2 Inspect  Microscope  
8.3 Inspect Nanospec  
    
9 Resist strip    
9.1 ACT Rinse Ultrasonic bath 15 mins, 50 °C  
9.2 IPA Rinse IPA 5 min  
9.3 Rinse & Dry DI gun, N2 gun  
9.4 Inspect  Microscope  
    
10 Dicing    
10.1 Photoresist coat Solvent wet deck Spray on resist 
10.2 Bake photoresist Hotplate 115 °C, 60 s 
10.3 Frame Extension Frame up wafers for saw 
10.4 Dicing Disco saw  
    
11 Resist strip after dicing   
11.1 ACT Rinse Solvent wet deck 20 s  
11.2 IPA Rinse Solvent wet deck 10 s  
11.3 DI Water Rinse &  N2 Dry Solvent wet deck 10 s 
11.4 Inspect  Microscope  
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Step  Description  
 
Equipment  Recipe/Instructions  
1 Insulate wafer – SiO2   
1.1 Thermal oxidation (1000 nm 
SiO2)  
Furnace  WETOX10, 2.30 mins 
1.2 Measure layer thickness  Nanospec  Oxide on silicon program 
    
2  Deposit metal – Ti and Pt    
2.1 Deposit titanium ANS E-Beam 
Evaporation 
30 nm 
2.2 Deposit platinum ANS E-Beam 
Evaporation 
100 nm 
2.3  Inspect Microscope   
2.4  Inspect Nanospec Measure reflectance  
2.5  Inspect Dektak Measure step height  
2.6  Inspect 4-point probe Measure sheet resistance 
    
3 Photolithography – pattern 
metal  
  
3.1 Barrel ash Barrel asher 1h 
3.2 Box Prime Wafers Wet Bench, HMDS box 10mins, HMDS Primer 
3.3 Spin on Photoresist Spin coater SPR 350 / 500 rpm, 5 s then 
1800 rpm, 60 s 
3.4 Bake photoresist Hot plate 90 °C, 60 s 
3.5 Expose wafer Karl Suss mask aligner Prox spacer, 7 s 
3.6 Develop Solvent wet deck MF26A developer, 1 min 
3.7 Rinse & Dry DI gun, N2 gun  
3.8 Inspect  Microscope  
    
4 Etch metal    
4.1 Etch Pt/Ti JLS RIE 80 Prog 8 (Ar mill), 10 mins 
4.2 Measure SiO2 conductivity Multimeter  
4.3 Inspect Microscope   
4.4 Inspect Nanospec  
    
5 Resist strip    
5.1 ACT Rinse Ultrasonic bath 30 mins, 50 °C  
5.2 IPA Rinse IPA 15 min  
5.3 Rinse & Dry DI gun, N2 gun  
5.4 Inspect  Microscope  
    
6 Coat passivation    
6.1 300 nm PECVD SiN Furnace  
6.2 Inspect Microscope   
6.3 Inspect Nanospec Measure thickness 
    
7 Photolithography – electrode 
and contact  
  
7.1 Barrel ash Barrel asher 1h 
7.2 Box Prime Wafers Wet Bench, HMDS box 10mins, HMDS Primer  
7.3 Spin on Photoresist Spin coater 
SPR 220 – 3/ 500 rpm, 5 s 
then 1800 rpm, 60 s  
7.4 Bake photoresist Hot plate 110 °C, 90 s 
7.5 Expose wafer Karl Suss mask aligner Low vac contact, 18 s 
7.6 Develop Solvent wet deck MF26A developer, 1 min 
7.7 Rinse & Dry DI gun, N2 gun  
7.8 Inspect  Microscope  
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8 Etch electrode and contact   
8.1 Etch SiN JLS RIE 80 
Prog 25, 75W, CF4 - 60/AR-
4, 13 mins 
8.2 Inspect  Microscope  
8.3 Inspect Nanospec  
    
9 Resist strip    
9.1 ACT Rinse Ultrasonic bath 30 mins, 50 °C  
9.2 IPA Rinse IPA 15 min  
9.3 Rinse & Dry DI gun, N2 gun  
9.4 Inspect  Microscope  
    
10 Photolithography – cavities   
10.1 Barrel ash Barrel asher 1h 
10.2 Box Prime Wafers Wet Bench, HMDS box 10mins, HMDS Primer  
10.3 Spin on Photoresist Spin coater 
SPR 220 – 3/ 500 rpm, 5 s 
then 2500 rpm, 60 s  
10.4 Bake photoresist Hot plate 110 °C, 90 s 
10.5 Expose wafer Karl Suss mask aligner Low vac contact, 18 s 
10.6 Develop Solvent wet deck MF26A developer, 1 min 
10.7 Cover bond pads Paintbrush  SPR 350 
10.8 Bake photoresist Hot plate 90 °C, 60 s 
10.9 Inspect  Microscope  
    
11 Etch cavities   
11.1 Etch Pt JLS RIE 80 
Prog 8 (Ar mill), 200W, 9 
mins 
11.2 Inspect Microscope   
11.3 Inspect Nanospec  
    
12 Resist strip    
12.1 ACT Rinse Ultrasonic bath 30 mins, 50 °C  
12.2 IPA Rinse IPA 15 min  
12.3 Rinse & Dry DI gun, N2 gun  
12.4 Inspect  Microscope  
    
13 Dicing    
13.1 Photoresist coat Solvent wet deck Spray on resist 
13.2 Bake photoresist Hotplate 115 °C, 60 s 
13.3 Frame Extension Frame up wafers for saw 
13.4 Dicing Disco saw  
    
14 Resist strip after dicing   
14.1 ACT Rinse Solvent wet deck 20 s  
14.2 IPA Rinse Solvent wet deck 10 s  
14.3 DI Water Rinse &  N2 Dry Solvent wet deck 10 s 
14.4 Inspect  Microscope  
 
  233 
 
clear all;close all;clc 
% read data 
data = xlsread('C:\Users\s1576099\Desktop\filename.csv'); 
% Consider only current data (2nd column in the data) 
currentData = data(:,2:4:size(data,2)); 
 
%% Plot all measurement data 
figure; 
for t=1:size(currentData,2) 
    plot(currentData(:,t)); 
    hold on; 
end 
 
%% Enter starting point 
startingPoint = input('Enter the peak starting point \n'); 
finishingPoint = input('Enter the peak finishing point \n'); 
%% Determine peak height 
% Initialize peakHeight 
peakHeight = zeros(size(currentData,2),1); 
% Find peak point and the height of the peak points 
for k=1:size(currentData,2) 
    % Draw a line between the starting and end point of the data graph 
    y1 = currentData(startingPoint,k); 
    y2 = currentData(finishingPoint,k); 
    % Calculate slope 
    m = (y2-y1)/((finishingPoint-startingPoint)+1); 
    % Obtain the line 
    lineY = y1+m.*(1:(finishingPoint-startingPoint)); 
    plot(startingPoint:finishingPoint-1,lineY,'--'); 
    % Find the maximum value and its location 
    [val,loc] = max(currentData(startingPoint:finishingPoint,k)); 
    % Find the value of the location on the line (-1 is used due to 
    % considering the starting point as 2 instead of 1) 
    lineValue = y1+m*(loc-1); 
    plot(startingPoint+loc-1,lineValue,' ok'); 
    % Calculate the height of the peak 
    peakHeight(k,1) = abs(val-lineValue); 
    % Clear temporary data 
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Miniaturisation of a peptide-based
electrochemical protease activity sensor using
platinum microelectrodes
Ahmet Ucar, a Eva González-Fernández, b Matteo Staderini,b
Nicolaos Avlonitis,b Alan F. Murray,a Mark Bradley *b and Andrew R. Mount *b
Proteases are ideal target biomarkers as they have been implicated in many disease states, including steps
associated with cancer progression. Electrochemical peptide-based biosensors have attracted much inter-
est in recent years. However, the significantly large size of the electrodes typically used in most of these
platforms has led to performance limitations. These could be addressed by the enhancements offered by
microelectrodes, such as rapid response times, improved mass transport, higher signal-to-noise and sensi-
tivity, as well as more localised and less invasive measurements. We present the production and characteris-
ation of a miniaturised electrochemical biosensor for the detection of trypsin, based on 25 μm diameter Pt
microelectrodes (rather than the ubiquitous Au electrodes), benchmarked by establishing the equivalent Pt
macroelectrode response in terms of quantitative response to the protease, the kinetics of cleavage and the
effects of non-specific protein binding and temperature. Interestingly, although there was little difference
between Au and Pt macroelectrode response, significant differences were observed between the responses
of the Pt macroelectrode and microelectrode systems indicative of increased reproducibility in the micro-
electrode SAM structure and sensor performance between the electrodes, increased storage stability and a
decrease in the cleavage rate at functionalised microelectrodes, which is mitigated by measurement at
normal body temperature. Together, these results demonstrate the robustness and sensitivity of the minia-
turised sensing platform and its ability to operate within the clinically-relevant concentration ranges of pro-
teases in normal and disease states. These are critical features for its translation into implantable devices.
Introduction
Proteolytic enzymes such as proteases and their dysregulation
are widely recognised for playing significant roles in many
disease states.1 As such, they are attracting widespread atten-
tion as key biomarkers of disorders including cardiovascular
diseases, HIV, Alzheimer’s disease, thrombosis, diabetes and
cancer.2–9 Therefore, the development of both sensitive and
selective assays and sensors that monitor protease activity has
generated considerable interest. According to Ong et al., these
can be classified into two main groups: homogeneous assays
(that include those based on colorimetry, mass spectrometry
and fluorescence resonance energy transfer) and hetero-
geneous systems (that include electrochemical assays, surface-
enhanced Raman scattering and surface plasmon resonance).2
In heterogeneous systems, the probe is typically immobilised
on a solid surface (which often provides ready interrogation,
signal generation and a detection interface) with the target
analyte present in the neighbouring aqueous medium,
whereas in homogeneous systems, both probe and analyte are
present in the aqueous medium, which can present contami-
nation and detection challenges. The principle of detection for
both systems is largely based on protease recognition and cata-
lytic cleavage of a specific peptide sequence attached to a
reporter e.g. a fluorophore, quantum dot or redox tag. The
reporter exerts analyte detection through the generation of an
output signal following cleavage by the target protease.10–13
Amongst the various methods used for protease sensing,
there has been considerable growth in the popularity of
electrochemical peptide-based biosensors, particularly those
where the peptide-sequence with an attached redox tag is
immobilised onto an electrode surface. These sensors offer
high sensitivity, rapid response times, ready applicability to
computer control and multiplexing, the use of cheap instru-
mentation, and ease of miniaturisation for point-of-care (PoC)
applications.14 Such electrochemical peptide-based biosensors
aSchool of Engineering, Institute for Bioengineering, The University of Edinburgh,
The King’s Buildings, Mayfield Road, Edinburgh EH9 3JL, UK
bEaStCHEM, School of Chemistry, University of Edinburgh, Joseph Black Building,
West Mains Road, Edinburgh, EH9 3FJ, UK. E-mail: a.mount@ed.ac.uk,
mark.bradley@ed.ac.uk; Tel: +44 (0)131-650-4747

























































































View Journal  | View Issue
typically use a specific substrate peptide as the selective reco-
gnition moiety and the protease as the analyte. There is exten-
sive literature reported on protease detection using this
approach.13–22 For example, Liu et al. described a method that
allowed detection of matrix metalloproteinases (MMPs), whose
proteolytic activities have close association with cancer pro-
gression, at very low concentrations (with a limit of detection
of 3.4 pM).15 An alternative approach was developed by Lee
et al. who reported on the reference electrode-free sensing of
MMP-9 using the self-gating effect on a concentric electrode
system which consisted of an island and enclosing electrode.22
We have previously proposed, produced, characterised and
optimised a macroelectrode-based sensor system for the detec-
tion of protease activity using a self-assembled monolayer
(SAM) on an electrode surface, which was successfully trans-
lated to the detection of other proteases such as human neu-
trophil elastase, allowing clinically relevant measurements of
its activity in human blood.20,23 However, the electrodes used
in most of these systems are still macroscopic which leads to
limitations with respect to sensor performance as well as their
applicability to implantation. Smaller, less invasive footprint,
microelectrodes offer potential advantages over macroelec-
trodes that include more rapid diffusion (which can lead to
shorter and more controlled response times through enhanced
and more reproducible mass transport) and higher signal-to-
noise which leads to higher sensitivity; together this makes
using microelectrodes an attractive route for electrochemical
biosensors.24,25 In addition, miniaturised technologies offer
advantages for biosensor design such as integrated high fide-
lity manufacturing with lower manufacturing costs per sensor,
the ability to work with small quantities of materials and
samples and ease of multiplexed measurement options.26,27
Despite these strong drivers for the development of minia-
turised SAM-based electrochemical systems for biosensors for
the detection of proteases, although some examples of in vitro
and/or in vivo microelectrode use in biosensing are found in
the literature,28–31 there has been little focus on the compari-
son of macro- and microelectrodes, especially those that are
SAM-based.
The purpose of this study was to investigate the miniaturi-
sation of our sensing platform onto novel Pt-based microelec-
trodes as a step towards their development and application as
implantable sensors. Microelectrode sensors were produced,
the resulting properties were optimised and finally evaluated
in terms of sensor performance, including determining the
kinetics and thermodynamics of enzyme–substrate cleavage
and the effects of non-specific protein binding. This perform-
ance was compared to the analogous Au and (for the first
time) equivalent Pt-based macroelectrode systems.
Experimental
Instrumentation
All electrochemical measurements were carried out using a
conventional three-electrode electrochemical cell which was
driven by a computer-controlled AutoLab PGstat-30 potentio-
stat by running the NOVA 1.11 software (Metrohm Autolab B.
V., The Netherlands). An in-house built platinum-coated
silicon dioxide chip was used as an auxiliary electrode, with
2 mm and 25 µm diameter platinum disc electrodes
(IJ Cambria, UK) used as working electrodes for the macro-
and microelectrode measurements, respectively. All the
working electrode potentials, E, were applied with respect to
(and are reported relative to) a Ag|AgCl|KCl (3 M) reference
electrode (Bioanalytical Systems, Inc., USA). A Lauda Eco Silver
thermostatic bath (VWR International Ltd, UK) with an exter-
nal pumping system and a water-jacketed glass cell was used
to control the temperature of all the experiments conducted at
25 °C or 37 °C.
Reagents and materials
Trypsin (MW 23.4 kDa), bovine serum albumin (BSA), casein,
ethanol, 6-mercaptohexanol (MCH), 2,2′-(ethylenedioxy)
diethanethiol (DT) and 10× PBS were purchased from Sigma
Aldrich (UK) and used as received. All reagents were of analyti-
cal grade and all solutions were prepared using protease-free
deionised water.
Synthetic methods
Two methylene blue-labelled peptides were synthesised in-
house following the synthetic experimental procedures
described previously.20,21 Briefly, the redox labelled peptides
(probe substrate and the control) (MB-Phe–Arg–Arg-PEG-6–
Cys) were synthesised using Fmoc solid-phase chemistry on a
polystyrene resin with a Rink-amide linker. First, cysteine was
coupled to the resin, followed by a polyethylene glycol unit
containing 6 ethylene glycol units (PEG-6) as a spacer, then a
cleavable short peptide sequence (specific to trypsin) (Phe–
Arg–Arg (FRR)) and finally the methylene blue redox label
(MB). Finally, the probe was cleaved from the resin with a TFA
cleavage mixture and purified by RP-HPLC.
Cleaning, pre-treatment and preparation of electrodes
Platinum working electrodes were first immersed in concen-
trated H2SO4 (95%) for 10 min to remove any organic residue
on the surface and then successively polished to a progress-
ively finer surface finish using a polishing cloth and a
sequence of aqueous slurries containing first 1, then 0.3 and
finally 0.05 μm alumina particles (Buehler, Germany). After
that, each electrode was subjected to an electrochemical clean-
ing step by carrying out cyclic voltammetry (CV), performing
cycles of E between −0.3 and +1.6 V in 0.1 M H2SO4 at a poten-
tial scan rate of 100 mV s−1 until the characteristic voltammo-
gram of clean platinum was obtained.32 Extending the estab-
lished macroelectrode protocol,20 the surface substrate mono-
layer was then formed as a mixed SAM (labelled peptide, DT
and MCH) on this platinum electrode surface by immersing
the electrode overnight at 4 °C in a 40 μM solution of the
methylene blue-labelled peptide (either the substrate contain-
ing cleavable L-amino acids or the control containing uncleava-
ble D-amino acids) and freshly prepared DT (600 μM for macro-
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electrodes, 150 μM for microelectrodes) in ethanol. After
washing with ethanol, the resulting SAM-modified electrode
was immersed in 1 mM MCH in ethanol (1 h for the macro-
electrodes and 10 min for the microelectrodes). It should be
noted that these reductions in concentration and/or time in
the optimised SAM microelectrode deposition protocol are
consistent with the expected enhancement in sensitivity and
mass transport kinetics of reactions at microelectrodes.
Finally, washing was carried out, firstly with ethanol and then
with phosphate-buffered saline (PBS) and the modified electro-
des were stored in PBS at 4 °C until use.
Electrochemical sensor measurements
The SAM-modified working electrodes were immersed in 1×
PBS (which has an optimum pH of 7.4 for trypsin activity) and
subjected to electrochemical measurements using square wave
voltammetry (SWV, applying E at a frequency of 60 Hz, with an
amplitude of 25 mV and a step potential of 5 mV) until a
stable background signal was obtained. After the addition of
the target enzyme (trypsin), or the proteins, casein and BSA for
characterisation of non-specific binding, the SWV signal was
continuously monitored with time. Following the established
analysis method for Au macroelectrodes,20,21 this resulting
signal is expressed as the percentage relative change in the
SWV peak current with respect to the initial peak current (hen-
ceforth called the % signal change).
Results and discussion
Successful SAM modification of both macroelectrode and
microelectrode surfaces was first demonstrated by recording
cyclic voltammograms (CVs) in ferri/ferrocyanide ([Fe(CN)6]
3−/
[Fe(CN)6]
4−), 1× PBS solution (Fig. 1). Notwithstanding the
expected difference of peaks (macroelectrodes) and waves
(microelectrodes) in the resulting clean electrode redox
responses arising from linear and hemispherical diffusional
control, respectively, the CVs recorded before and after the over-
night incubation of the electrodes with the probe solution show
the expected significant inhibition of the redox reaction of the
external redox agent characteristic of blocking SAM layers.
SWV redox peak MB currents of 3.1 ± 1.0 µA (macroelec-
trodes) and 1.3 ± 0.4 nA (microelectrodes) were obtained in 1×
PBS solution (n ≥ 9 functionalised electrodes). This is consist-
ent with the ratio of macroelectrode to microelectrode area of
6400 and demonstrates that these SWV parameters, previously
established and optimised for Au macroelectrodes,20,23 again
provided a clear MB peak and a stable and low background
signal required for both Pt macroelectrode and microelectrode
SAM analysis in this study.
The electrochemical detection principle is based on the
specific proteolytic cleavage of the redox-tagged peptide probes
anchored onto the platinum electrode surface by the target
protease, trypsin, which should lead to the release of the
soluble redox-tagged peptide fragment and a corresponding
decrease in the redox peak as measured by the square wave vol-
tammetry (SWV) technique (Fig. 2A). Based on previous macro-
electrode optimisation work,20,21 the sensing layer consisted of
a mixed SAM; the probe with the target peptide was tagged
with MB and attached to a thiol-terminated PEG-6 spacer,
backfilling MCH to minimise pinholes in the SAM layer and
co-adsorbent PEG-based DT molecules to support the orien-
tation, specificity and accessibility of the probe on the elec-
trode surface. Two different MB-labelled peptides were used,
the L-amino acid sequence for a trypsin-cleavable substrate or
the D-amino acid sequence analogue as a trypsin-uncleavable
control. The general sequence structure is depicted in Fig. 2B.
Analytical performance comparison of the macro- and
microelectrodes as an electrochemical platform for trypsin
analysis
In order to compare the analytical characteristics offered by
the macro and micro platinum electrodes in protease sensing,
Fig. 1 CVs of (A) a Pt macroelectrode and (B) a Pt microelectrode
recorded before (black) and after (red) SAM probe immobilisation in
5 mM potassium ferri/ferrocyanide in 1× PBS. CVs were recorded
between potentials of 0 and 0.5 V at a scan rate of 100 mV s−1.
Fig. 2 (A) Principle of detection of the peptide-based electrochemical
platform. The protease (trypsin) catalyses the cleavage of the immobi-
lised redox-labelled peptide releasing the redox-containing fragment
into solution and leading to a decrease of the electrochemical signal
which is measured by SWV. (B) Chemical structure of the probe, con-
taining methylene blue (blue) as the redox tag, phenylalanine–arginine–
arginine (orange) as the peptide and PEG-6 (green) as the spacer and
cysteine (red) as the anchor.
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both macro- and microelectrode surfaces were modified with
the mixed SAM as described previously. They were then
immersed in buffer solutions containing varying concen-
trations of trypsin (1–100 nM) and the electrochemical signal
was interrogated by SWV with time. The addition of trypsin
caused the expected decrease in signal for the macroelectrode
(Fig. 3A), with the initial rate of % signal change observed to
be proportional to the trypsin concentration (Fig. 3B). Given
that this system has been shown to follow Langmuir kinetics,20
this is to be expected at these relatively low concentrations of
trypsin compared to the Michaelis constant, where the pro-
portion of surface covered by the trypsin–protein complex is
expected to be low and proportional to the concentration of
trypsin and the resulting rate of proteolytic cleavage is deter-
mined by this. As predicted by the method developed in pre-
vious work,23 the natural logarithm of A(t ), the percentage of
signal left to change at time t, calculated as A(t ) = [((% signal
change at t ) − (% signal change as t → ∞))/((% signal change
at t = 0) − (% signal change as t → ∞ and for the highest
trypsin concentration, as [E] → ∞))] × 100%, is proportional to
the trypsin concentration, [E] (Fig. 3B inset), which confirms
that the response is first order with respect to [E].
An equivalent proteolytic trypsin cleavage behaviour was
also recorded when using microelectrodes (Fig. 4A and B and
inset), also indicating a first order cleavage process, but it is
interesting that the corresponding cleavage rates were signifi-
cantly slower at the same trypsin concentration when using
microelectrodes compared to macroelectrodes.
Microelectrodes have been reported many times to show
enhanced diffusional kinetics due to hemispherical diffusion
compared to the linear diffusion observed for macroelec-
trodes.33 Therefore, it is clear from these observed cleavage
rates that this difference in the rate of proteolytic cleavage is
not as a result of the rate of trypsin diffusion. Given that the
rate must therefore be determined by surface reactions, it is
likely that this difference results from the macro- and micro-
electrode surfaces having a different SAM structure and/or
probe or target surface disposition. It was previously noted
that macro- and microelectrodes might differ from each other
regarding the deposition and disposition of SAMs on their
surfaces, which could affect the resulting properties such as
electron transfer.34 Although the trypsin cleavage reaction is
not under diffusional control, such distinctions could arise
from the differences in diffusional rates during SAM film for-
mation and/or the differences in the uniformity of diffusion
to macro and microelectrode surfaces when under diffusional
control. A difference in the observed initial SWV peak poten-
tials for macro and microelectrodes of around 70 mV sup-
ports a dissimilarity in the average redox environment and
overall film structure. It is interesting that higher error bars
were obtained for the data sets recorded for the macroelec-
trodes compared to the microelectrodes, reflected by the
errors in the linear fit data (Fig. 3 and 4 insets). This suggests
a more reproducible microelectrode film structure and result-
ing cleavage rate.
Using the observed and expected linear dependency of
ln A(t ) to concentration (Fig. 3 and 4 insets), the limit of detec-
tion (LOD) for [E] was estimated for each electrode type to be
equivalent at 2.5 nM for the macroelectrode and 2.9 nM for
the microelectrode with a linear dependency for sensing up to
25 nM. The calculated linear response range and LOD success-
fully completely cover the clinically relevant range for trypsin
levels in, for example, normal patients (11 ± 4 nM), and par-
tially cover that for chronic renal failure (47 ± 25 nM) and
chronic pancreatitis conditions (60 ± 27 nM).35,36
Fig. 3 (A) Typical background-subtracted SWV curves for a SAM-func-
tionalised probe substrate macroelectrode recorded for 100 nM trypsin
at different incubation times between 0 and 60 min (with intervals of
5 min) in 1× PBS. (B) Plot of % signal decrease vs. time for SAM-functio-
nalised probe macroelectrodes immersed in varying trypsin concen-
trations in PBS (0, 1, 5, 10, 25, 50, 100 nM for the substrate probe and
100 nM for the negative control probe, containing D-amino acids). All
data represent the average (and standard deviations) from (typically) 3
functionalised electrodes. Inset: Natural logarithm of the adjusted
signal, A(%), after 92 min, plotted against the concentration of trypsin.
The straight line corresponds to the best linear regression fit (ln A =
−0.075 [trypsin]/nM + 4.498; r2 = 0.96). The point of [trypsin] = 50 nM
was not included in the fit due to having large replicate errors compared
to the other concentrations.
Fig. 4 (A) Typical background-subtracted SWV curves recorded for a
SAM-functionalised microelectrode and 100 nM trypsin at different
incubation times between 0 and 900 min (with intervals of 60 min) in 1×
PBS. (B) Plot of % signal decrease vs. time for SAM-functionalised micro-
electrodes immersed in varying trypsin concentrations in 1× PBS (0, 1, 5,
10, 25, 50, 100 nM for the probe substrate and 100 nM for the negative
control probe, containing D-amino acids). All data represent the average
(and standard deviations) from (typically) 3 functionalised electrodes.
Inset: Natural logarithm of A(%), after 900 min, plotted against the con-
centration of trypsin. The straight line corresponds to the best linear
regression fit (ln A = −0.030 [trypsin/nM] + 4.354; r2 = 0.84). The point
of [trypsin] = 50 nM was not included again in the fit due to having large
replicate errors compared to the other concentrations.
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Kinetic analysis of proteolytic cleavage
Although single time point analysis and linear calibration is a
simple method, this does not apply across the entire clinically
relevant range for all conditions and time-dependent analysis
of multiple data points is likely to be more robust and sensi-
tive. When combined with Michaelis–Menten kinetic analysis,
which models the non-linearity of trypsin binding and the
resulting response with [E], analysis should be possible over a
wider range of trypsin concentration. The measured % signal
changes for varying trypsin concentrations were therefore ana-
lysed as a function of time using the previously established
Michaelis–Menten kinetic model.20 According to this model,
the % signal change, A, is expressed as a variation in the frac-
tion (θ(t ) = 1 − A(t )) of the cleavable peptide which has been
cleaved at any time, t. Data for each trypsin concentration are
then fitted to the equation:
θ ¼ 1 ekeff t ð1Þ
Although good fits were obtained to this equation for the Pt
macroelectrode system, consistent with our previous obser-
vations on gold macroelectrodes, this was not the case for the
Pt microelectrode system. Inspection of Fig. 4 indicates that
this is likely due to an increase in the fraction of the cleavable
probe with increasing [E], as shown by the increasing
maximum % signal change as t → ∞. All data were therefore
fitted to eqn (2), which includes the additional concentration-
dependent variable, a, which is the fraction of the cleavable
peptide that can be cleaved at each trypsin concentration, [E],
(with a → 1 and eqn (2) → eqn (1) as [E] → ∞ and at all [E] for
macroelectrodes):
θ ¼ a½1 ekeff t ð2Þ
This simple equation was shown to fit well to all data and
generally enabled the extraction of both a and keff (effective
rate constant) values for each trypsin concentration (both
Fig. 5, for which a = 1 and eqn (2) collapses to eqn (1), and
Fig. 6). The only exception was for the lowest [E] in Fig. 6,
where over this measurement time range the product kefft was
sufficiently small for eqn (2) to become effectively linear and
only a combined constant akeff could be determined.
For the estimation of kcat (enzyme turn-over number) and
KM (Michaelis–Menten binding constant) values, these
extracted keff values were plotted as a function of trypsin con-
centration (Fig. 5B and 6B) and fitted to the Michaelis–Menten
enzyme cleavage model using the equation:
keff ¼ kcat=ð1þ KM=½EÞ ð3Þ
This non-linear fitting enabled us to estimate the values of
kcat and KM as 0.035 min
−1 and 19 ± 3 nM for macroelectrodes
and, 0.0075 min−1 and 15 ± 3 nM for microelectrodes,
respectively.
These calculated KM values are comparable to each other
and also to previously reported values by Anne et al. (∼17 nM)
and also to our previous work on gold macroelectrodes (28 ± 3
nM).13,20 These comparable KM values suggest that there is
little difference between the thermodynamics of the trypsin
binding to the probe substrate to form the enzyme–substrate
complex in all cases. However, the markedly lower kcat value
indicates that it is the significantly lower kinetics of the reac-
tion of this enzyme–substrate complex on the SAM-functiona-
lised microelectrodes which gives rise to the markedly lower
cleavage rates. This indicates that the catalytic efficiency (kcat/
KM) of the enzyme is lower for this surface, and that although
absolute and relative enzyme–substrate association and dis-
sociation rates appear similar (which given the size and mul-
tiple interactions of the enzyme with the surface is likely to be
reflective of more general enzyme-SAM surface association and
dissociation) the trypsin–substrate complex cleavage rates are
different (which are likely to reflect variations in probe acces-
sibility). Therefore, the rationale for slower proteolytic cleavage
observed is lower probe accessibility to the enzyme active site
on the SAM microelectrode surface, which would result in
lower probe reactivity. It is possible that this (and the fact that
Fig. 5 (A) Calculated fractional cleavage, θ, vs. time plots for data for
macroelectrode cleavage data from Fig. 3. The data points (from bottom
to top) correspond to immersion in varying trypsin concentrations in 1×
PBS (namely 1, 5, 10, 25, 50 and 100 nM), whilst each line shows the best
fit to eqn (1). (B) Effective rate constant, keff, as a function of the bulk
trypsin solution concentration. Data represented by dots correspond to
the experimental data obtained from the fits to the data in (a) and the
solid red line shows the fitting processed according to eqn (3).
Fig. 6 (A) Calculated fractional cleavage, θ, vs. time plots for data for
microelectrode cleavage data from Fig. 4. The data points (from bottom
to top) correspond to immersion in varying trypsin concentrations in 1×
PBS (namely 1, 5, 10, 25, 50 and 100 nM), whilst each line shows the best
fit to eqn (2) from which values of a = 0.39, 0.39, 0.58, 0.59, 0.76 and
0.98 respectively have been obtained. (B) Effective rate constant, keff, as
a function of the bulk trypsin solution concentration. Data represented
by dots correspond to the experimental data obtained from the fits to
the data in (a) and the solid red line shows the best iterative fit to eqn (3).
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a < 1 in eqn (2) for microelectrodes) is due to the relative inac-
cessibility of the enhanced proportion of the probe nearer to
the electrode edge, due to the dramatic increase in the amount
and importance of edge per unit area on decreasing from the
macro to the microelectrode dimension. This is in addition to
the uncleavable subset of the immobilised peptides at all [E]
for both electrode types, previously attributed to electrode
roughness and probe orientation variation as the sources of
local site inaccessibility.21,23
It is clear that this analysis method has now extended the
trypsin measurement range to 100 nM, covering the clinically
relevant range even for chronic pancreatitis conditions (60 ±
27 nM).
Characterisation of selectivity for the microelectrodes
In order to assess the selectivity of the miniaturised trypsin
sensor, the modified microelectrodes were exposed to solu-
tions containing BSA and casein, as models for evaluating the
potential for interference in real-world samples arising from
non-specific binding of proteins. Fig. 7 shows the % signal
decrease of both the substrate (orange) and the control (cyan)
SAM structures upon the addition either of the non-specific
proteins or the target enzyme trypsin. Although there was a
significant amount of signal decrease recorded for both casein
and BSA at these very long measurement times, no statistically
significant difference between the substrate and control probe
responses was observed, which confirms that the signal
decrease in both cases was due to non-specific binding occur-
ring presumably due to the consequent reduction in probe
flexibility that hinders the redox tag–electrode interaction and
therefore, the redox activity. This is in contrast to the
maximum signal decrease of ∼80% recorded for substrate-
modified surfaces upon the addition of trypsin, which was
markedly and statistically different to the relatively small
response of the control-modified probe surface. This clear
difference highlights that the proposed microelectrode-based
sensing system is highly selective towards trypsin, and that a
combination of substrate and control measurement offers
potential for direct measurements in real-world samples con-
taining proteins.
Effect of temperature on microelectrode-based proteolytic
cleavage
It is known that temperature has an important role in the func-
tional activity characteristics of most enzymes.37 Therefore, the
kinetics of proteolytic trypsin cleavage was determined on the
microelectrode-based sensor not only at room temperature
(25 °C) but also at the clinically relevant normal body tempera-
ture (37 °C). Fig. 8A shows the comparative signal decrease
recorded for both control- and substrate-modified microelec-
trodes at these temperatures with time. For both temperature
cases, it is clearly seen that the signal decrease for the trypsin-
cleavable substrate-modified electrodes is higher than the
control-modified electrodes, which again demonstrates the
trypsin selectivity of the sensor. A higher rate of signal
decrease (∼30% after 200 min) was observed for the control-
modified surfaces at 37 °C, compared to that (∼10% after
200 min) recorded at 25 °C, which is indicative of an enhanced
detachment and loss of the probe from the surface at these
elevated temperatures. The fact that this is an additional and
parallel process also present in the substrate-modified surfaces
which, like trypsin cleavage, results in probe signal loss is
shown by subtracting the time dependent control-modified
electrode response from that of the substrate-modified elec-
trode. This was then converted to fractional cleavage, θ and
A(t ) following the same process as detailed before, but in this
case this was normalised to the signal for these data as t → ∞
at this value of [E] (Fig. 8B). This shows the expected character-
istic change in signal with time due only to probe loss arising
from trypsin cleavage, as shown by the good fit to eqn (2)
(which is equivalent to eqn (1), as this normalisation by defi-
nition fixes a as 1 in eqn (2)) (Fig. 8B). This fit gives keff = 0.082
± 0.004 min−1 at 37 °C, which is around four-times larger than
the 0.021 ± 0.002 min−1 obtained at 25 °C. This enhancement
in kinetics is consistent with the previously reported work,38
Fig. 7 Comparative % signal decrease recorded for SAM-functionalised
microelectrodes after 900 minutes upon the addition of 100 nM trypsin
or non-specific binding proteins; casein and BSA for both substrate-
(orange) and control-modified (cyan) sensing layers. Average data and
error bars are typically from 3 individual SAM sensing layers.
Fig. 8 (A) Comparative signal decrease vs. time curves recorded for the
miniaturised sensor upon the addition of 100 nM trypsin in 1× PBS at
25 °C (pink) and 37 °C (black) for both control- (triangle) and substrate-
modified (circle) microelectrodes. (B) Calculated fractional cleavage, θ,
vs. time plots for control-subtracted substrate data from (A). The data
points correspond to temperatures of 25 °C (pink) and 37 °C (black)
whilst the green dotted lines show the best iterative fits to eqn (1) with
keff = 0.021 ± 0.002 min
−1 and 0.082 ± 0.004 min−1 respectively.
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which suggests an activation energy of around 90 kJ mol−1 and
indicates the potential for markedly faster trypsin measure-
ment in vivo on implanted microelectrodes. It is also worth
noting that the undesirable need for control data subtraction
arising from the significant parallel probe loss at normal body
temperature could be addressed by use of a stronger tri-
branched thiol anchor as previously demonstrated on a simi-
larly functionalised electrode surface.39
Characterisation of sensor storage stability
It is widely accepted that the storage stability is quite signifi-
cant for SAM-based biosensors and much effort is being
devoted in the literature to enhancing this storage lifetime.40
Therefore, Pt macro- and microelectrodes were modified with
the probe as detailed above and their storage stability at 4 °C
was investigated by monitoring their SWV signal over one week
period. Fig. 9 shows that the macroelectrodes showed a higher
rate of decrease in signal (∼40%) than the microelectrodes
(∼20%) over this period. This amount of decrease observed in
the Pt macroelectrodes was also consistent with the previous
work,39 where the storage stability of Au macroelectrodes was
assessed for 30 days, confirming that Au or Pt macroelectrode
surfaces do not differ significantly in this respect.
Additionally, there is some evidence that the drop in the signal
on microelectrodes occurs within one day, with little evidence
of a statistically significant decrease after this. Again, there is
also more variation between individual electrodes in the macro-
electrode set, compared to the microelectrode set. This supports
the suggestion that more reproducible as well as durable SAM
probes are formed on these miniaturised electrodes.
Conclusions
This paper presents results which demonstrate the successful
development of a peptide-based electrochemical microelec-
trode biosensor system for protease detection. Using a pre-
viously developed detection mechanism based on the signal
change due to the proteolytic cleavage by trypsin of a SAM-
immobilised peptide sequence resulting in the loss of the
redox tag, the performance of this miniaturised electrode in
terms of trypsin detection was assessed and compared to the
results of previously reported (gold) and new (platinum)
macroelectrodes. These comparisons demonstrated the feasi-
bility of using microelectrodes, with comparable analytical per-
formance being observed in terms of target binding and speci-
ficity, and with enhanced reproducibility of the response
between electrodes, which we attribute to the enhanced repro-
ducibility of SAM film formation and the resulting structure.
We have also shown insensitivity to the non-specific adsorp-
tion of proteins through comparison of the responses of
control and substrate systems, showing its potential for
measurement in natural biological media. This system was
also shown to give a quantitative response across a measured
concentration range which encompassed the clinically relevant
concentration range for trypsin detection for normal and dis-
eased states, and fits well to a Michaelis–Menten surface clea-
vage model, which enabled the estimation of kcat and KM
values and the ready extraction of trypsin concentration from
measured signals. Some interesting differences were also
observed between the microelectrode and macroelectrode
systems, attributed to the differences in the SAM film struc-
ture. First the reproducibility of response was enhanced on
microelectrodes, indicating less variability in SAM formation
and structure. It is to be recognised that analysis of additional
microelectrode data collected across this concentration range
should further increase the accuracy of modelling and concen-
tration determination. Secondly the overall cleavage rate was
seen to be markedly slower at room temperature on microelec-
trodes, as a result of a slower trypsin-substrate cleavage rate.
Although this was significantly increased at normal body
temperature, reducing required measurement times, future
work will focus on minimising response times and translating
these findings to electrode-on-silicon chip technologies.
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